Form 8-K
8-K — Polar Power, Inc.
Accession: 0001493152-26-034878
Filed: 2026-07-28
Period: 2026-07-27
CIK: 0001622345
SIC: 3690 (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES)
Item: Entry into a Material Definitive Agreement
Item: Unregistered Sales of Equity Securities
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — form8-k.htm (Primary)
EX-10.1 (ex10-1.htm)
EX-10.2 (ex10-2.htm)
EX-99.1 (ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: form8-k.htm · Sequence: 1
false
0001622345
0001622345
2026-07-27
2026-07-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event Reported): July 27, 2026
Polar
Power, Inc.
(Exact
Name of Registrant as Specified in Charter)
001-37960
(Commission
File Number)
Delaware
33-0479020
(State
or Other Jurisdiction
of
Incorporation)
(I.R.S.
Employer
Identification
Number)
249
East Gardena Boulevard
Gardena,
CA 90248
(Address
of principal executive offices, with zip code)
(310)
830-9153
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common Stock, par value
$0.0001 per share
POLA
The Nasdaq Stock Market
LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
On
July 27, 2026, Polar Power, Inc. (the “Company”) entered into a Common Stock Purchase Agreement (the “Purchase
Agreement”) and a related Registration Rights Agreement (the “Registration Rights Agreement”), with Roth Principal
Investments, LLC (“Roth Principal Investments”). Upon the terms and subject to the satisfaction of the conditions set forth
in the Purchase Agreement, the Company will have the right, in its sole discretion, to sell to Roth Principal Investments up to $25,000,000
of newly issued shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), subject to
certain conditions and limitations contained in the Purchase Agreement, from time to time during the term of the Purchase Agreement.
Sales of Common Stock pursuant to the Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the
Company is under no obligation to sell any securities to Roth Principal Investments under the Purchase Agreement.
Upon
the initial satisfaction of each of the conditions to Roth Principal Investments’ purchase obligation set forth in the Purchase
Agreement (the initial satisfaction of such conditions, the “Commencement”, and the date on which the Commencement occurs,
the “Commencement Date”), including that a registration statement registering under the Securities Act of 1933, as amended
(the “Securities Act”), the resale by Roth Principal Investments of shares of Common Stock issued to it by the Company under
the Purchase Agreement, which the Company agreed to file with the Securities and Exchange Commission (the “SEC”) pursuant
to the Registration Rights Agreement (the “Registration Statement”), is declared effective by the SEC, the Company will have
the right, but not the obligation, from time to time in its sole discretion for a period of up to 36 months beginning on the Commencement
Date, to direct Roth Principal Investments to purchase up to a specified maximum amount of shares of Common Stock, in one or more Market
Open Purchases, Intraday Purchases, Pre-Market Purchases and/or Post-Market Purchases (each, as defined below, and together, “Purchases”),
by timely delivering written notice to Roth Principal Investments for each such Purchase in accordance with the Purchase Agreement on
any trading day selected by the Company as the purchase date therefor (the “Purchase Date”), so long as (i) the closing sale
price of Common Stock on the trading day immediately prior to such Purchase Date is not less than a specified threshold price as set
forth in the Purchase Agreement (the “Threshold Price”) and (ii) all shares of Common Stock subject to all prior Purchases
effected by the Company under the Purchase Agreement, including all prior Purchases effected on the same Purchase Date, have been received
by Roth Principal Investments at such time and in the manner set forth in the Purchase Agreement.
The
purchase price of the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Purchase pursuant to
a timely delivered written notice in accordance with the Purchase Agreement after 7:30 a.m., New York City time and prior to 9:00 a.m.
New York City time on the Purchase Date (a “Market Open Purchase”) will be determined by reference to the volume weighted
average price of the Common Stock (“VWAP”) during the period (the “Market Open Purchase Valuation Period”) beginning
at the official open (or “commencement”) of the regular trading session on The Nasdaq Capital Market on the applicable Purchase
Date and ending at the earliest to occur of (i) such time of official close of the regular trading session, (ii) such time during such
regular trading hour period, the trading volume threshold calculated in accordance with the Purchase Agreement is reached, and (iii)
if the Company further specifies in the applicable purchase notice for such Market Open Purchase that a “limit order discontinue
election” shall apply to such Market Open Purchase, such time the trading price of the Common Stock on The Nasdaq Capital Market
during such Market Open Purchase Valuation Period falls below the applicable minimum price threshold determined in accordance with the
Purchase Agreement, less a fixed 3.0% discount to the VWAP for such Market Open Purchase Valuation Period.
In
addition to the Market Open Purchases described above, after the Commencement, the Company will also have the right, but not the obligation
(subject to the continued satisfaction of the purchase conditions contained in the Purchase Agreement), to direct Roth Principal Investments
to purchase, on any trading day that would qualify as a Purchase Date on which the Company may elect to effect a Market Open Purchase,
whether or not a Market Open Purchase is effected by the Company on such trading day, a specified number of shares of Common Stock, not
to exceed certain limitations set forth in the Purchase Agreement that are similar to those applicable to Market Open Purchases (each,
an “Intraday Purchase”), by timely delivering an irrevocable written notice of such Intraday Purchase to Roth Principal Investments
after 10:00 a.m., New York City time (and after the Market Open Purchase Valuation Period for any earlier Market Open Purchase and the
Intraday Purchase Valuation Period (defined below) for the most recent prior Intraday Purchase effected on the same Purchase Date, if
applicable, have ended), and prior to 2:00 p.m., New York City time, on such Purchase Date (each, an “Intraday Purchase Notice”).
The
per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in an Intraday
Purchase pursuant to the Purchase Agreement, if any, will be calculated in the same manner as in the case of a Market Open Purchase (including
the same fixed 3.0% discount to the applicable VWAP used to calculate the per share purchase price for a Market Open Purchase, as described
above), provided that the VWAP for each Intraday Purchase effected on a Purchase Date will be calculated over different purchase valuation
periods during the regular trading session on The Nasdaq Capital Market on such Purchase Date than the Market Open Purchase Valuation
Period applicable to a Market Open Purchase effected on such Purchase Date (if any), each of which will commence and end at different
times on such Purchase Date and will not overlap with any other purchase valuation period on such Purchase Date (each, an “Intraday
Purchase Valuation Period”).
In
addition to the Market Open Purchases and Intraday Purchases described above, after the Commencement, the Company will also have the
right, but not the obligation (subject to the continued satisfaction of the purchase conditions contained in the Purchase Agreement),
to direct Roth Principal Investments to purchase, on any trading day that would qualify as a Purchase Date on which the Company may elect
to effect a Market Open Purchase, whether or not a Market Open Purchase is effected by the Company on such trading day, a specified number
of shares of Common Stock, not to exceed certain limitations set forth in the Purchase Agreement (each, a “Pre-Market Purchase”),
by timely delivering an irrevocable written notice of such Pre-Market Purchase to Roth Principal Investments after 7:00 a.m., New York
City time, and prior to 8:30 a.m., New York City time, on such Purchase Date (each, a “Pre-Market Purchase Notice”).
The
per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Pre-Market
Purchase pursuant to the Purchase Agreement, if any, will be determined by reference to the VWAP of the Common Stock over a purchase
valuation period to be calculated in accordance with the Purchase Agreement, which period will not overlap with the valuation period
for any other Purchase effected on the same Purchase Date, less a fixed 6.0% discount to such VWAP (such period, a “Pre-Market
Purchase Valuation Period”).
In
addition to the Market Open Purchases, Intraday Purchases and Pre-Market Purchases described above, after the Commencement, the Company
will also have the right, but not the obligation (subject to the continued satisfaction of the purchase conditions contained in the Purchase
Agreement), to direct Roth Principal Investments to purchase, on any trading day that would qualify as a Purchase Date on which the Company
may elect to effect a Market Open Purchase, whether or not a Market Open Purchase is effected by the Company on such trading day, a specified
number of shares of Common Stock, not to exceed certain limitations set forth in the Purchase Agreement (each, a “Post-Market Purchase”),
by timely delivering an irrevocable written notice of such Post-Market Purchase to Roth Principal Investments after 4:05 p.m., New York
City time, and prior to 5:00 p.m., New York City time, on such Purchase Date (each, a “Post-Market Purchase Notice”).
The
per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Post-Market
Purchase pursuant to the Purchase Agreement, if any, will be determined by reference to the VWAP over a purchase valuation period to
be calculated in accordance with the Purchase Agreement, which period will not overlap with the valuation period for any other Purchase
effected on the same Purchase Date, less a fixed 6.0% discount to such VWAP (such period, a “Post-Market Purchase Valuation Period,”
and together with the Market Open Purchase Valuation Period, Intraday Purchase Valuation Period and Pre-Market Purchase Valuation Period,
the “Valuation Period”).
There
is no upper limit on the price per share that Roth Principal Investments could be obligated to pay for Common Stock the Company may elect
to sell to it in any Purchase under the Purchase Agreement. The purchase price per share of Common Stock that the Company may elect to
sell to Roth Principal Investments in a Purchase under the Purchase Agreement will be equitably adjusted for any reorganization, recapitalization,
non-cash dividend, stock split, reverse stock split or other similar transaction occurring during the applicable Valuation Period for
such Purchase.
The
Company will control the timing and amount of any sales of Common Stock to Roth Principal Investments that it may elect, in its sole
discretion, to effect from time to time from and after the Commencement Date and during the term of the Purchase Agreement. Actual sales
of shares of Common Stock to Roth Principal Investments under the Purchase Agreement will depend on a variety of factors to be determined
by the Company from time to time, including, among other things, market conditions, the trading price of the Common Stock and determinations
by the Company as to the appropriate sources of funding for the Company and its operations.
Under
the applicable Nasdaq rules, in no event may the Company issue to Roth Principal Investments under the Purchase Agreement more than
769,952 shares of Common Stock, which number of shares is equal to 19.99% of the shares of Common Stock issued and outstanding immediately
prior to the execution of the Purchase Agreement (the “Exchange Cap”), unless (i) the Company obtains stockholder approval
to issue shares of Common Stock in excess of the Exchange Cap in accordance with applicable Nasdaq rules, or (ii) the average price per
share paid by Roth Principal Investments for all of the shares of Common Stock that the Company directs Roth Principal Investments to
purchase from the Company pursuant to the Purchase Agreement, if any, equals or exceeds $[2.0994] (representing the sum of (i)
$[0.6494] and (ii) the lower of (a) the official closing price of the Common Stock on Nasdaq immediately preceding the execution
of the Purchase Agreement and (b) the average official closing price of the Common Stock on Nasdaq for the five consecutive trading days
immediately preceding the execution of the Purchase Agreement, as adjusted in accordance with applicable Nasdaq rules), so that the Exchange
Cap limitation will not apply to issuances and sales of Common Stock pursuant to the Purchase Agreement.
In
addition, the Company may not issue or sell any shares of Common Stock to Roth Principal Investments under the Purchase Agreement which,
when aggregated with all other shares of Common Stock then beneficially owned by Roth Principal Investments and its affiliates (as calculated
pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 13d-3 thereunder),
would result in Roth Principal Investments beneficially owning more than 4.99% of the outstanding shares of Common Stock.
The
net proceeds from sales of Common Stock by the Company to Roth Principal Investments under the Purchase Agreement, if any, will depend
on the frequency and prices at which the Company sells shares of Common Stock to Roth Principal Investments under the Purchase Agreement.
To the extent the Company elects to sell shares of Common Stock to Roth Principal Investments under the Purchase Agreement from and after
the Commencement Date, the Company currently plans to use any net proceeds therefrom for working capital and general corporate purposes,
including its DC power systems and power generation business.
There
are no restrictions on future financings, rights of first refusal, participation rights, penalties or liquidated damages in the Purchase
Agreement or Registration Rights Agreement, other than a prohibition (with certain limited exceptions) on entering into specified “Variable
Rate Transactions” (as such term is defined in the Purchase Agreement) during the term of the Purchase Agreement. Such transactions
include, among others, the issuance of convertible securities with a conversion or exercise price that is based upon or varies with the
trading price of the Common Stock after the date of issuance, or the Company effecting or entering into an agreement to effect an “equity
line of credit” or other substantially similar continuous offering with a third party, in which the Company may offer, issue or
sell Common Stock or any securities exercisable, exchangeable or convertible into Common Stock at a future determined price. The foregoing
restriction is subject to certain limited exceptions set forth in the Purchase Agreement, including continued sales under the Company’s
existing at-the-market offering program, subject to the limitations set forth therein.
In
addition, the Company has agreed, subject to limited exceptions (including continued sales under the ATM facility described above), that
from the date of the Purchase Agreement through the effective date of the Registration Statement, it will not, without the prior written
consent of Roth Principal Investments, offer, sell or otherwise dispose of any shares of Common Stock or any securities convertible into
or exchangeable for Common Stock. Roth Principal Investments may, in its sole discretion, release all or any portion of the securities
subject to this restriction at any time.
Roth
Principal Investments has agreed that during the term of the Purchase Agreement, none of Roth Principal Investments, any of its officers,
or any entity managed or controlled by Roth Principal Investments, will enter into or effect, directly or indirectly, either for Roth
Principal Investments’ own principal account or for the principal account of any such entity managed or controlled by Roth Principal
Investments, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or any hedging
transaction, which establishes a net short position with respect to the Common Stock.
The
Purchase Agreement and the Registration Rights Agreement contain customary representations, warranties, conditions and indemnification
obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for the purposes
of such agreements, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the
contracting parties.
The
Purchase Agreement will automatically terminate on the earliest to occur of (i) the first day of the month following the 36-month anniversary
of the Commencement Date, (ii) the date on which Roth Principal Investments shall have purchased from the Company under the Purchase
Agreement shares of Common Stock for an aggregate gross purchase price of $25,000,000, (iii) the date on which the Common Stock shall
have failed to be listed or quoted on Nasdaq or another U.S. national securities exchange identified as an “eligible market”
in the Purchase Agreement for a period of one trading day, (iv) the 30th trading day after the date on which a voluntary or involuntary
bankruptcy proceeding involving the Company has been commenced that is not discharged or dismissed prior to such 30th trading day, and
(v) the date on which a bankruptcy custodian is appointed for all or substantially all of the Company’s property or the Company
makes a general assignment for the benefit of its creditors.
As
consideration for Roth Principal Investments’ commitment to purchase shares of Common Stock at the Company’s direction upon
the terms and subject to the conditions set forth in the Purchase Agreement, the Company agreed to pay to Roth Principal Investments
a cash commitment fee of $500,000 (the “Commitment Fee”), which is equal to 2.0% of Roth Principal Investments’ $25,000,000
total aggregate dollar amount purchase commitment under the Purchase Agreement. The $500,000 Commitment Fee will be paid over time by
Roth Principal Investments withholding cash amounts equal to 10% of the total aggregate purchase price payable by Roth Principal Investments
to the Company in connection with each Purchase of shares of Common Stock effected under the Purchase Agreement, until such time as Roth
Principal Investments shall have received from such cash withholdings a total aggregate amount in cash equal to $500,000, representing
the entire Commitment Fee payable to Roth Principal Investments pursuant to the Purchase Agreement.
In
addition, the Company agreed to reimburse Roth Principal Investments for the reasonable legal fees and disbursements of Roth Principal
Investments’ legal counsel in connection with the transactions contemplated by the Purchase Agreement and the Registration Rights
Agreement in an amount equal to $100,000, payable upon execution of the Purchase Agreement and Registration Rights Agreement. The Company
also agreed to reimburse Roth Principal Investments up to $7,500 per fiscal quarter for the reasonable legal fees and disbursements of
Roth Principal Investments’ legal counsel in connection with quarterly and annual bring-down due diligence investigations and related
matters as contemplated by the Purchase Agreement.
The
Company has the right to terminate the Purchase Agreement at any time after Commencement upon 5 trading days’ prior written notice
to Roth Principal Investments. The Company will not incur any termination penalty, except that if the Company terminates the Purchase
Agreement within 90 days following the effective date of the Registration Statement, the Company will be obligated to pay Roth Principal
Investments, in cash within 3 business days of such termination, the amount, if any, by which $500,000 exceeds the aggregate amount of
the Commitment Fee previously withheld by Roth Principal Investments from the purchase prices paid for shares of Common Stock. The Company’s
right to terminate is also subject to its having paid all Commitment Fee amounts and legal fee reimbursements then required to be paid
to Roth Principal Investments. The Company and Roth Principal Investments may also agree to terminate the Purchase Agreement by mutual
written consent, provided that no termination of the Purchase Agreement will be effective during the pendency of any Purchase that has
not then fully settled in accordance with the Purchase Agreement. Neither the Company nor Roth Principal Investments may assign or transfer
any of their respective rights or obligations under the Purchase Agreement or the Registration Rights Agreement, and no provision of
the Purchase Agreement or the Registration Rights Agreement may be modified or waived by the Company or Roth Principal Investments from
and after the date that is one trading day immediately preceding the date on which the initial Registration Statement is first filed
with the SEC.
The
Company has engaged Digital Offering, LLC, a registered broker-dealer and FINRA member (the “Qualified Independent Underwriter”),
to be the qualified independent underwriter in connection with the offering to be registered under the Registration Statement and, in
such capacity, participate in the preparation of the Registration Statement and exercise the usual standards of “due diligence”
with respect thereto, in order for such offering to be in full compliance with the applicable rules and regulations of the Financial
Industry Regulatory Authority, Inc. (“FINRA”), including FINRA Rule 5121. The Company has agreed to reimburse Roth Principal
Investments for the fees and expenses of the Qualified Independent Underwriter up to $50,000, as consideration for its services in connection
with acting as the qualified independent underwriter in the offering to be registered under the Registration Statement. The Qualified
Independent Underwriter will receive no other compensation for acting as the qualified independent underwriter in connection with such
offering.
The
foregoing descriptions of the Purchase Agreement and the Registration Rights Agreement are qualified in their entirety by reference to
the full text of such agreements, copies of which are attached hereto as Exhibit 10.1 and 10.2, respectively, and each of which is incorporated
herein in its entirety by reference.
Item
3.02 Unregistered Sales of Equity Securities.
The
information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. The shares of Common Stock that may
be issued pursuant to the Purchase Agreement will be issued without registration under the Securities Act, in reliance on the exemptions
provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering and Rule 506(b) promulgated under
the Securities Act as sales to accredited investors, and in reliance on similar exemptions under applicable state laws. This Current
Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company, nor shall
there be any sale of any securities of the Company in any state or other jurisdiction in which such an offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Item
7.01 Regulation FD Disclosure.
On
July 27, 2026, the Company issued a press release announcing the execution of the Purchase Agreement and the Registration Rights
Agreement. The press release is attached hereto and furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The
information provided in this Item 7.01, including the accompanying Exhibit 99.1, shall be deemed “furnished” and shall not
be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such section,
nor shall it be incorporated by reference in any filing made by the Company pursuant to the Securities Act, or the Exchange Act, regardless
of the general incorporation language of such filing, except as expressly set forth by specific reference in such filing.
Forward-Looking
Statements
This
Current Report on Form 8-K contains “forward-looking statements” relating to the Company’s business, including statements
related to the satisfaction of the conditions to Roth Principal Investments’ purchase obligations and the intended use of any proceeds
to the Company from the sale of shares of Common Stock pursuant to the Purchase Agreement, that are often identified using “believes”,
“expects”, or similar expressions. Forward-looking statements involve several estimates, assumptions, risks, and other uncertainties
that may cause actual results to be materially different from those anticipated, believed, estimated, expected, etc. Accordingly, forward-looking
statements are not guarantees of future results. Actual results could differ from those projected due to numerous factors and uncertainties.
Although the Company believes that the expectations, opinions, projections, and comments reflected in these forward-looking statements
are reasonable, the Company can give no assurance that such statements will prove to be correct, and that the Company’s actual
results of operations, financial condition and performance will not differ materially from the results of operations, financial
condition and performance reflected or implied by these forward-looking statements. Undue reliance should not be placed on the forward-looking
statements and investors should refer to the risk factors outlined in the “Risk Factors” section of the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2025 and the Company’s subsequent filings with the SEC. These forward-looking
statements are made as of the date hereof, and the Company assumes no obligation to update these statements or the reasons why actual
results could differ from those projected, except as required by law.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No.
Description
10.1*
Common
Stock Purchase Agreement, dated as of July 27, 2026, by and between Polar Power, Inc. and Roth Principal Investments, LLC
10.2*
Registration
Rights Agreement, dated as of July 27, 2026, by and between Polar Power, Inc. and Roth Principal Investments, LLC
99.1
Press
Release, dated July 27, 2026
104
The
cover page of this Current Report on Form 8-K formatted in Inline XBRL
*
Certain schedules, exhibits
and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish
copies of such omitted materials supplementally upon request by the SEC.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
POLAR POWER, INC.
Date:
July 27, 2026
By:
/s/ Arthur D. Sams
Arthur D. Sams
President and Chief Executive Officer
EX-10.1
EX-10.1
Filename: ex10-1.htm · Sequence: 2
Exhibit 10.1
COMMON
STOCK PURCHASE AGREEMENT
Dated
as of July 27, 2026
by
and between
POLAR
POWER, INC.
and
ROTH
PRINCIPAL INVESTMENTS, LLC
Table
of Contents
Page
Article I DEFINITIONS
1
Article II PURCHASE AND SALE OF COMMON STOCK
2
Section
2.1.
Purchase
and Sale of Stock
2
Section
2.2.
Closing
Date; Settlement Dates
2
Section
2.3.
Initial
Public Announcements and Required Filings
2
Article III PURCHASE TERMS
3
Section
3.1.
Market
Open Purchases
3
Section
3.2.
Intraday
Purchases
4
Section
3.3
Extended
Hours Purchases
5
Section
3.4.
Settlement
7
Section
3.5.
Compliance
with Rules of Trading Market.
8
Section
3.6.
Beneficial
Ownership Limitation
9
Article IV REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR
9
Section
4.1.
Organization
and Standing of the Investor
9
Section
4.2.
Authorization
and Power
10
Section
4.3.
No
Conflicts
10
Section
4.4.
Investment
Purpose
10
Section
4.5.
Accredited
Investor Status
11
Section
4.6.
Reliance
on Exemptions
11
Section
4.7.
Information
11
Section
4.8.
No
Governmental Review
11
Section
4.9.
No
General Solicitation
12
Section
4.10.
Not
an Affiliate
12
Section
4.11.
No
Prior Short Sales
12
Section
4.12.
Statutory
Underwriter Status
12
Section
4.13.
Resales
of Shares
12
Article V REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY
13
Section
5.1.
Organization,
Good Standing and Power
13
Section
5.2.
Authorization,
Enforcement
13
Section
5.3.
Capitalization
13
Section
5.4.
Payment
of Commitment Fee; Issuance of Shares
14
Section
5.5.
No
Conflicts
14
Section
5.6.
Commission
Documents, Financial Statements; Disclosure Controls and Procedures; Internal Controls Over Financial Reporting; Accountants
15
Section
5.7.
Subsidiaries
17
Section
5.8.
No
Material Adverse Effect or Material Change
18
Section
5.9.
No
Undisclosed Liabilities
18
Section
5.10.
No
Material Defaults on Indebtedness
18
Section
5.11.
Solvency
19
Section
5.12.
Title
to Real and Personal Property
19
Section
5.13.
Litigation
19
Section
5.14.
Compliance
with Applicable Laws
19
Section
5.15.
Certain
Fees
20
Section
5.16.
Disclosure
20
Section
5.17.
Material
Permits
21
Section
5.18.
Environmental
Matters
21
Section
5.19.
Intellectual
Property Rights
21
Section
5.20.
Material
Contracts
22
Section
5.21.
Transactions
With Affiliates
22
Section
5.22.
Labor
Relations
22
Section
5.23.
Use
of Proceeds
22
Section
5.24.
Investment
Company Act Status
22
Section
5.25.
Tax
Matters
23
Section
5.26.
Insurance
23
Section
5.27.
Exemption
from Registration
23
Section
5.28.
No
General Solicitation or Advertising
23
Section
5.29.
No
Integrated Offering
23
Section
5.30.
Dilutive
Effect
24
Section
5.31.
Manipulation
of Price
24
Section
5.32.
Securities
Act
24
Section
5.33.
Listing
and Maintenance Requirements; DTC Eligibility
24
Section
5.34.
Application
of Takeover Protections
25
Section
5.35.
Foreign
Corrupt Practices
25
Section
5.36.
Office
of Foreign Assets Control
25
Section
5.37.
Money
Laundering
25
Section
5.38.
ERISA
26
Section
5.39.
IT
Systems
26
Section
5.40.
Compliance
with Data Privacy Laws
27
Section
5.41.
U.S.
Real Property Holding Corporation
27
Section
5.42.
Margin
Rules
27
Section
5.43.
Smaller
Reporting Company Status
27
Section
5.44.
No
Disqualification Events
27
Section
5.45.
Market
Capitalization
28
Section
5.46.
Broker/Dealer
Relationships; FINRA Information
28
Section
5.47.
Acknowledgement
Regarding Relationship with Investor and RCP
28
Section
5.48.
Acknowledgement
Regarding Investor’s Affiliate Relationships
29
Article VI ADDITIONAL COVENANTS
29
Section
6.1.
Securities
Compliance
29
Section
6.2.
Reservation
of Common Stock
30
Section
6.3.
Registration
and Listing
30
Section
6.4.
Compliance
with Laws.
31
Section
6.5.
Keeping
of Records and Books of Account; Due Diligence.
31
Section
6.6.
No
Frustration; No Variable Rate Transactions; No Sales Prior to Effective Date.
32
Section
6.7.
Corporate
Existence
33
Section
6.8.
Fundamental
Transaction
33
Section
6.9.
Selling
Restrictions.
33
Section
6.10.
Effective
Registration Statement
34
Section
6.11.
Blue
Sky
34
Section
6.12.
Non-Public
Information
34
Section
6.13.
Broker-Dealer
34
Section
6.14.
FINRA
Filing
35
Section
6.15.
QIU
35
Section
6.16.
Disclosure
Schedule.
36
Section
6.17.
Delivery
of Compliance Certificates, Bring-Down Negative Assurance Letters and Bring-Down Comfort Letters Upon Occurrence of Certain Events
36
Article VII CONDITIONS TO CLOSING, COMMENCEMENT AND PURCHASES
37
Section
7.1.
Conditions
Precedent to Closing
37
Section
7.2.
Conditions
Precedent to Commencement
37
Section
7.3.
Conditions
Precedent to Purchases after Commencement Date
41
Article VIII TERMINATION
46
Section
8.1.
Automatic
Termination
46
Section
8.2.
Other
Termination
46
Section
8.3.
Effect
of Termination
46
Article IX INDEMNIFICATION
47
Section
9.1.
Indemnification
of Investor
47
Section
9.2.
Indemnification
Procedures
47
Article X MISCELLANEOUS
48
Section
10.1.
Certain
Fees and Expenses; Commitment Fee; Commencement Irrevocable Transfer Agent Instructions.
48
Section
10.2.
Specific
Enforcement, Consent to Jurisdiction, Waiver of Jury Trial.
50
Section
10.3.
Entire
Agreement
50
Section
10.4.
Notices
51
Section
10.5.
Waivers
52
Section
10.6.
Amendments
52
Section
10.7.
Headings
52
Section
10.8.
Construction
52
Section
10.9.
Binding
Effect
53
Section
10.10.
No
Third Party Beneficiaries
53
Section
10.11.
Governing
Law
53
Section
10.12.
Survival
53
Section
10.13.
Counterparts
53
Section
10.14.
Publicity
53
Section
10.15.
Severability
53
Section
10.16.
Further
Assurances
53
Annex I. Definitions
COMMON STOCK PURCHASE AGREEMENT
This
COMMON STOCK PURCHASE AGREEMENT is made and entered into as of July 27, 2026 (this “Agreement”),
by and between Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”), and
Polar Power, Inc., a Delaware corporation (the “Company”).
RECiTALS
WHEREAS,
the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and sell
to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to the lesser of (i) $25,000,000
in aggregate gross purchase price of newly issued shares of the Company’s common stock, par value $0.0001 per share (the “Common
Stock”), and (ii) the Exchange Cap (to the extent applicable under Section 3.5);
WHEREAS,
such sales of Common Stock by the Company to the Investor will be made in reliance upon the provisions of Section 4(a)(2) of the Securities
Act (“Section 4(a)(2)”) and Rule 506(b) of Regulation D promulgated by the Commission under the Securities
Act (“Regulation D”), and upon such other exemption from the registration requirements of the Securities Act
as may be available with respect to any or all of the sales of Common Stock to the Investor to be made hereunder;
WHEREAS,
the parties hereto are concurrently entering into a Registration Rights Agreement in the form attached as Exhibit A hereto (the
“Registration Rights Agreement”), pursuant to which the Company shall register under the Securities Act the
resale of the Registrable Securities (as defined in the Registration Rights Agreement) by the Investor, upon the terms and subject to
the conditions set forth therein;
WHEREAS,
in consideration for the Investor’s execution and delivery of this Agreement, the Company shall pay or cause to be paid to the
Investor the Commitment Fee, pursuant to, at such time(s) and in such manner as set forth in Section 10.1(ii) of this Agreement; and
WHEREAS,
the Company acknowledges that the Investor’s Affiliate, Roth Capital Partners, LLC (“RCP”), is acting
as the Investor’s representative in connection with the transactions contemplated by the Transaction Documents.
NOW,
THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows:
Article
I
DEFINITIONS
Capitalized
terms used in this Agreement shall have the meanings ascribed to such terms in Annex I hereto, and hereby made a part hereof,
or as otherwise set forth in this Agreement.
1
Article
II
PURCHASE
AND SALE OF COMMON STOCK
Section
2.1. Purchase and Sale of Stock. Upon the terms and subject to the conditions of this Agreement, during the Investment Period,
the Company, in its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor
shall purchase from the Company, up to the lesser of (i) $25,000,000 (the “Total Commitment”) in aggregate
gross purchase price of duly authorized, validly issued, fully paid and non-assessable shares of Common Stock and (ii) the Exchange Cap,
to the extent applicable under Section 3.5 (such lesser amount of shares of Common Stock, the “Aggregate Limit”),
by the delivery to the Investor of Purchase Notices as provided in Article III.
Section
2.2. Closing Date; Settlement Dates. This Agreement shall become effective and binding (the “Closing”)
upon (a) the delivery of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the
parties hereto and thereto, and (b) the delivery of all other documents, instruments and writings required to be delivered at the Closing,
in each case as provided in Section 7.1(iv), to the offices of Reed Smith LLP, at 599 Lexington Avenue, New York, NY 10022, at [●]
[a.m./p.m.], New York City time, on the Closing Date. In consideration of and in express reliance upon the representations, warranties
and covenants contained in, and upon the terms and subject to the conditions of, this Agreement, during the Investment Period, the Company,
at its sole option and discretion, may issue and sell to the Investor, and, if the Company elects to so issue and sell, the Investor
shall purchase from the Company, the Shares in respect of each Purchase. The delivery of Shares in respect of each Purchase, and the
payment for such Shares, shall occur in accordance with Section 3.4.
Section
2.3. Initial Public Announcements and Required Filings. The Company shall, not later than 9:00 a.m., New York City time, no
later than the fourth Trading Day after the date of this Agreement, file with the Commission a Current Report on Form 8-K disclosing
the execution of this Agreement and the Registration Rights Agreement by the Company and the Investor and describing the material terms
thereof, including, without limitation, the Commitment Fee payable by the Company to the Investor pursuant to Section 10.1(ii) of this
Agreement, and attaching as exhibits thereto copies of each of this Agreement and the Registration Rights Agreement and, if applicable,
any press release issued by the Company disclosing the execution of this Agreement and the Registration Rights Agreement by the Company
(including all exhibits thereto, the “Current Report”). The Company shall provide the Investor a reasonable
opportunity to comment on a draft of the Current Report prior to filing the Current Report with the Commission and shall give due consideration
to all such comments. From and after the filing of the Current Report with the Commission, the Company shall have publicly disclosed
all material, nonpublic information delivered to the Investor (or the Investor’s representatives or agents) by the Company or any
of its Subsidiaries, or any of their respective officers, directors, employees, agents or representatives (if any) in connection with
the transactions contemplated by the Transaction Documents. The Investor covenants that until such time as the transactions contemplated
by this Agreement and the Registration Rights Agreement are publicly disclosed by the Company as described in this Section 2.3, the Investor
shall maintain the confidentiality of all disclosures made to it in connection with the transactions contemplated by the Transaction
Documents (including the existence and terms of the transactions contemplated thereby), except that the Investor may disclose the terms
of such transactions to its financial, accounting, legal and other advisors (provided that the Investor directs such Persons to maintain
the confidentiality of such information). Not later than 15 calendar days following the Closing Date, the Company shall file with the
Commission a Form D with respect to the issuance and sale of the Shares in accordance with Regulation D and shall provide a copy thereof
to the Investor promptly after such filing. The Company shall use its commercially reasonable efforts to prepare and, as soon as practicable,
but in no event later than the applicable Filing Deadline, file with the Commission the Initial Registration Statement and any New Registration
Statement covering only the resale by the Investor of the Registrable Securities in accordance with the Securities Act and the Registration
Rights Agreement. At or before 8:30 a.m. (New York City time) on the Trading Day immediately following the Effective Date of the Initial
Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall file with the
Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with resales of the
Registrable Securities by the Investor pursuant to such Registration Statement (or post-effective amendment thereto).
2
Article
III
PURCHASE
TERMS
Subject
to the satisfaction of the conditions set forth in Article VII, the parties agree as follows:
Section
3.1. Market Open Purchases. Upon the initial satisfaction of all of the conditions set forth in Section 7.2 (the “Commencement”
and the date of initial satisfaction of all of such conditions, the “Commencement Date”) and from time to time
thereafter, subject to the satisfaction of all of the conditions set forth in Section 7.3, the Company shall have the right, but not
the obligation, to direct the Investor, by its timely delivery to the Investor of a Market Open Purchase Notice for a Market Open Purchase
(each, a “Market Open Purchase”), specifying in such Market Open Purchase Notice (a) the Market Open Purchase
Percentage for such Market Open Purchase and (b) whether a Limit Order Continue Election or a Limit Order Discontinue Election shall
apply to such Market Open Purchase, on the applicable Purchase Date therefor, to purchase a specified Market Open Purchase Share Amount,
which shall not exceed the applicable Market Open Purchase Maximum Amount, at the applicable Market Open Purchase Price therefor on such
Purchase Date in accordance with this Agreement. The Company may timely deliver to the Investor a Market Open Purchase Notice for a Market
Open Purchase on any Trading Day selected by the Company as the Purchase Date for such Market Open Purchase, so long as (i) the Closing
Sale Price of the Common Stock on the Trading Day immediately preceding such Purchase Date is not less than the Threshold Price, and
(ii) all Shares subject to all prior Purchases effected by the Company pursuant to this Agreement on or before the Trading Day immediately
preceding such Purchase Date (as applicable) have been timely received by the Investor as DWAC Shares on the applicable Purchase Share
Delivery Dates for such prior Purchases in accordance with Section 3.4. The Investor is obligated to accept each Market Open Purchase
Notice prepared and delivered by the Company in accordance with the terms of and subject to the satisfaction of the conditions contained
in this Agreement. If the Company delivers any Market Open Purchase Notice directing the Investor to purchase a Market Open Purchase
Share Amount in excess of the applicable Market Open Purchase Maximum Amount that the Company is then permitted to include in such Market
Open Purchase Notice (taking into account the Market Open Purchase Percentage specified by the Company in the applicable Market Open
Purchase Notice for such Market Open Purchase), such Market Open Purchase Notice shall be void ab initio to the extent of the
amount by which the Market Open Purchase Share Amount set forth in such Market Open Purchase Notice exceeds such applicable Market Open
Purchase Maximum Amount, and the Investor shall have no obligation to purchase, and shall not purchase, such excess Shares pursuant to
such Market Open Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the applicable
Market Open Purchase Maximum Amount pursuant to such Market Open Purchase. At or prior to 7:00 p.m., New York City time, on the Purchase
Date for each Market Open Purchase, the Investor shall provide to the Company, by email correspondence to each of the individual notice
recipients of the Company set forth in the applicable Market Open Purchase Notice, a written confirmation for such Market Open Purchase,
setting forth the applicable Market Open Purchase Price per Share to be paid by the Investor for the Shares purchased by the Investor
in such Market Open Purchase, and the total aggregate Market Open Purchase Price to be paid by the Investor for the total Market Open
Purchase Share Amount purchased by the Investor in such Market Open Purchase. Notwithstanding the foregoing, the Company shall not deliver
any Market Open Purchase Notices to the Investor during the PEA Period, any Allowable Grace Period, any MPA Period or at any other time
that the Company is in possession of information reasonably determined by the Company to be material non-public information regarding
the Company, its Subsidiaries or their securities.
3
Section
3.2. Intraday Purchases. Upon the initial satisfaction of all of the conditions set forth in Section 7.2 on the Commencement
Date and from time to time thereafter, subject to the satisfaction of all of the conditions set forth in Section 7.3, in addition to
Market Open Purchases as described in Section 3.1, the Company shall also have the right, but not the obligation, to direct the Investor,
by its timely delivery to the Investor of an Intraday Purchase Notice for an Intraday Purchase (each, an “Intraday Purchase”),
specifying in such Intraday Purchase Notice (a) the Intraday Purchase Percentage for such Intraday Purchase and (b) whether a Limit Order
Continue Election or a Limit Order Discontinue Election shall apply to such Intraday Purchase, on the applicable Purchase Date therefor,
to purchase a specified Intraday Purchase Share Amount, which shall not exceed the applicable Intraday Purchase Maximum Amount, at the
applicable Intraday Purchase Price therefor on such Purchase Date in accordance with this Agreement. The Company may timely deliver to
the Investor an Intraday Purchase Notice for an Intraday Purchase on any Trading Day selected by the Company as the Purchase Date for
such Intraday Purchase, so long as (i) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding such Purchase
Date is not less than the Threshold Price, and (ii) all Shares subject to all prior Purchases effected by the Company pursuant to this
Agreement on or before the Trading Day immediately preceding such Purchase Date (as applicable) have been timely received by the Investor
as DWAC Shares on the applicable Purchase Share Delivery Dates for such prior Purchases in accordance with Section 3.4. The Investor
is obligated to accept each Intraday Purchase Notice prepared and delivered by the Company in accordance with the terms of and subject
to the satisfaction of the conditions contained in this Agreement. If the Company delivers any Intraday Purchase Notice directing the
Investor to purchase an Intraday Purchase Share Amount in excess of the applicable Intraday Purchase Maximum Amount that the Company
is then permitted to include in such Intraday Purchase Notice (taking into account the Intraday Purchase Percentage specified by the
Company in the applicable Intraday Purchase Notice for such Intraday Purchase), such Intraday Purchase Notice shall be void ab initio
to the extent of the amount by which the Intraday Purchase Share Amount set forth in such Intraday Purchase Notice exceeds such applicable
Intraday Purchase Maximum Amount, and the Investor shall have no obligation to purchase, and shall not purchase, such excess Shares pursuant
to such Intraday Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the applicable
Intraday Purchase Maximum Amount pursuant to such Intraday Purchase. At or prior to 7:00 p.m., New York City time, on the Purchase Date
on which one or more Intraday Purchases shall have occurred, the Investor shall provide to the Company, by email correspondence to each
of the individual notice recipients of the Company set forth in the applicable Intraday Purchase Notice, a written confirmation for each
such Intraday Purchase, setting forth the applicable Intraday Purchase Price per Share to be paid by the Investor for the Shares purchased
by the Investor in such Intraday Purchase, and the total aggregate Intraday Purchase Price to be paid by the Investor for the total Intraday
Purchase Share Amount purchased by the Investor in such Intraday Purchase. Notwithstanding the foregoing, the Company shall not deliver
any Intraday Purchase Notices to the Investor during the PEA Period, any Allowable Grace Period, any MPA Period or at any other time
that the Company is in possession of information reasonably determined by the Company to be material non-public information regarding
the Company, its Subsidiaries or their securities.
4
Section
3.3 Extended Hours Purchases.
(a)
Pre-Market Purchases. Upon the initial satisfaction of all of the conditions set forth in Section 7.2 on the Commencement
Date and from time to time thereafter, subject to the satisfaction of all of the conditions set forth in Section 7.3, in addition to
Market Open Purchases as described in Section 3.1 and Intraday Purchases as described in Section 3.2, the Company shall also have the
right, but not the obligation, to direct the Investor, by its timely delivery to the Investor of a Pre-Market Purchase Notice for a Pre-Market
Purchase (each, a “Pre-Market Purchase”), specifying in such Pre-Market Purchase Notice (a) the Pre-Market
Purchase Percentage for such Pre-Market Purchase and (b) whether a Limit Order Continue Election or a Limit Order Discontinue Election
shall apply to such Pre-Market Purchase, on the applicable Purchase Date therefor, to purchase a specified Pre-Market Purchase Share
Amount, which shall not exceed the applicable Pre-Market Purchase Maximum Amount, at the applicable Pre-Market Purchase Price therefor
on such Purchase Date in accordance with this Agreement. The Company may timely deliver to the Investor a Pre-Market Purchase Notice
for Pre-Market Purchase on any Trading Day selected by the Company as the Purchase Date for such Pre-Market Purchase, so long as (i)
the Closing Sale Price of the Common Stock on the Trading Day immediately preceding such Purchase Date is not less than the Threshold
Price, and (ii) all Shares subject to all prior Purchases effected by the Company pursuant to this Agreement on or before the Trading
Day immediately preceding such Purchase Date (as applicable) have been timely received by the Investor as DWAC Shares on the applicable
Purchase Share Delivery Dates for such prior Purchases in accordance with Section 3.4. The Investor is obligated to accept each Pre-Market
Purchase Notice prepared and delivered by the Company in accordance with the terms of and subject to the satisfaction of the conditions
contained in this Agreement. If the Company delivers any Pre-Market Purchase Notice directing the Investor to purchase a Pre-Market Purchase
Share Amount in excess of the applicable Pre-Market Purchase Maximum Amount that the Company is then permitted to include in such Pre-Market
Purchase Notice (taking into account the Pre-Market Purchase Percentage specified by the Company in the applicable Pre-Market Purchase
Notice for such Pre-Market Purchase), such Pre-Market Purchase Notice shall be void ab initio to the extent of the amount by which
the Pre-Market Purchase Share Amount set forth in such Pre-Market Purchase Notice exceeds such applicable Pre-Market Purchase Maximum
Amount, and the Investor shall have no obligation to purchase, and shall not purchase, such excess Shares pursuant to such Pre-Market
Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the applicable Pre-Market Purchase
Maximum Amount pursuant to such Pre-Market Purchase. At or prior to 7:00 p.m., New York City time, on the Purchase Date on which a Pre-Market
Purchase shall have occurred, the Investor shall provide to the Company, by email correspondence to each of the individual notice recipients
of the Company set forth in the applicable Pre-Market Purchase Notice, a written confirmation for such Pre-Market Purchase, setting forth
the applicable Pre-Market Purchase Price per Share to be paid by the Investor for the Shares purchased by the Investor in such Pre-Market
Purchase, and the total aggregate Pre-Market Purchase Price to be paid by the Investor for the total Pre-Market Purchase Share Amount
purchased by the Investor in such Pre-Market Purchase. Notwithstanding the foregoing, the Company shall not deliver any Pre-Market Purchase
Notices to the Investor during the PEA Period, any Allowable Grace Period, any MPA Period or at any other time that the Company is in
possession of information reasonably determined by the Company to be material non-public information regarding the Company, its Subsidiaries
or their securities.
5
(b)
Post-Market Purchases. Upon the initial satisfaction of all of the conditions set forth in Section 7.2 on the Commencement
Date and from time to time thereafter, subject to the satisfaction of all of the conditions set forth in Section 7.3, in addition to
Market Open Purchases as described in Section 3.1, Intraday Purchases as described in Section 3.2 and Pre-Market Purchases as described
in Section 3.3(a), the Company shall also have the right, but not the obligation, to direct the Investor, by its timely delivery to the
Investor of a Post-Market Purchase Notice for a Post-Market Purchase (each, a “Post-Market Purchase”), specifying
in such Post-Market Purchase Notice (a) the Post-Market Purchase Percentage for such Post-Market Purchase and (b) whether a Limit Order
Continue Election or a Limit Order Discontinue Election shall apply to such Post-Market Purchase, on the applicable Purchase Date therefor,
to purchase a specified Post-Market Purchase Share Amount, which shall not exceed the applicable Post-Market Purchase Maximum Amount,
at the applicable Post-Market Purchase Price therefor on such Purchase Date in accordance with this Agreement. The Company may timely
deliver to the Investor a Post-Market Purchase Notice for Post-Market Purchase on any Trading Day selected by the Company as the Purchase
Date for such Post-Market Purchase, so long as (i) the Closing Sale Price of the Common Stock on such Purchase Date is not less than
the Threshold Price, and (ii) all Shares subject to all prior Purchases effected by the Company pursuant to this Agreement on or before
the Trading Day immediately preceding such Purchase Date (as applicable) have been timely received by the Investor as DWAC Shares on
the applicable Purchase Share Delivery Dates for such prior Purchases in accordance with Section 3.4. The Investor is obligated to accept
each Post-Market Purchase Notice prepared and delivered by the Company in accordance with the terms of and subject to the satisfaction
of the conditions contained in this Agreement. If the Company delivers any Post-Market Purchase Notice directing the Investor to purchase
a Post-Market Purchase Share Amount in excess of the applicable Post-Market Purchase Maximum Amount that the Company is then permitted
to include in such Post-Market Purchase Notice (taking into account the Post-Market Purchase Percentage specified by the Company in the
applicable Post-Market Purchase Notice for such Post-Market Purchase), such Post-Market Purchase Notice shall be void ab initio
to the extent of the amount by which the Post-Market Purchase Share Amount set forth in such Post-Market Purchase Notice exceeds such
applicable Post-Market Purchase Maximum Amount, and the Investor shall have no obligation to purchase, and shall not purchase, such excess
Shares pursuant to such Post-Market Purchase Notice; provided, however, that the Investor shall remain obligated to purchase
the applicable Post-Market Purchase Maximum Amount pursuant to such Post-Market Purchase. At or prior to 7:00 p.m., New York City time,
on the Purchase Date on which one or more Post-Market Purchases shall have occurred, the Investor shall provide to the Company, by email
correspondence to each of the individual notice recipients of the Company set forth in the applicable Post-Market Purchase Notice, a
written confirmation for each such Post-Market Purchase, setting forth the applicable Post-Market Purchase Price per Share to be paid
by the Investor for the Shares purchased by the Investor in such Post-Market Purchase, and the total aggregate Post-Market Purchase Price
to be paid by the Investor for the total Post-Market Purchase Share Amount purchased by the Investor in such Post-Market Purchase. Notwithstanding
the foregoing, the Company shall not deliver any Post-Market Purchase Notices to the Investor during the PEA Period, any Allowable Grace
Period, any MPA Period or at any other time that the Company is in possession of information reasonably determined by the Company to
be material non-public information regarding the Company, its Subsidiaries or their securities.
6
Section
3.4. Settlement. The Shares constituting (i) the applicable Market Open Purchase Share Amount purchased by the Investor in
each Market Open Purchase, (ii) the applicable Intraday Purchase Share Amount purchased by the Investor in each Intraday Purchase, (iii)
the applicable Pre-Market Purchase Share Amount purchased by the Investor in each Pre-Market Purchase, and (iv) the applicable Post-Market
Purchase Share Amount purchased by the Investor in each Post-Market Purchase, as applicable, in each case shall be delivered to the Investor
as DWAC Shares not later than 10:00 a.m., New York City time, on the Trading Day immediately following the Purchase Date for such Purchase
(the “Purchase Share Delivery Date”). Subject to the provisions set forth in (i) Section 10.1(i) regarding
deductions from the amount otherwise payable to the Company under this Section 3.4 for partial satisfaction of the QIU Fee Reimbursement
and the Additional Investor Legal Fee Expense Reimbursement and (ii) Section 10.1(ii) regarding deductions from the amount otherwise
payable to the Company under this Section 3.4 for partial satisfaction of the Commitment Fee, for each Purchase effected by the Company
under this Article III, the Investor shall pay to the Company an amount in cash equal to the product of (a) the total number of Shares
purchased by the Investor in such Purchase and (b) the applicable Purchase Price for such Shares, as full payment for such Shares purchased
by the Investor in such Purchase, via wire transfer of immediately available funds, not later than 5:00 p.m., New York City time, on
the Trading Day immediately following the applicable Purchase Share Delivery Date for such Purchase, provided the Investor shall have
timely received, as DWAC Shares, all of such Shares purchased by the Investor in such Purchase on such Purchase Share Delivery Date in
accordance with the first sentence of this Section 3.4, or, if any of such Shares are received by the Investor after 1:00 p.m., New York
City time, then the Company’s receipt of such funds in its designated account may occur on the Trading Day next following the Trading
Day on which the Investor shall have received all of such Shares as DWAC Shares, but not later than 5:00 p.m., New York City time, on
such next Trading Day. If the Company or its transfer agent shall fail for any reason (other than a failure of the Investor or its Broker-Dealer
to set up a DWAC and required instructions) to deliver to the Investor, as DWAC Shares, any Shares purchased by the Investor in a Purchase
effected by the Company under this Article III, prior to 10:00 a.m., New York City time, on the Trading Day immediately following the
applicable Purchase Share Delivery Date for such Purchase, and if on or after such Trading Day the Investor purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Investor of such Shares that the Investor
anticipated receiving from the Company on such Purchase Share Delivery Date in respect of such Purchase, then the Company shall, within
one (1) Trading Day after the Investor’s request, either (i) pay cash to the Investor in an amount equal to the Investor’s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “Cover Price”),
at which point the Company’s obligation to deliver such Shares as DWAC Shares shall terminate, or (ii) promptly honor its obligation
to deliver to the Investor such Shares as DWAC Shares and pay cash to the Investor in an amount equal to the excess (if any) of the Cover
Price over the total purchase price paid by the Investor pursuant to this Agreement for all of the Shares purchased by the Investor in
such Purchase. The Company shall not issue any fraction of a share of Common Stock to the Investor in connection with any Purchase effected
pursuant to this Agreement. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company shall
round such fraction of a share of Common Stock up or down to the nearest whole share. All payments to be made by the Investor pursuant
to this Agreement shall be made by wire transfer of immediately available funds to such account as the Company may from time to time
designate by written notice to the Investor in accordance with the provisions of this Agreement.
7
Section
3.5. Compliance with Rules of Trading Market.
(a)
Exchange Cap. Subject to Section 3.5(b), the Company shall not issue or sell any shares of Common Stock pursuant to this
Agreement, and the Investor shall not purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent that after
giving effect thereto, the aggregate number of shares of Common Stock that would be issued pursuant to this Agreement and the transactions
contemplated hereby would exceed 769,952 shares of Common Stock (such number of shares equal to 19.99%
of the aggregate number of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement),
which number of shares shall be reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant
to any transaction or series of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable
rules of the Trading Market (such maximum number of shares of Common Stock, the “Exchange Cap”), unless the
Company’s stockholders have approved the issuance of Common Stock pursuant to this Agreement in excess of the Exchange Cap in accordance
with the applicable rules of the Trading Market. For the avoidance of doubt, the Company may, but shall be under no obligation to, request
its stockholders to approve the issuance of Common Stock pursuant to this Agreement; provided, that if such stockholder approval
is not obtained, the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at
all times during the term of this Agreement (except as set forth in Section 3.5(b)).
(b)
At-Market Transaction. Notwithstanding Section 3.5(a) above, the Exchange Cap shall not be applicable for any purposes
of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall
equal or exceed the Base Price (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of
this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the stockholder
approval referred to in Section 3.5(a) is obtained). The parties acknowledge and agree that the Minimum Price used to determine the Base
Price hereunder represents the lower of (i) the Nasdaq official closing price of the Common Stock on the Trading Market (as reflected
on Nasdaq.com) on [the Trading Day immediately prior to]1 the date of this Agreement and (ii) the average Nasdaq official
closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com) for the five (5) consecutive Trading Days ending
on [the Trading Day immediately prior to]2 the date of this Agreement.
1
Use if agreements are executed before market close on a Trading Day.
2
Use if agreements are executed before market close on a Trading Day.
8
(c)
General. The Company shall not issue or sell any shares of Common Stock pursuant to this Agreement if such issuance or
sale would reasonably be expected to result in (A) a violation of the Securities Act or (B) a breach of the rules of the Trading Market.
The provisions of this Section 3.5 shall be implemented in a manner otherwise than in strict conformity with the terms of this Section
3.5 only if necessary to ensure compliance with the Securities Act and the applicable rules of the Trading Market. For the avoidance
of doubt, nothing in this Section 3.3 shall require the Company to issue, or permit the Company to issue, any shares of Common Stock
in violation of the applicable rules of the Trading Market, including Nasdaq Listing Rule 5635(d), and the Company may decline to effect
any Purchase (or any portion thereof) to the extent the issuance of Shares in connection therewith would result in such a violation.
Section
3.6. Beneficial Ownership Limitation. Notwithstanding anything to the contrary contained in this Agreement, the Company shall
not issue or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when aggregated
with all other shares of Common Stock then beneficially owned by the Investor and its Affiliates (as calculated pursuant to Section 13(d)
of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of more than 4.99%
of the outstanding shares of Common Stock (the “Beneficial Ownership Limitation”). Upon the written request
of the Investor, the Company shall promptly (but not later than the next business day on which the Company’s transfer agent is
open for business) confirm orally or in writing to the Investor the number of shares of Common Stock then outstanding. The Investor and
the Company shall each cooperate in good faith in the determinations required under this Section 3.6 and the application of this Section
3.6. The Investor’s written certification to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting
effect thereof hereunder at any time, shall be conclusive with respect to the applicability thereof and such result absent manifest error.
The provisions of this Section 3.6 shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 3.6 to the extent necessary to properly give effect to the limitations contained in this Section 3.6.
Article
IV
REPRESENTATIONS,
WARRANTIES AND COVENANTS OF THE INVESTOR
The
Investor hereby makes the following representations, warranties and covenants to the Company:
Section
4.1. Organization and Standing of the Investor. The Investor is a limited liability company duly organized, validly existing
and in good standing under the laws of the State of Delaware.
9
Section
4.2. Authorization and Power. The Investor has the requisite limited liability company power and authority to enter into and
perform its obligations under this Agreement and the Registration Rights Agreement and to purchase or acquire the Shares in accordance
with the terms hereof. The execution, delivery and performance by the Investor of this Agreement and the Registration Rights Agreement
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary limited liability
company action, and no further consent or authorization of the Investor, its officers or its sole member is required. Each of this Agreement
and the Registration Rights Agreement has been duly executed and delivered by the Investor and constitutes a valid and binding obligation
of the Investor enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation, conservatorship, receivership, or similar Laws relating to, or affecting generally
the enforcement of, creditor’s rights and remedies or by other equitable principles of general application (including any limitation
of equitable remedies).
Section
4.3. No Conflicts. The execution, delivery and performance by the Investor of this Agreement and the Registration Rights Agreement
and the consummation by the Investor of the transactions contemplated hereby and thereby do not and shall not (i) result in a violation
of such Investor’s certificate of formation, limited liability company agreement or other applicable organizational instruments,
(ii) conflict with, constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or
give rise to any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust,
indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party or is bound, (iii) create
or impose any lien, charge or encumbrance on any property of the Investor under any agreement or any commitment to which the Investor
is party or under which the Investor is bound or under which any of its properties or assets are bound, or (iv) result in a violation
of any federal, state, local or foreign statute, rule, or regulation, or any Order of any Governmental Entity applicable to the Investor
or by which any of its properties or assets are bound or affected, except, in the case of clauses (ii), (iii) and (iv), for such conflicts,
defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, prohibit
or otherwise interfere with, in any material respect, the ability of the Investor to enter into and perform its obligations under this
Agreement and the Registration Rights Agreement. The Investor is not required under any applicable Law to obtain any consent, authorization
or Order of, or make any filing or registration with, any Governmental Entity in order for it to execute, deliver or perform any of its
obligations under this Agreement and the Registration Rights Agreement or to purchase or acquire the Shares in accordance with the terms
hereof, other than as may be required by FINRA; provided, however, that for purposes of the representation made in this
sentence, the Investor is assuming and relying upon the accuracy of the relevant representations and warranties and the compliance with
the relevant covenants and agreements of the Company in the Transaction Documents to which it is a party.
Section
4.4. Investment Purpose. The Investor is acquiring the Shares for its own account, for investment purposes and not with a
view towards, or for resale in connection with, the public sale or distribution thereof, in violation of the Securities Act or any applicable
state securities or “blue sky” Laws; provided, however, that by making the representations herein, the Investor
does not agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves
the right to dispose of the Shares at any time in accordance with, or pursuant to, a Registration Statement filed pursuant to the Registration
Rights Agreement or an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding,
directly or indirectly, with any Person to sell or distribute any of the Shares. The Investor is acquiring the Shares hereunder in the
ordinary course of its business.
10
Section
4.5. Accredited Investor Status. The Investor is an “accredited investor” as that term is defined in Rule 501(a)
of Regulation D.
Section
4.6. Reliance on Exemptions. The Investor understands that the Shares are being offered and sold to it in reliance on specific
exemptions from the registration requirements of U.S. federal and state securities or “blue sky” Laws and that the Company
is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the
eligibility of the Investor to acquire the Shares.
Section
4.7. Information. All materials relating to the business, financial condition, management and operations of the Company
and materials relating to the offer and sale of the Shares which have been requested by the Investor have been furnished or otherwise
made available to the Investor or its advisors, including, without limitation, the Commission Documents. The Investor understands that
its investment in the Shares involves a high degree of risk. The Investor is able to bear the economic risk of an investment in the Shares
and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of a proposed
investment in the Shares. The Investor and its advisors have been afforded the opportunity to ask questions of and receive answers from
representatives of the Company concerning the financial condition and business of the Company and other matters relating to an investment
in the Shares. Neither such inquiries nor any other due diligence investigations conducted by the Investor or its advisors, if any, or
its representatives shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties
contained in this Agreement or in any other Transaction Document to which the Company is a party or the Investor’s right to rely
on any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction
contemplated hereby (including, without limitation, the opinions of the Company’s counsel delivered pursuant to Sections 7.1(iv),
7.2(xv) and 7.3(x)). The Investor has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to its acquisition of the Shares. The Investor understands that it (and not the Company) shall be responsible
for its own tax liabilities that may arise as a result of this investment or the transactions contemplated by this Agreement.
Section
4.8. No Governmental Review. The Investor understands that no United States federal or state agency or any other government
or Governmental Entity has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of an investment
in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Shares.
11
Section
4.9. No General Solicitation. The Investor is not purchasing or acquiring the Shares as a result of any form of general solicitation
or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Shares.
Section
4.10. Not an Affiliate. The Investor is not an officer, director or an Affiliate of the Company. As of the date of this Agreement,
the Investor does not beneficially own any shares of Common Stock or securities exercisable for or convertible into shares of Common
Stock. During the Investment Period, the Investor will not acquire for its own account any shares of Common Stock or securities exercisable
for or convertible into shares of Common Stock, other than pursuant to this Agreement; provided, however, that nothing
in this Agreement shall prohibit or be deemed to prohibit the Investor from purchasing, in an open market transaction or otherwise, shares
of Common Stock necessary to make delivery by the Investor in satisfaction of a sale by the Investor of Shares that the Investor anticipated
receiving from the Company in connection with the settlement of a Market Open Purchase or an Intraday Purchase (as applicable) if the
Company or its transfer agent shall have failed for any reason (other than a failure of the Investor or its Broker-Dealer to set up a
DWAC and required instructions) to electronically transfer all of the Shares subject to such Market Open Purchase or such Intraday Purchase
(as applicable) to the Investor on the applicable Purchase Share Delivery Date by crediting the Investor’s or its designated Broker-Dealer’s
account at DTC through its DWAC delivery system in compliance with Section 3.4 of this Agreement. For the avoidance of doubt, the foregoing
restriction does not apply to any Affiliate of the Investor, provided that any such purchases do not cause the Investor to violate any
applicable Exchange Act requirement, including Regulation M.
Section
4.11. No Prior Short Sales. At no time prior to the date of this Agreement has the Investor, any of its officers, or any entity
managed or controlled by the Investor, engaged in or effected, in any manner whatsoever, directly or indirectly, for the Investor’s
own principal account or for the principal account of any such entity managed or controlled by the Investor, any (i) “short sale”
(as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging transaction, which establishes
a net short position with respect to the Common Stock that remains in effect as of the date of this Agreement.
Section
4.12. Statutory Underwriter Status. The Investor acknowledges that it will be disclosed as an “underwriter” and
a “selling stockholder” in each Registration Statement and in any Prospectus contained therein to the extent required by
applicable Law and to the extent the Prospectus is related to the resale of Registrable Securities.
Section
4.13. Resales of Shares. The Investor represents, warrants and covenants that it will resell Shares purchased or acquired
by the Investor from the Company pursuant to this Agreement only pursuant to the Registration Statement in which the resale of such Shares
is registered under the Securities Act and the Prospectus contained therein, in a manner described under the caption “Plan of Distribution”
in such Registration Statement and Prospectus, and in a manner in compliance with all applicable U.S. federal and applicable state securities
or “blue sky” Laws.
12
Article
V
REPRESENTATIONS,
WARRANTIES AND COVENANTS OF THE COMPANY
Except
as set forth in the disclosure schedule delivered by the Company to the Investor, if any (which is hereby incorporated by reference in,
and constitutes an integral part of, this Agreement) (the “Disclosure Schedule”), the Company hereby makes
the following representations, warranties and covenants to the Investor:
Section
5.1. Organization, Good Standing and Power. The Company is a corporation duly organized, validly existing and in good standing
under the Laws of the State of Delaware and has the corporate power and authority to own, lease or operate its assets and properties
and to conduct its business as now being conducted in all material respects. The Company is duly licensed or qualified to do business
and in good standing (or equivalent status as applicable) in each jurisdiction in which the assets owned or leased by it or the character
of its activities require it to be licensed or qualified or in good standing (or equivalent status as applicable), except where the failure
to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably be expected to have a Material
Adverse Effect.
Section
5.2. Authorization, Enforcement. The Company has the requisite corporate power and authority to enter into and perform its
obligations under each of the Transaction Documents to which it is a party and to issue the Shares in accordance with the terms hereof
and thereof. Except for approvals of the Company’s Board of Directors or a committee thereof as may be required in connection with
any issuance and sale of Shares to the Investor hereunder (which approvals shall be obtained prior to the delivery of any Market Open
Purchase Notice and any Intraday Purchase Notice), the execution, delivery and performance by the Company of each of the Transaction
Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate action, and no further consent or authorization of the Company, its Board of Directors or its stockholders
is required. Each of the Transaction Documents to which the Company is a party has been duly executed and delivered by the Company and
constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership
or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles
of general application (including any limitation of equitable remedies).
Section
5.3. Capitalization. The authorized capital stock of the Company and the shares thereof issued and outstanding were
as set forth in the Commission Documents as of the dates reflected therein. All of the outstanding shares of Common Stock have been duly
authorized and validly issued, and are fully paid and non-assessable. Except as set forth in the Commission Documents, this Agreement
and the Registration Rights Agreement, there are no agreements or arrangements under which the Company is obligated to register the sale
of any securities under the Securities Act. Except as set forth in the Commission Documents, no shares of Common Stock are entitled to
preemptive rights and there are no outstanding debt securities and no contracts, commitments, understandings, or arrangements by which
the Company is or may become bound to issue additional shares of the capital stock of the Company or options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exchangeable
for, any shares of capital stock of the Company other than those issued or granted in the ordinary course of business pursuant to the
Company’s equity incentive and/or compensatory plans or arrangements. Except as set forth in the Commission Documents, the Company
is not a party to, and it has no Knowledge of, any agreement restricting the voting or transfer of any shares of the capital stock of
the Company. Except as set forth in the Commission Documents, there are no securities or instruments containing anti-dilution or similar
provisions that will be triggered by this Agreement, the Registration Rights Agreement or any of the other Transaction Documents, or
the consummation of the transactions described herein or therein. The Company has filed with the Commission true and correct copies of
the Company’s Certificate of Incorporation, as amended and in effect on the Closing Date (the “Charter”),
and the Company’s Bylaws, as amended and in effect on the Closing Date (the “Bylaws”).
13
Section
5.4. Payment of Commitment Fee; Issuance of Shares. Payment of the Commitment Fee by the Company to the Investor in such manner,
at such time(s) and otherwise pursuant to and in accordance with Section 10.1(ii) of this Agreement, has been duly authorized by all
necessary corporate action on the part of the Company. The Total Commitment worth of Shares available for issuance by the Company to
the Investor under this Agreement have been, or with respect to the amount of Shares to be purchased by the Investor pursuant to a particular
Purchase Notice will be, prior to the delivery to the Investor hereunder of such Purchase Notice, in each case duly authorized by all
necessary corporate action on the part of the Company. An aggregate [●] shares of Common Stock have been duly authorized and reserved
by the Company for issuance and sale to the Investor as Shares pursuant to one or more Purchases under this Agreement.
Section
5.5. No Conflicts. The execution, delivery and performance by the Company of each of the Transaction Documents to which it
is a party and the consummation by the Company of the transactions contemplated hereby and thereby do not and shall not (i) result in
a violation of any provision of the Company’s Charter or Bylaws, (ii) result in a breach or violation of any of the terms or provisions
of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give rise to
any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond,
license, lease agreement, instrument or obligation to which the Company or any of its Subsidiaries is a party or is bound, (iii) create
or impose a lien, charge or encumbrance on any property or assets of the Company or any of its Subsidiaries under any agreement or any
commitment to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or
to which any of their respective properties or assets is subject, or (iv) result in a violation of any Law or Order applicable to the
Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries are bound or affected
(including federal and state securities or “blue sky” Laws and the rules and regulations of the Trading Market or applicable
Eligible Market), except, in the case of clauses (ii), (iii) and (iv), for such conflicts, defaults, terminations, amendments, acceleration,
cancellations, liens, charges, encumbrances and violations as would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect. Except as specifically contemplated by this Agreement or the Registration Rights Agreement and as required
under the Securities Act and any applicable state securities or “blue sky” Laws, the Company is not required under any Law
to obtain any consent, authorization or Order of, or make any filing or registration with, any Governmental Entity (including, without
limitation, the Trading Market) in order for it to execute, deliver or perform any of its obligations under the Transaction Documents
to which it is a party, or to issue the Shares to the Investor in accordance with the terms hereof and thereof (other than such consents,
authorizations, Orders, filings or registrations as have been obtained or made prior to the Closing Date); provided, however,
that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the representations
and warranties of the Investor in this Agreement and the compliance by it with its covenants and agreements contained in this Agreement
and the Registration Rights Agreement.
14
Section
5.6. Commission Documents, Financial Statements; Disclosure Controls and Procedures; Internal Controls Over Financial Reporting; Accountants.
(a)
Since January 1, 2025, the Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25 under the
Exchange Act) all Commission Documents required to be filed with or furnished to the Commission by the Company under the Securities Act
or the Exchange Act, including those required to be filed with or furnished to the Commission under Section 13(a) or Section 15(d) of
the Exchange Act. As of the Closing Date, no Subsidiary of the Company is required to file or furnish any report, schedule, registration,
form, statement, information or other document with the Commission. As of its filing date (or, if amended or superseded by a filing prior
to the Closing Date, as of the date of such amended or superseded filing), each Commission Document filed with or furnished to the Commission
prior to the Closing Date complied in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable.
Each Registration Statement, on the date it is filed with the Commission, on the date it is declared effective by the Commission and
on each Purchase Date, shall comply in all material respects with the requirements of the Securities Act (including, without limitation,
Rule 415 under the Securities Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein not misleading, except that this representation and warranty
shall not apply to statements in or omissions from such Registration Statement made in reliance upon and in conformity with information
relating to the Investor furnished to the Company in writing by or on behalf of the Investor expressly for use therein. The Prospectus
and each Prospectus Supplement required to be filed pursuant to this Agreement or the Registration Rights Agreement after the Closing
Date, when taken together, on its date and on each Purchase Date, shall comply in all material respects with the requirements of the
Securities Act (including, without limitation, Rule 424(b) under the Securities Act) and shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, except that this representation and warranty shall not apply to
statements in or omissions from the Prospectus or any Prospectus Supplement made in reliance upon and in conformity with information
relating to the Investor furnished to the Company in writing by or on behalf of the Investor expressly for use therein. Each Commission
Document (other than the Initial Registration Statement or any New Registration Statement, or the Prospectus included therein or any
Prospectus Supplement thereto) to be filed with or furnished to the Commission after the Closing Date and filed as part of or incorporated
by reference in the Initial Registration Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus
Supplement thereto required to be filed pursuant to this Agreement or the Registration Rights Agreement (including, without limitation,
the Current Report), when such document is filed with or furnished to the Commission and, if applicable, when such document becomes effective,
as the case may be, shall comply in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable.
The Company has delivered or made available to the Investor via EDGAR or otherwise true and complete copies of all comment letters and
substantive correspondence received by the Company from the Commission relating to the Commission Documents filed with or furnished to
the Commission as of the Closing Date, together with all written responses of the Company thereto in the form such responses were filed
via EDGAR. Except as disclosed in the Commission Documents, there are no outstanding or unresolved comments or undertakings in such comment
letters received by the Company from the Commission. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the Securities Act or the Exchange Act.
15
(b)
The consolidated financial statements of the Company included or incorporated by reference in the Commission Documents, together with
the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and its
Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity
of the Company and its Subsidiaries for the periods specified (subject, in the case of unaudited statements, to normal year-end audit
adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published
requirements of the Securities Act and the Exchange Act, as applicable, and in conformity with generally accepted accounting principles
in the United States (“GAAP”) applied on a consistent basis (except (i) for such adjustments to accounting
standards and practices as are noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes
or may be condensed or summary statements) during the periods involved. The pro forma financial statements or data included or incorporated
by reference in the Commission Documents, if any, comply in all material respects with the applicable requirements of Regulation S-X
of the Securities Act, including, without limitation, Article 11 thereof, and the assumptions used in the preparation of such pro forma
financial statements and data are reasonable, the pro forma adjustments used therein are appropriate to give effect to the circumstances
referred to therein and the pro forma adjustments have been properly applied to the historical amounts in the compilation of those statements
and data. The other financial, statistical and market-related data with respect to the Company and the Subsidiaries contained or incorporated
by reference in the Commission Documents, if any, are based on or derived from sources that the
Company believes, after reasonable inquiry, to be reliable and accurate or represent the Company’s good faith estimates that are
made on the basis of data derived from such sources. There are no financial statements (historical or pro forma) that are required
to be included or incorporated by reference in the Commission Documents that are not included or incorporated by reference as required.
All disclosures contained or incorporated by reference in the Commission Documents, if any, regarding “non-GAAP financial measures”
(as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange
Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable.
(c)
Except as set forth in the Commission Documents, the Company maintains a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Except as set forth in the Commission Documents, the Company is not aware of any material weaknesses in its internal
control over financial reporting. Except as set forth in the Commission Documents, since the date of the latest audited financial statements
of the Company included in the Commission Documents, there has been no change in the Company’s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial
reporting. Except as set forth in the Commission Documents, the Company has established disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15 and 15d-15) that comply with the requirements of the Exchange Act. The Company’s certifying officers
have evaluated the effectiveness of the Company’s controls and procedures as of a date within 90 days prior to the filing date
of the Form 10-K for the fiscal year most recently ended (such date, the “Evaluation Date”). The Company presented
in its Form 10-K for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the most recent Evaluation Date and, except as set forth in such Form 10-K or
any Commission Document filed with the Commission for a period subsequent to the period covered by such Form 10-K, the “disclosure
controls and procedures” are effective.
16
(d)
Weinberg & Company, P.A. (the “Accountant”), whose report on the consolidated financial statements of the
Company is filed with the Commission as part of the 2025 Form 10-K and shall be filed with the Commission as part of the Initial Registration
Statement, are and, during the periods covered by their report, were independent public accountants within the meaning of the Securities
Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation
of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with
respect to the Company.
(e)
Since January 1, 2025, the Company has timely filed all certifications and statements the Company is required to file under (i) Rule
13a-14 or Rule 15d-14 under the Exchange Act or (ii) 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act) with respect to all
Commission Documents with respect to which the Company is required to file such certifications and statements thereunder.
Section
5.7. Subsidiaries. Exhibit 21.1 to the 2025 Form 10-K sets forth each Subsidiary of the Company as of the Closing Date, other
than those that may be omitted pursuant to Item 601 of Regulation S-K, and the Company does not have any other Subsidiaries as of the
Closing Date, other than those that may be omitted pursuant to Item 601 of Regulation S-K. Each Subsidiary of the Company has been duly
incorporated or organized, as the case may be, and is validly existing and in good standing (where such concept is recognized) under
the laws of the jurisdiction of its incorporation or organization and has the power and authority (corporate or other) to own, lease
and operate its properties and to conduct its business as described in the 2025 Form 10-K. Each of the Company’s Subsidiaries is
duly qualified to transact business and is in good standing (where such concept is recognized) in each jurisdiction in which such qualification
is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so
qualified or in good standing, as the case may be, or have such power or authority would not, individually or in the aggregate, have
a Material Adverse Effect. All of the issued and outstanding capital stock or other equity or ownership interests of each of the Company’s
Subsidiaries have been duly authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly or
through Subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim.
17
Section
5.8. No Material Adverse Effect or Material Change. Except as otherwise disclosed in any Commission Documents, since December
31, 2025: (i) there has been no material adverse change, or any development that would reasonably be expected to result in a material
adverse change, in the condition, financial or otherwise, or in the earnings, business, properties, operations, assets, liabilities,
whether or not arising from transactions in the ordinary course of business, of the Company and its Subsidiaries, considered as one entity;
(ii) the Company and its Subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect, direct
or contingent, including without limitation any losses or interference with its business from fire, explosion, flood, earthquakes, accident
or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree,
that are material, individually or in the aggregate, to the Company and its Subsidiaries, considered as one entity; (iii) there has not
been any material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or
its Subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for dividends
paid to the Company or other Subsidiaries, by any of the Company’s Subsidiaries on any class of capital stock, or any repurchase
or redemption by the Company or any of its Subsidiaries of any class of capital stock; and (iv) there has been no Material Adverse Effect.
Section
5.9. No Undisclosed Liabilities. There are no direct or contingent liabilities, obligations, transactions, arrangements or
other relationships between or among the Company, or any of its Affiliates and any unconsolidated entity, including any structural finance,
special purpose or limited purpose entity (including any off-balance sheet obligations) or any “variable interest entities”
as that term is used in Accounting Standards Codification Paragraph 810-10-25-20, that would reasonably be expected to affect materially
the Company’s liquidity or the availability of or requirements for its capital resources, required to be described in the Commission
Documents which have not been described as required.
Section
5.10. No Material Defaults on Indebtedness. Except as set forth in the Commission Documents, neither
the Company nor any of its Subsidiaries is (i) in violation of its charter or bylaws or similar organizational documents or (ii) in default,
and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance
of any term, covenant or condition contained in any indenture, mortgage, deed of trust, promissory note, or loan agreement or other instrument
relating to Indebtedness to which the Company is a party or by which the Company is bound or to which any of the property or assets of
the Company is subject, except, in the case of clause (ii) above, for any such default that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
18
Section
5.11. Solvency. The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant
to any Bankruptcy Law, nor does the Company have any Knowledge that its creditors intend to initiate involuntary bankruptcy, insolvency,
reorganization or liquidation Proceedings or other Proceedings for relief under any Bankruptcy Law. Except as set forth in the Commission
Documents (including the going-concern disclosures therein), to the Company’s Knowledge, (i) the fair saleable value of the Company’s
assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such
debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).
Section
5.12. Title to Real and Personal Property. The Company and its Subsidiaries have good
and valid title in fee simple to all items of real property and good and valid title to all personal property described in the Commission
Documents as being owned by them that are material to the businesses of the Company and its Subsidiaries, in each case, free and clear
of all liens, encumbrances and claims, except those that would reasonably be expected to not, individually or in the aggregate, have
a Material Adverse Effect. Any real property described in the Commission Documents as being leased by the Company or its Subsidiaries
is held by them under valid, existing and enforceable leases, except those that would not be reasonably be expected, individually or
in the aggregate, have a Material Adverse Effect.
Section
5.13. Litigation. Except as disclosed in the Commission Documents, there is no Proceeding pending or, to the Company’s
Knowledge, threatened against the Company or any of its Subsidiaries that, if adversely decided or resolved, would, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect. Except as disclosed in the Commission Documents, neither the
Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Proceeding involving a claim of violation
of or liability under federal or state securities or “blue sky” Laws or a claim of breach of fiduciary duty, which would
reasonably expected to result in an Order having a Material Adverse Effect. Except as disclosed in the Commission Documents, there has
not been, and to the Knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the
Company, any of its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries, which would
reasonably expected to result in an Order having a Material Adverse Effect.
Section
5.14. Compliance with Applicable Laws. Except as disclosed in the Commission Documents, the business of the Company and its
Subsidiaries has been and is presently being conducted in compliance with all applicable Laws, except for such non-compliance which,
individually or in the aggregate, would not have a Material Adverse Effect. Except as disclosed in the Commission Documents, neither
the Company nor any of its Subsidiaries is in violation of any Order applicable to the Company or any of its Subsidiaries, except in
all cases for any such violations which could not, individually or in the aggregate, have a Material Adverse Effect.
19
Section
5.15. Certain Fees. Except as contemplated by the Transaction Documents (including in connection with the engagement of any
Qualified Independent Underwriter as contemplated by Section 6.15 hereof) or as disclosed in the Commission Documents, no brokerage or
finder’s fees or commissions are or will be payable by the Company or any of its Subsidiaries to any broker, financial advisor
or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the
Transaction Documents. Except for any fees and other compensation payable to any Qualified Independent Underwriter engaged to participate
in the transactions contemplated by the Transaction Documents pursuant to Section 6.15 hereof, none of the Investor, RCP or any of their
respective Affiliates shall have any obligation with respect to any fees or with respect to any claims made by or on behalf of other
Persons for fees of a type contemplated in this Section 5.15 incurred by the Company or any of its Subsidiaries that may be due or payable
in connection with the transactions contemplated by the Transaction Documents.
Section
5.16. Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor
or any of its agents, advisors or counsel with any information that constitutes or could reasonably be expected to constitute material,
nonpublic information concerning the Company or any of its Subsidiaries that has not been publicly disclosed by the Company in a Commission
Document filed by the Company with the Commission, other than the existence of the transactions contemplated by the Transaction Documents.
The Company understands and confirms that the Investor will rely on the foregoing representations in effecting resales of Securities
under the Registration Statement. All disclosure provided to Investor regarding the Company and its Subsidiaries, their businesses and
the transactions contemplated by the Transaction Documents (including, without limitation, the representations and warranties of the
Company contained in the Transaction Documents to which it is a party (as modified by the Disclosure Schedule)) furnished in writing
by or on behalf of the Company or any of its Subsidiaries for purposes of or in connection with the Transaction Documents, taken together,
is true and correct in all material respects on the date on which such information is dated or certified, and does not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light
of the circumstances under which they were made, not misleading at such time. Each press release issued by the Company or any of its
Subsidiaries since the Business Combination Date did not at the time of release (or, if amended or superseded by a later dated press
release issued by the Company or any of its Subsidiaries prior to the Closing Date or by a later dated Commission Document filed with
or furnished to the Commission by the Company prior to the Closing Date, at the time of issuance of such later dated press release or
filing or furnishing of such Commission Document, as applicable) contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they are made, not misleading.
20
Section
5.17. Material Permits. Except as disclosed in the Commission Documents, each of the Company and its Subsidiaries has all
Permits that are required to own, lease or operate its properties and assets and to conduct its business as currently conducted, except
for such Permits that are not, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole (the
“Material Permits”). Except as disclosed in the Commission Documents or as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, (i) to the Company’s Knowledge, each Material Permit is in
full force and effect in accordance with its terms, (ii) no written notice of revocation, cancellation or termination of any Material
Permit has been received by the Company or any of its Subsidiaries and (iii) there are, and have been, no Proceedings pending or, to
the Company’s Knowledge, threatened relating to the suspension, revocation or material and adverse modification of any of such
Material Permit. This Section 5.17 does not relate to environmental matters, such items being the subject of Section 5.18.
Section
5.18. Environmental Matters. Except as would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect: (i) neither the Company nor any of its Subsidiaries is in violation of any federal, state, local or foreign statute,
law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including
any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment
(including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without
limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic
substances, hazardous substances, petroleum or petroleum products (collectively, “Hazardous Materials”) or
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively,
“Environmental Laws”); (ii) the Company and its Subsidiaries have all permits, authorizations and approvals
required under any applicable Environmental Laws and are each in compliance with their requirements; (iii) there are no pending or, to
the Knowledge of the Company, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens,
notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its
Subsidiaries; and (iv) there are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up
or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company
or any of its Subsidiaries relating to Hazardous Materials or any Environmental Laws.
Section
5.19. Intellectual Property Rights. Except as would not reasonably be expected to have a Material Adverse Effect, (i) the
Company and its Subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, domain names and other source indicators, copyrights and copyrightable works, know-how, trade
secrets, systems, procedures, proprietary or confidential information and all other worldwide intellectual property, industrial property
and proprietary rights (collectively, “Intellectual Property”) used in the conduct of their respective businesses
as they are currently being conducted; (ii) the Company’s and its Subsidiaries’ conduct of their respective businesses does
not infringe, misappropriate or otherwise violate any Intellectual Property of any person; (iii) the Company and its Subsidiaries have
not received any written notice of any claim relating to the infringement, misappropriation or violation of any third party’s Intellectual
Property; and (iv) to the Knowledge of the Company, the Intellectual Property of the Company and its Subsidiaries is not being infringed,
misappropriated or otherwise violated by any person.
21
Section
5.20. Material Contracts. Except as set forth in the Commission Documents, the descriptions in the Commission Documents of
the material Contracts therein described present fairly in all material respects the information required to be shown, and there are
no material Contracts of a character required to be described in the Commission Documents or to be filed as exhibits thereto which are
not described or filed as required; all material Contracts between the Company or any of its Subsidiaries and third parties expressly
referenced in the Commission Documents are legal, valid and binding obligations of the Company or one or more of its Subsidiaries, enforceable
in accordance with their respective terms, except to the extent enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or similar Laws affecting creditors’ rights generally and by general equitable principles, and except where the failure
of any such Contract to be enforceable in accordance with its terms would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.
Section
5.21. Transactions With Affiliates. No relationship, direct or indirect, exists between or among any of the Company or any
Affiliate of the Company, on the one hand, and any director, officer, member, stockholder, customer or supplier of the Company or any
Affiliate of the Company, on the other hand, which is required by the Securities Act to be disclosed pursuant to the requirements of
Item 404 of Regulation S-K which has not been so disclosed. Except as disclosed in the Commission Documents, there are no outstanding
loans, advances (except advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company
or any Affiliate of the Company to or for the benefit of any of the officers or directors of the Company or any Affiliate of the Company
or any of their respective family members.
Section
5.22. Labor Relations. Except as disclosed in the Commission Documents, there is: (i) no unfair labor practice complaint pending
against the Company or any of its Subsidiaries, nor to the Company’s Knowledge, threatened against it or any of its Subsidiaries,
before the National Labor Relations Board, any state or local labor relation board or any foreign labor relations board, and no grievance
or arbitration proceeding arising out of or under any collective bargaining agreement is so pending against the Company or any of its
Subsidiaries, or, to the Company’s Knowledge, threatened against it or any of its Subsidiaries; and (ii) no labor disturbance by
the employees of the Company or any of its Subsidiaries exists or, to the Company’s Knowledge, is imminent, and the Company is
not aware of any existing or imminent labor disturbance by the employees of any of its or its Subsidiaries, principal suppliers, manufacturers,
customers or contractors.
Section
5.23. Use of Proceeds. The proceeds from the sale of the Shares by the Company to Investor shall be used by the Company in
the manner as will be set forth in the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and
any Prospectus Supplement thereto filed pursuant to the Registration Rights Agreement.
Section
5.24. Investment Company Act Status. The Company is not, and as a result of the consummation of the transactions contemplated
by the Transaction Documents and the application of the proceeds from the sale of the Shares as will be set forth in the Prospectus included
in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to the
Registration Rights Agreement the Company will not be required to register as an “investment company” within the meaning
of the Investment Company Act of 1940, as amended.
22
Section
5.25. Tax Matters. Except in any case in which failure to pay or file (as applicable) would not, individually or in the aggregate,
have a Material Adverse Effect, the Company and its Subsidiaries have filed all necessary federal, state and foreign income and franchise
tax returns or have properly requested extensions thereof and have paid all taxes required to be paid by any of them and, if due and
payable, any related or similar assessment, fine or penalty levied against any of them except (x) as may be being contested in good faith
and by appropriate proceedings or (y) as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. Except to the extent of any inadequacy that would not, individually or in the aggregate, result in a Material Adverse Effect,
the Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section 5.6(b) above
in respect of all federal, state and foreign income and franchise taxes for all periods as to which the tax liability of the Company
or any of its Subsidiaries has not been finally determined.
Section
5.26. Insurance. The Company and each of its Subsidiaries carries, or is covered by, insurance in such amounts and covering
such risks as is commercially reasonable for the conduct of its business and the value of its properties and as is customary for companies
engaged in similar businesses in similar industries, including, but not limited to, directors and officers insurance coverage. Except
as disclosed in the Commission Documents, the Company has no reason to believe that it or any of its Subsidiaries will not be able to
renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business without a significant increase in cost.
Section
5.27. Exemption from Registration. Subject to, and in reliance on, the representations, warranties and covenants made herein
by the Investor, the offer and sale of the Shares by the Company to the Investor in accordance with the terms and conditions of this
Agreement is exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) and Rule 506(b) of Regulation
D; provided, however, that at the request of and with the express agreement of the Investor (including, without limitation,
the representations, warranties and covenants of Investor set forth in Sections 4.10 through 4.13), the Shares to be issued from and
after Commencement to or for the benefit of the Investor pursuant to this Agreement shall be issued to the Investor or its designee only
as DWAC Shares and will not bear legends noting restrictions as to resale of such securities under federal or state securities or “blue
sky” Laws, nor will any such Shares be subject to stop transfer instructions.
Section
5.28. No General Solicitation or Advertising. Neither the Company, nor any of its Subsidiaries or Affiliates, nor any Person
acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D) in connection with the offer or sale of the Shares.
Section
5.29. No Integrated Offering. None of the Company or any of its Affiliates, nor any Person acting on their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require
registration of the offer, issuance and sale by the Company to the Investor of any of the Shares under the Securities Act, whether through
integration with prior offerings or otherwise, or cause this offering of the Shares to require approval of stockholders of the Company
under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations of the Trading Market.
None of the Company, its Subsidiaries, their Affiliates nor any Person acting on their behalf will take any action or steps referred
to in the preceding sentence that would require registration of the offer, issuance and sale by the Company to the Investor of any of
the Shares under the Securities Act or cause the offering of any of the Shares to be integrated with any other offering of securities
of the Company.
23
Section
5.30. Dilutive Effect. The Company is aware and acknowledges that issuance of the Shares could cause dilution to existing
stockholders and could significantly increase the number of outstanding shares of Common Stock. The Company further acknowledges that
its obligation to issue the Shares pursuant to the terms of a Purchase Notice in accordance with this Agreement is, in each case, absolute
and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other stockholders of the
Company.
Section
5.31. Manipulation of Price. Neither the Company nor any of its officers, directors or to the Knowledge of the Company, any
of its Affiliates has, and, to the Knowledge of the Company, no Person acting on their behalf has, (i) taken, directly or indirectly,
any action designed or intended to cause or to result in the stabilization or manipulation of the price of any security of the Company,
or which caused or resulted in, or which would in the future reasonably be expected to cause or result in, the stabilization or manipulation
of the price of any security of the Company, in each case to facilitate the sale or resale of any of the Shares, (ii) sold, bid for,
purchased, or paid any compensation for soliciting purchases of, any of the Shares, or (iii) paid or agreed to pay to any Person any
compensation for soliciting another to purchase any other securities of the Company. Neither the Company nor any of its officers, directors
or Affiliates will during the term of this Agreement, and, to the Knowledge of the Company, no Person acting on their behalf will during
the term of this Agreement, take any of the actions referred to in the immediately preceding sentence.
Section
5.32. Securities Act. The Company has complied and shall comply with all applicable federal and state securities or “blue
sky” Laws in connection with the offer, issuance and sale of the Shares hereunder, including, without limitation, the applicable
requirements of the Securities Act. Each Registration Statement, upon filing with the Commission and at the time it is declared effective
by the Commission, shall satisfy all of the requirements of the Securities Act to register the resale of the Registrable Securities included
therein by the Investor in accordance with the Registration Rights Agreement on a delayed or continuous basis under Rule 415 under the
Securities Act at then-prevailing market prices, and not fixed prices. The Company is not currently, and has never been, an issuer identified
in, or subject to, paragraph (i)(1) of Rule 144.
Section
5.33. Listing and Maintenance Requirements; DTC Eligibility. The Common Stock is registered pursuant to Section 12(b) of the
Exchange Act, and the Company has taken no action designed to, or which to its Knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating
terminating such registration. Except as disclosed in the Commission Documents, the Company has not received written notice from the
Trading Market (or, if the Common Stock is then listed on an Eligible Market, from such Eligible Market) to the effect that the Company
is not in compliance with the listing or maintenance requirements of the Trading Market (or of such Eligible Market, as applicable).
Except as disclosed in the Commission Documents, the Company is in compliance with all applicable listing and maintenance requirements
of the Trading Market. The Common Stock may be issued and transferred electronically to third parties via DTC through its Deposit/Withdrawal
at Custodian (“DWAC”) delivery system. The Company has not received written notice from DTC to the effect that
a suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC
with respect to the Common Stock is being imposed or is contemplated.
24
Section
5.34. Application of Takeover Protections. The Company and its Board of Directors have taken all necessary action, if any,
in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a
rights agreement) or other similar anti-takeover provision under the Company’s Charter or the Delaware General Corporation Law,
as amended, that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling their respective
obligations or exercising their respective rights under the Transaction Documents (as applicable), including, without limitation, as
a result of the Company’s issuance and sale of the Shares to the Investor pursuant to this Agreement and the Investor’s acquisition
and ownership of the Shares.
Section
5.35. Foreign Corrupt Practices. Neither the Company nor, any of its Subsidiaries, or any director or officer of the Company
or any Subsidiary, nor, to the Knowledge of the Company, any employee, representative, agent, Affiliate of the Company or any of its
Subsidiaries or any other Person acting on behalf of the Company or any of its Subsidiaries, is aware of or has taken any action, directly
or indirectly, that would result in a violation by such Persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules
and regulations thereunder (the “FCPA”), including, without limitation, making use of the mails or any means
or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment
of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official”
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office,
in contravention of the FCPA and the Company and, to the Knowledge of the Company, its Affiliates have conducted their businesses in
compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected
to continue to ensure, continued compliance therewith.
Section
5.36. Office of Foreign Assets Control. Neither the Company nor any of its Subsidiaries nor, to the Knowledge of the Company,
any director, officer, employee, representative, agent or Affiliate of the Company or any of its Subsidiaries, or any other Person acting
on behalf of the Company or any of its Subsidiaries, is currently subject to or the target of any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly
or indirectly use the proceeds of the offering of the Shares contemplated hereby, or lend, contribute or otherwise make available such
proceeds to any Person, for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered
by OFAC.
Section
5.37. Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money
Laundering Laws”). No Proceeding by or before any Governmental Entity involving the Company or any of its Subsidiaries
with respect to the Money Laundering Laws is pending or, to the Knowledge of the Company, threatened.
25
Section
5.38. ERISA. The Company and its Subsidiaries and any “employee benefit plan” (as defined under the Employee Retirement
Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”))
established or maintained by the Company, its Subsidiaries or their “ERISA Affiliates” (as defined below) are in compliance
in all material respects with ERISA. “ERISA Affiliate” means, with respect to the Company or any of its Subsidiaries,
any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended,
and the regulations and published interpretations thereunder (the “Code”) of which the Company or such Subsidiary
is a member. No “reportable event” (as defined under ERISA), for which notice has not been waived, has occurred or is reasonably
expected to occur with respect to any “employee benefit plan” established or maintained by the Company, its Subsidiaries
or any of their ERISA Affiliates that would reasonably be expected to result in a material liability to the Company and its Subsidiaries.
No “employee benefit plan” established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates, if
such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined
under ERISA) that would reasonably be expected to result in a material liability to the Company and its Subsidiaries. Neither the Company,
its Subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any material liability under (i) Title
IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections 412, 4971, 4975
or 4980B of the Code. Each employee benefit plan established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates
that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the Knowledge of the Company, nothing has occurred,
whether by action or failure to act, which would reasonably be expected to cause the loss of such qualification.
Section
5.39. IT Systems. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, to the Company’s Knowledge, the Company and its Subsidiaries’ information technology assets and equipment, computers,
systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are
adequate for, and operate and perform as required in connection with the operation of the business of the Company and its Subsidiaries
as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants.
Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, the Company and its
Subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures,
and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and
security of all IT Systems and data, including “Personal Data,” processed by them in connection with their businesses. “Personal
Data” means the following data in the Company’s and its Subsidiaries’ possession or control and processed by
them in connection with their business (i) a natural person’s name, street address, telephone number, e-mail address, photograph,
social security number or tax identification number, driver’s license number, passport number, credit card number, individually
identifiable bank information, or customer or account number; (ii) any information which would qualify as “personally identifying
information” under the Federal Trade Commission Act, as amended; (iii) “personal data” as defined by GDPR; (iv) any
information which would qualify as “protected health information” under HIPAA; and (v) any other piece of information that
allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related to
an identified person’s health or individually identifiable sexual orientation. Except as would not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect, to the Company’s Knowledge, (i) there have been no breaches, violations,
outages or unauthorized uses of or accesses to same nor any incidents under internal review or investigations relating to the same; and
(ii) the Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules
and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating
to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized
use, access, misappropriation or modification.
26
Section
5.40. Compliance with Data Privacy Laws. To the Company’s Knowledge, the Company and its Subsidiaries are, and at all
prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations (collectively,
the “Privacy Laws”). To ensure compliance with the Privacy Laws, the Company and its Subsidiaries have in place,
comply with, and take commercially reasonable steps reasonably designed to ensure compliance in all material respects with their policies
and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal
Data (as defined below) (the “Policies”). The Company and its Subsidiaries have at all times made all disclosures
to users or customers required by the Privacy Laws, and none of such disclosures made or contained in any Policy have, to the knowledge
of the Company, been inaccurate or in violation of any Privacy Laws in any material respect. The Company further certifies that neither
it nor any Subsidiary: (i) has received written notice of any actual or potential liability under or relating to, or actual or potential
violation of, any of the Privacy Laws, (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation,
or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement from or with a governmental
or regulatory authority or agency that imposes any obligation or liability under any Privacy Law.
Section
5.41. U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been, and so
long as any of the Shares are held by the Investor, shall become a U.S. real property holding corporation within the meaning of Section
897 of the Code.
Section
5.42. Margin Rules. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the
Company as described in the Commission Documents will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System
or any other regulation of such Board of Governors.
Section
5.43. Smaller Reporting Company Status. As of the Closing Date the Company was, and as of the Commencement Date the Company
will be, a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.
Section
5.44. No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”)
is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act
(a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under
the Securities Act. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event.
27
Section
5.45. Market Capitalization. As of the date of this Agreement, the aggregate market value of the outstanding voting and non-voting
common equity (as defined in Rule 405 of the Securities Act) of the Company held by Persons other than Affiliates of the Company (pursuant
to Rule 144, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common
control with, the Company) (the “Non-Affiliate Shares”), was approximately $6.5 million (calculated by multiplying
(i) the highest price at which the common equity of the Company closed on the Trading Market within 60 days of the date of this Agreement
by (ii) the number of Non-Affiliate Shares).
Section
5.46. Broker/Dealer Relationships; FINRA Information. Neither the Company nor any of the Subsidiaries (i) is required
to register as a “broker” or “dealer” in accordance with the provisions of the Exchange Act or (ii) directly
or indirectly through one or more intermediaries, controls or is a “person associated with a member” or “associated
person of a member” (within the meaning set forth in the FINRA Manual). All of the information provided to the Investor, RCP or
to their counsel, specifically for use by RCP in connection with the FINRA Filing (and related disclosure) with FINRA, by the Company,
its counsel, its officers and directors and the holders of any securities (debt or equity) or options to acquire any securities of the
Company in connection with the transactions contemplated by the Transaction Documents is true, complete, correct and compliant with FINRA’s
rules and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules.
Section
5.47. Acknowledgement Regarding Relationship with Investor and RCP. The Company acknowledges and agrees, to the fullest
extent permitted by Law, that the Investor is acting solely in the capacity of an arm’s-length purchaser with respect to this Agreement,
the Registration Rights Agreement and the transactions contemplated by the Transaction Documents, and RCP is acting as a representative
of the Investor in connection with the transactions contemplated by the Transaction Documents, and of no other party, including the Company.
The Company further acknowledges that while the Investor will be deemed to be a statutory “underwriter” with respect to certain
of the transactions contemplated by the Transaction Documents in accordance with interpretive positions of the Staff of the Commission,
the Investor is a “trader” that is not required to register with the Commission as a broker-dealer under Section 15(a) of
the Exchange Act. The Company further acknowledges that the Investor and its representatives are not acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to this Agreement, the Registration Rights Agreement and the transactions
contemplated by the Transaction Documents, and any advice given by the Investor or any of its representatives (including RCP) or agents
in connection therewith is merely incidental to the Investor’s acquisition of the Shares. The Company understands and acknowledges
that employees of RCP may discuss market color, Purchase Notice timing and parameter considerations and other related capital markets
considerations with the Company in connection with the Transaction Documents and the transactions contemplated thereby, in all cases
on behalf of the Investor. The Company acknowledges and agrees that the Investor has not made and does not make any representations or
warranties with respect to the transactions contemplated by the Transaction Documents other than those specifically set forth in Article
IV.
28
Section
5.48. Acknowledgement Regarding Investor’s Affiliate Relationships. Affiliates of the Investor, including RCP, engage
in a wide range of activities for their own accounts and the accounts of customers, including corporate finance, mergers and acquisitions,
merchant banking, equity and fixed income sales, trading and research, derivatives, foreign exchange, futures, asset management, custody,
clearance and securities lending. In the course of their respective business, Affiliates of the Investor may, directly or indirectly,
hold long or short positions, trade and otherwise conduct such activities in or with respect to debt or equity securities or bank debt
of, or derivative products relating to, the Company. Any such position will be created, and maintained, independently of the position
the Investor takes in the Company. In addition, at any given time Affiliates of the Investor, including RCP, may have been or in the
future may be engaged by one or more entities that may be competitors with, or otherwise adverse to, the Company in matters unrelated
to the transactions contemplated by the Transaction Documents, and Affiliates of the Investor, including RCP may have or may in the future
provide investment banking or other services to the Company in matters unrelated to the transactions contemplated by the Transaction
Documents. Activities of any of the Investor’s Affiliates performed on behalf of the Company may give rise to actual or apparent
conflicts of interest given the Investor’s potentially competing interests with those of the Company. The Company expressly acknowledges
the benefits it receives from the Investor’s participation in the transactions contemplated by the Transaction Documents, on the
one hand, and the Investor’s Affiliates’ activities, if any, on behalf of the Company unrelated to the transactions contemplated
by the Transaction Documents, on the other hand, and understands the conflict or potential conflict of interest that may arise in this
regard, and has consulted with such independent advisors as it deems appropriate in order to understand and assess the risks associated
with these potential conflicts of interest. Consistent with applicable legal and regulatory requirements, applicable Affiliates of the
Investor have adopted policies and procedures to establish and maintain the independence of their research departments and personnel
from their investment banking groups and the Investor. As a result, research analysts employed by Affiliates of the Investor may hold
views, make statements or investment recommendations or publish research reports with respect to the Company or the transactions contemplated
by the Transaction Documents that differ from the views of the Investor.
Article
VI
ADDITIONAL
COVENANTS
The
Company covenants with the Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the
benefit of the other party, during the Investment Period (and with respect to the Company, for the period following the termination of
this Agreement specified in Section 8.3 pursuant to and in accordance with Section 8.3):
Section
6.1. Securities Compliance. The Company shall notify the Commission and the Trading Market (or, if applicable, other Eligible
Market), if and as applicable, in accordance with their respective rules and regulations, of the transactions contemplated by the Transaction
Documents, and shall take all necessary action, undertake all proceedings and obtain all registrations, permits, consents and approvals
for the legal and valid issuance of the Shares to the Investor in accordance with the terms of the Transaction Documents, as applicable.
29
Section
6.2. Reservation of Common Stock. The Company has available and the Company shall reserve and keep available at all times,
free of preemptive and other similar rights of stockholders, the requisite aggregate number of authorized but unissued shares of Common
Stock to enable the Company to timely effect the issuance, sale and delivery of all Shares to be issued, sold and delivered in respect
of each Purchase effected under this Agreement, at least prior to the delivery by the Company to the Investor of the applicable Purchase
Notice in connection with such Purchase. Without limiting the generality of the foregoing, as of the date of this Agreement the Company
has reserved, and as of the Commencement Date shall have continued to reserve, out of its authorized and unissued Common Stock, [●]
shares of Common Stock solely for the purpose of issuing Shares pursuant to one or more Purchases that may be effected by the Company,
in its sole discretion, from time to time from and after the Commencement Date under this Agreement. The number of shares of Common Stock
so reserved for the purpose of effecting issuances of Shares pursuant to Purchases under this Agreement (as applicable) may be increased
from time to time by the Company from and after the Commencement Date, and such number of reserved shares may be reduced from and after
the Commencement Date only by the number of Shares actually issued, sold and delivered to the Investor pursuant to any Purchase effected
from and after the Commencement Date pursuant to this Agreement.
Section
6.3. Registration and Listing. The Company shall use its commercially reasonable efforts to cause the Common Stock to continue
to be registered as a class of securities under Section 12(b) of the Exchange Act, and to comply with its reporting and filing obligations
under the Exchange Act, and shall not take any action or file any document (whether or not permitted by the Securities Act or the Exchange
Act) to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under the Exchange Act
or Securities Act, except as permitted herein. The Company shall use its commercially reasonable efforts to continue the listing and
trading of its Common Stock and the listing of the Shares purchased or acquired by the Investor hereunder on the Trading Market (or another
Eligible Market) and to comply with the Company’s reporting, filing and other obligations under the rules and regulations of the
Trading Market (or other Eligible Market, as applicable). The Company shall not take any action which could be reasonably expected to
result in the delisting or suspension of the Common Stock on the Trading Market (or other Eligible Market, as applicable). If the Company
receives any final and non-appealable notice that the listing or quotation of the Common Stock on the Trading Market (or other Eligible
Market, as applicable) shall be terminated on a date certain, the Company shall promptly (and in any case within 24 hours) notify the
Investor of such fact in writing and shall use its commercially reasonable efforts to cause the Common Stock to be listed or quoted on
another Eligible Market.
30
Section
6.4. Compliance with Laws.
(i)
During the Investment Period, the Company shall comply, and cause each of its Subsidiaries to comply, with (a) all Laws and Orders applicable
to the business and operations of the Company and its Subsidiaries, except as would not reasonably be expected to have a Material Adverse
Effect and (b) with applicable provisions of the Securities Act, the Exchange Act, including Regulation M thereunder, applicable state
securities or “blue sky” Laws, and applicable listing rules of the Trading Market (or, if the Common Stock is listed for
trading on any Eligible Market, applicable listing rules of such Eligible Market), in connection with the transactions contemplated by
this Agreement and the Registration Rights Agreement, except as would not, individually or in the aggregate, prohibit or otherwise interfere
with the ability of the Company to enter into and perform its obligations under this Agreement in any material respect or for Investor
to conduct resales of Shares under the Registration Statement and the Prospectus contained therein in any material respect. Without limiting
the foregoing, neither the Company nor any of its Subsidiaries, nor to the Knowledge of the Company, any of its or their respective directors,
officers, agents, employees or any other Persons acting on their behalf shall, in connection with the operation of the Company’s
and its Subsidiaries’ respective businesses, (1) use any corporate funds for unlawful contributions, payments, gifts or entertainment
or to make any unlawful expenditures relating to political activity to government officials, candidates or members of political parties
or organizations, (2) pay, accept or receive any unlawful contributions, payments, expenditures or gifts, or (3) violate or operate in
noncompliance with any export restrictions, anti-boycott regulations, embargo regulations or other applicable Laws, including, without
limitation, the FCPA, OFAC and Money Laundering Laws.
(ii)
The Investor shall comply with all Laws and Orders applicable to the performance by it of its obligations under this Agreement and its
investment in the Shares, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the ability of
the Investor to enter into and perform its obligations under this Agreement in any material respect. Without limiting the foregoing,
the Investor shall comply with all applicable provisions of the Securities Act and the Exchange Act, including Regulation M thereunder,
the rules and regulations of FINRA, and all applicable state securities or “blue sky” Laws.
Section
6.5. Keeping of Records and Books of Account; Due Diligence.
(i)
The Investor and the Company shall each maintain records showing the remaining Total Commitment, the remaining Aggregate Limit, the Purchase
Date and Market Open Purchase Share Amount for each Market Open Purchase, the Purchase Date and Intraday Purchase Share Amount for each
Intraday Purchase, the Purchase Date and Pre-Market Purchase Share Amount for each Pre-Market Purchase, and the Purchase Date and Post-Market
Purchase Share Amount for each Post-Market Purchase.
(ii)
Subject to the requirements of Section 6.12, from time to time from and after the Closing Date, the Company shall make available for
inspection and review by the Investor during normal business hours and after reasonable notice, customary documentation reasonably requested
by the Investor and/or its appointed counsel or advisors to conduct due diligence; provided, however, that after the Closing
Date, the Investor’s continued due diligence shall not be a condition precedent to the Commencement or to the Investor’s
obligation to accept each Purchase Notice timely delivered by the Company to the Investor in accordance with this Agreement.
31
Section
6.6. No Frustration; No Variable Rate Transactions; No Sales Prior to Effective Date.
(i)
No Frustration. The Company shall not enter into, announce or recommend to its stockholders any agreement, plan, arrangement
or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the
Company to perform its obligations under the Transaction Documents to which it is a party, including, without limitation, the obligation
of the Company to (i) pay or cause to be paid to the Investor the Commitment Fee, pursuant to, at such time(s) and in such manner as
set forth in Section 10.1(ii) of this Agreement, and (ii) deliver the Shares to the Investor in respect of each Purchase effected by
the Company pursuant to this Agreement, in each case not later than the applicable Purchase Share Delivery Date with respect to such
Purchase in accordance with Section 3.4. For the avoidance of doubt, nothing in this Section 6.6(i) shall in any way limit the Company’s
right to terminate this Agreement in accordance with Section 8.2 (subject in all cases to Section 8.3).
(ii)
No Variable Rate Transactions. The Company shall not effect or enter into an agreement to effect any issuance by the Company
or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate
Transaction, other than in connection with an Exempt Issuance. The Investor shall be entitled to seek injunctive relief against the Company
and its Subsidiaries to preclude any such issuance, which remedy shall be in addition to any right to collect damages, without the necessity
of showing economic loss and without any bond or other security being required.
(iii)
No Sales Prior to Effective Date. The Company will not, without the prior written consent of the Investor (such consent
not to be unreasonably withheld, conditioned or delayed), from the date of this Agreement and continuing to the Effective Date of the
Initial Registration Statement (but in no event later than the thirtieth (30th) calendar day following the date of this Agreement), (i)
offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any shares
of Common Stock or any Common Stock Equivalents (or any combination thereof) or (ii) enter into any swap or other agreement that transfers,
in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause
(i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, except (A) the issuance
by the Company of shares of Common Stock upon the exercise of any stock options or warrants, or upon the conversion, or in payment of
dividends or interest on, any shares of preferred stock or convertible notes of the Company, outstanding as of the date hereof and disclosed
in the Commission Documents; (B) the issuance by the Company of shares of Common Stock or securities convertible into shares of Common
Stock pursuant to the Company’s equity incentive plans in effect on the date hereof and described in the Commission Documents;
(C) the filing of a registration statement on Form S-8 with respect to the Company’s equity incentive plans in effect on the date
hereof and described in the Commission Documents; (D) the sale or issuance of or entry into an agreement providing for the issuance of
shares of Common Stock, or any security convertible into or exercisable for shares of Common Stock, in connection with the acquisition
by the Company of the securities, business or assets of another person or entity or pursuant to an employee benefit plan assumed by the
Company in connection with such acquisition, or in connection with joint ventures, commercial relationships or other strategic transactions;
provided, that the aggregate number of shares of Common Stock that the Company may sell or issue or agree to sell or issue pursuant to
this clause (D) shall not exceed 5% of the total number of shares of Common Stock issued and outstanding as of the date of this Agreement;
or (E) the issuance and sale of the Series A Convertible Preferred Stock and the Related Warrants, and the issuance of shares of Common
Stock upon conversion of the Series A Convertible Preferred Stock or the Mayers Note or upon exercise of the Related Warrants (and in
payment of dividends or interest thereon), in each case constituting a Permitted Company Financing (as defined in the definition of “Exempt
Issuance”). Certain Acknowledgments Regarding Permitted Company Financings. The Company and the Investor acknowledge and agree
that the Permitted Company Financings contain anti-dilution and other price-adjustment provisions that may be triggered by, and result
in adjustments as a consequence of, the issuance and sale of Shares to the Investor under this Agreement, and that no such adjustment
shall, in and of itself, constitute a breach by the Company of this Agreement.
Certain
Acknowledgments Regarding Permitted Company Financings. The Company and the Investor acknowledge and agree that the Permitted Company
Financings contain anti-dilution and other price-adjustment provisions that may be triggered by, and result in adjustments as a consequence
of, the issuance and sale of Shares to the Investor under this Agreement, and that no such adjustment shall, in and of itself, constitute
a breach by the Company of this Agreement.
32
Section
6.7. Corporate Existence. The Company shall take all steps necessary to preserve and continue the corporate existence of the
Company; provided, however, that, except as provided in Section 6.8, nothing in this Agreement shall be deemed to prohibit
the Company from engaging in any Fundamental Transaction with another Person. For the avoidance of doubt, nothing in this Section 6.7
shall in any way limit the Company’s right to terminate this Agreement in accordance with Section 8.2 (subject in all cases to
Section 8.3).
Section
6.8. Fundamental Transaction. If a Purchase Notice has been delivered to the Investor and the transactions contemplated therein
have not yet been fully settled in accordance with Section 3.4 of this Agreement, the Company shall not effect any Fundamental Transaction
until the expiration of five (5) Trading Days following the date of full settlement thereof and the issuance to the Investor of all of
the Shares that are issuable to the Investor pursuant to the Purchase to which such Purchase Notice relates.
Section
6.9. Selling Restrictions.
(i)
Except as expressly set forth below, the Investor covenants that from and after the Closing Date through and including the Trading Day
next following the expiration or termination of this Agreement as provided in Article VIII (the “Restricted Period”),
none of the Investor, any of its officers, or any entity managed or controlled by the Investor (collectively, the “Restricted
Persons” and each of the foregoing is referred to herein as a “Restricted Person”) shall, directly
or indirectly, for the principal account of the Investor or any such entity managed or controlled by the Investor, (i) engage in any
Short Sales of the Common Stock or (ii) hedging transaction, which establishes a net short position with respect to the Common Stock.
Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein shall (without implication that the
contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (1) selling “long” (as
defined under Rule 200 promulgated under Regulation SHO) the Shares; or (2) selling a number of shares of Common Stock equal to the number
of Shares that the Investor is unconditionally obligated to purchase under any pending Purchase Notice for any Purchase, but has not
yet received from the Company or its transfer agent pursuant to this Agreement, so long as (X) the Investor (or its Broker-Dealer, as
applicable) delivers the Shares purchased pursuant to such pending Purchase Notice to the purchaser thereof promptly upon the Investor’s
receipt of such Shares from the Company in accordance with Section 3.4 of this Agreement and (Y) neither the Company nor its transfer
agent shall have failed for any reason to deliver such Shares to the Investor or its Broker-Dealer so that such Shares are timely received
by the Investor as DWAC Shares on the applicable Purchase Share Delivery Date for such pending Purchase in accordance with Section 3.4
of this Agreement.
(ii)
In addition to the foregoing, in connection with any sale of Shares (including any sale permitted by paragraph (i) above), the Investor
shall comply in all respects with all applicable Laws and Orders, including, without limitation, the requirements of the Securities Act
and the Exchange Act.
33
Section
6.10. Effective Registration Statement. During the Investment Period, the Company shall use its commercially reasonable efforts
to maintain the continuous effectiveness of the Initial Registration Statement and each New Registration Statement filed with the Commission
under the Securities Act for the applicable Registration Period pursuant to and in accordance with the Registration Rights Agreement.
Section
6.11. Blue Sky. The Company shall take such action, if any, as is necessary by the Company in order to obtain an exemption
for or to qualify the Shares for sale by the Company to the Investor pursuant to the Transaction Documents, and at the request of the
Investor, the subsequent resale of Registrable Securities by the Investor, in each case, under applicable state securities or “blue
sky” Laws and shall provide evidence of any such action so taken to the Investor from time to time following the Closing Date;
provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 6.11, (y) subject itself
to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.
Section
6.12. Non-Public Information. Neither the Company or any of its Subsidiaries, nor any of their respective directors, officers,
employees or agents shall disclose any material non-public information about the Company to the Investor, unless a simultaneous public
announcement thereof is made by the Company in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant
by the Company or any of its Subsidiaries, or any of their respective directors, officers, employees and agents (as determined in the
reasonable good faith judgment of the Investor), (i) the Investor shall promptly provide written notice of such breach to the Company
and (ii) after such notice has been provided to the Company and, provided that the Company shall have failed to publicly disclose such
material, non-public information within 24 hours following demand therefor by the Investor or the Company shall have failed to demonstrate
to the Investor in writing within 24 hours that such information does not constitute material, non-public information, in addition to
any other remedy provided herein or in the other Transaction Documents, the Investor shall have the right to make a public disclosure,
in the form of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval
by the Company, any of its Subsidiaries, or any of their respective directors, officers, employees or agents. The Investor shall not
have any liability to the Company, any of its Subsidiaries, or any of their respective directors, officers, employees, stockholders or
agents, for any such disclosure.
Section
6.13. Broker-Dealer. The Investor shall use RCP, a registered broker-dealer, FINRA member, and an Affiliate of the Investor
(or another registered broker-dealer/FINRA member) to effectuate all sales, if any, of the Shares that it may purchase or otherwise acquire
from the Company pursuant to the Transaction Documents, as applicable (collectively, the “Broker-Dealer”).
The Investor shall, from time to time, provide the Company and the Company’s transfer agent with all information regarding the
Broker-Dealer reasonably requested by the Company. The Investor shall be solely responsible for all fees and commissions of the Broker-Dealer
(if any), which shall not exceed customary brokerage fees and commissions and shall be responsible for designating only a DTC participant
eligible to receive DWAC Shares.
34
Section
6.14. FINRA Filing. The Company shall assist the Investor and RCP with RCP’s preparation and filing with FINRA’s
Corporate Financing Department via the Public Offering System of all documents and information required to be filed with FINRA pursuant
to FINRA Rule 5110 with regard to the transactions contemplated by this Agreement (the “FINRA Filing”). In
connection therewith, on or prior to the date the FINRA Filing is first made by RCP with FINRA, the Company shall pay to FINRA by wire
transfer of immediately available funds the applicable filing fee with respect to the FINRA Filing, and the Company shall be solely responsible
for payment of such fee. The parties hereby agree to provide each other and RCP all requisite information and otherwise to assist each
other and RCP in a timely fashion in order for RCP to complete the preparation and submission of the FINRA Filing in accordance with
this Section 6.14 and to assist RCP in promptly responding to any inquiries or requests from FINRA or its staff. Each party hereto shall
(a) promptly notify the other party and RCP of any communication to that party or its Affiliates from FINRA, including, without limitation,
any request from FINRA or its staff for amendments or supplements to or additional information in respect of the FINRA Filing and permit
the other party and RCP to review in advance any proposed written communication to FINRA and (b) furnish the other party and RCP with
copies of all written correspondence, filings and communications between them and their affiliates and their respective representatives
and advisors, on the one hand, and FINRA or members of its staff, on the other hand, with respect to this Agreement, the Registration
Rights Agreement or the transactions contemplated by the Transaction Documents. Each of the parties hereto agrees to use its commercially
reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other
party and RCP in doing, all things necessary, proper or advisable in order for RCP to obtain as promptly as practicable written confirmation
from FINRA to the effect that FINRA’s Corporate Financing Department has determined not to raise any objection with respect to
the fairness and reasonableness of the terms of the transactions contemplated by the Transaction Documents. Notwithstanding anything
to the contrary contained in this Agreement, the Commencement Date shall not occur, unless and until RCP shall have received written
confirmation from FINRA to the effect that FINRA’s Corporate Financing Department has determined not to raise any objection with
respect to the fairness and reasonableness of the terms of the transactions contemplated by this Agreement.
Section
6.15. QIU. If the Investor or any of its Affiliates, including RCP, reasonably determines that a Qualified Independent Underwriter
is required to participate in the transactions contemplated by the Transaction Documents in order for such transactions to be in full
compliance with the rules and regulations of FINRA, including, without limitation, FINRA Rule 5121, each of the parties hereto shall
have executed such documentation as may reasonably be required to engage a Qualified Independent Underwriter to participate in the transactions
contemplated by the Transaction Documents in accordance with the rules and regulations of FINRA, including, without limitation, FINRA
Rule 5121 (including an engagement agreement setting forth the terms of such engagement of such Qualified Independent Underwriter, including
the amount of compensation to be paid to such Qualified Independent Underwriter).
35
Section
6.16. Disclosure Schedule.
(i)
The Company may, from time to time, update the Disclosure Schedule as may be required to satisfy the conditions set forth in Section
7.2(i) and Section 7.3(i) (to the extent such condition set forth in Section 7.3(i) relates to the condition in Section 7.2(i) as of
a specific Purchase Condition Satisfaction Time). For purposes of this Section 6.16, any disclosure made in a schedule to the Compliance
Certificate shall be deemed to be an update of the Disclosure Schedule. Notwithstanding anything in this Agreement to the contrary, no
update to the Disclosure Schedule pursuant to this Section 6.16 shall cure any breach of a representation or warranty of the Company
contained in this Agreement and made prior to the update and shall not affect any of the Investor’s rights or remedies with respect
thereto.
(ii)
Notwithstanding anything to the contrary contained in the Disclosure Schedule or in this Agreement, the information and disclosure contained
in any Schedule of the Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in any other Schedule of the
Disclosure Schedule as though fully set forth in such Schedule for which applicability of such information and disclosure is readily
apparent on its face. The fact that any item of information is disclosed in the Disclosure Schedule shall not be construed to mean that
such information is required to be disclosed by this Agreement. Except as expressly set forth in this Agreement, such information and
the thresholds (whether based on quantity, qualitative characterization, dollar amounts or otherwise) set forth herein shall not be used
as a basis for interpreting the terms “material” or “Material Adverse Effect” or other similar terms in this
Agreement.
Section
6.17. Delivery of Compliance Certificates, Bring-Down Negative Assurance Letters and Bring-Down Comfort Letters Upon Occurrence of
Certain Events. Within three (3) Trading Days immediately following: (i) each date on which the Company files with the Commission
(A) an annual report on Form 10-K under the Exchange Act, (B) a Form 10-K/A containing amended (or restated) financial information or
a material amendment to a previously filed annual report on Form 10-K, (C) a quarterly report on Form 10-Q under the Exchange Act, or
(D) a current report on Form 8-K containing amended (or restated) financial information (other than information “furnished”
pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification
of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange
Act; and (ii) the effective date of (A) each post-effective amendment to the Initial Registration Statement, (B) each New Registration
Statement and (C) each post-effective amendment to each New Registration Statement, and in any case, not more than once per calendar
quarter (each, a “Representation Date”), the Company shall (I) deliver to the Investor a Compliance Certificate,
dated the date of delivery to the Investor, (II) cause to be furnished to the Investor an opinion and negative assurance letter “bring-down”
from outside counsel to the Company, dated the date of delivery to the Investor, substantially in the form mutually agreed to by the
Company and the Investor prior to the date of this Agreement, modified, as necessary, to relate to a New Registration Statement or a
post-effective amendment to the Initial Registration Statement or a New Registration Statement, and the Prospectus contained in a Registration
Statement or post-effective amendment as then amended or supplemented by any Prospectus Supplement thereto as of the date of such letter,
as applicable (each, a “Bring-Down Negative Assurance Letter”) and (III) other than with respect to a Representation
Date pursuant to clause (i)(C) above, cause to be furnished to the Investor a customary “comfort letter” provided by the
Accountant, or a successor independent registered public accounting firm for the Company (as applicable), dated the date of delivery
to the Investor, substantially in the form, scope and substance as the information contained in the Initial Comfort Letter (to the extent
such information is then applicable), stating, as of such date, the conclusions and findings of such firm with respect to the financial
information and other matters covered by the Initial Comfort Letter (to the extent such financial information or other matters are then
applicable), modified, as necessary, to address such new, amended or restated financial information contained in any of the Commission
Documents referred to in clause (i) above or to relate to a New Registration Statement or a post-effective amendment to the Initial Registration
Statement or a New Registration Statement, or the Prospectus contained in a Registration Statement or post-effective amendment as then
amended or supplemented by any Prospectus Supplement thereto as of the date of such letter, as applicable (each, a “Bring-Down
Comfort Letter”). The requirement to provide the documents identified in the previous sentence shall be tolled with respect
to any Representation Date, if (A) the Company has given written notice to the Investor (with a copy to its counsel) in accordance with
Section 10.4, not later than one (1) Trading Day prior to the applicable Representation Date, of the Company’s decision to suspend
delivery of Purchase Notices for future Purchases (each, a “Future Purchase Suspension”) (it being hereby acknowledged
and agreed that no Future Purchase Suspension shall limit, alter, modify, change or otherwise affect any of the Company’s or the
Investor’s rights or obligations under the Transaction Documents with respect to any pending Purchase that has not been fully settled
in accordance with the terms and conditions of this Agreement, and that the parties shall fully perform their respective obligations
with respect to any such pending Purchase under the Transaction Documents), and (B) such Representation Date does not occur during the
period beginning on the Trading Day immediately preceding the Purchase Date for a Purchase and ending on the third (3rd) Trading
Day following the date of full settlement thereof and the issuance to the Investor of all of the Shares that are issuable to the Investor
pursuant to such Purchase, which tolling shall continue until the earlier to occur of (1) the Trading Day immediately preceding the Purchase
Date for such Purchase, which for such calendar quarter shall be considered a Representation Date, and (2) the next occurring Representation
Date. Notwithstanding the foregoing, if the Company subsequently decides to deliver a Purchase Notice following a Representation Date
when a Future Purchase Suspension was in effect and did not provide the Investor with the documents identified in clauses (I), (II) and
(III) of the first sentence of this Section 6.17, then prior to the Company’s delivery to the Investor of such Purchase Notice
on a Purchase Date, the Company shall provide the Investor with the documents identified in clauses (I), (II) and (III) of the first
sentence of this Section 6.17, dated as of the applicable Purchase Date.
36
Article
VII
CONDITIONS
TO CLOSING, COMMENCEMENT AND PURCHASES
Section
7.1. Conditions Precedent to Closing. The Closing is subject to the satisfaction of each of the conditions set forth in this
Section 7.1 on the Closing Date.
(i)
Accuracy of the Investor’s Representations and Warranties. The representations and warranties of the Investor contained
in this Agreement (a) that are not qualified by “materiality” shall be true and correct in all material respects as of the
Closing Date, except to the extent such representations and warranties are as of another date, in which case, such representations and
warranties shall be true and correct in all material respects as of such other date and (b) that are qualified by “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in
which case, such representations and warranties shall be true and correct as of such other date.
(ii)
Accuracy of the Company’s Representations and Warranties. The representations and warranties of the Company contained
in this Agreement (a) that are not qualified by “materiality” or “Material Adverse Effect” shall be true and
correct in all material respects as of the Closing Date, except to the extent such representations and warranties are as of another date,
in which case, such representations and warranties shall be true and correct in all material respects as of such other date and (b) that
are qualified by “materiality” or “Material Adverse Effect” shall be true and correct as of the Closing Date,
except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct as of such other date.
(iii)
Payment of Initial Investor Legal Fee Expense Reimbursement. On the Closing Date, the Company shall pay by wire transfer
of immediately available funds to an account designated by the Investor (or the Investor’s counsel, as applicable) on or prior
to the date hereof, the Initial Investor Legal Fee Expense Reimbursement in accordance with Section 10.1(i), all of which Initial Investor
Legal Fee Expense Reimbursement shall be fully earned by the Investor and shall be non-refundable as of the Closing Date, regardless
of whether the Commencement occurs or whether any Purchases are made or settled hereunder or any subsequent termination of this Agreement.
(iv)
Closing Deliverables. At the Closing, counterpart signature pages of this Agreement and the Registration Rights Agreement
executed by each of the parties hereto shall be delivered as provided in Section 2.2. Simultaneously with the execution and delivery
of this Agreement and the Registration Rights Agreement, the Investor’s counsel shall have received (a) the opinions of outside
counsel to the Company, dated the Closing Date, in the forms mutually agreed to by the Company and the Investor prior to the date of
this Agreement, (b) the closing certificate from the Company, dated the Closing Date, in the form of Exhibit B hereto, and (c)
as applicable, counterpart signature pages of any engagement agreement between the Company and the Qualified Independent Underwriter
engaged by the Company pursuant to Section 6.15 executed by each of the parties thereto.
Section
7.2. Conditions Precedent to Commencement. The right of the Company to commence delivering Purchase Notices under this Agreement,
and the obligation of the Investor to accept Purchase Notices timely delivered to the Investor by the Company under this Agreement, are
subject to the initial satisfaction, at Commencement, of each of the conditions set forth in this Section 7.2.
(i)
Accuracy of the Company’s Representations and Warranties. The representations and warranties of the Company contained
in this Agreement (a) that are not qualified by “materiality” or “Material Adverse Effect” shall have been true
and correct in all material respects when made and shall be true and correct in all material respects as of the Commencement Date with
the same force and effect as if made on such date, except to the extent such representations and warranties are as of another date, in
which case, such representations and warranties shall be true and correct in all material respects as of such other date and (b) that
are qualified by “materiality” or “Material Adverse Effect” shall have been true and correct when made and shall
be true and correct as of the Commencement Date with the same force and effect as if made on such date, except to the extent such representations
and warranties are as of another date, in which case, such representations and warranties shall be true and correct as of such other
date.
37
(ii)
Performance of the Company. The Company shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied
with by the Company at or prior to the Commencement. The Company shall deliver to the Investor on the Commencement Date the compliance
certificate substantially in the form attached hereto as Exhibit C (the “Compliance Certificate”).
(iii)
Initial Registration Statement Effective. The Initial Registration Statement covering the resale by the Investor of the
Registrable Securities included therein required to be filed by the Company with the Commission pursuant to Section 2(a) of the Registration
Rights Agreement shall have been declared effective under the Securities Act by the Commission, and the Investor shall be permitted to
utilize the Prospectus therein to resell all of the Shares included in such Prospectus.
(iv)
No Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request by
the Commission or any other Governmental Entity for any additional information relating to the Initial Registration Statement, the Prospectus
contained therein or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement,
the Prospectus contained therein or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other Governmental Entity
of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of the Prospectus
contained therein or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification of the
Shares for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose; (c)
the objection of FINRA to the terms of the transactions contemplated by the Transaction Documents or (d) the occurrence of any event
or the existence of any condition or state of facts, which makes any statement of a material fact made in the Initial Registration Statement,
the Prospectus contained therein or any Prospectus Supplement thereto untrue or which requires the making of any additions to or changes
to the statements then made in the Initial Registration Statement, the Prospectus contained therein or any Prospectus Supplement thereto
in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then
made therein (in the case of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were made) not
misleading, or which requires an amendment to the Initial Registration Statement or a supplement to the Prospectus contained therein
or any Prospectus Supplement thereto to comply with the Securities Act, any applicable state securities or “blue sky” Laws
or any other Law. The Company shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the
suspension of the effectiveness of the Initial Registration Statement or the prohibition or suspension of the use of the Prospectus contained
therein or any Prospectus Supplement thereto in connection with the resale of the Registrable Securities by the Investor.
38
(v)
Other Commission Filings. The Current Report and the Form D shall have been filed with the Commission as required pursuant
to Section 2.3. The final Prospectus included in the Initial Registration Statement shall have been filed with the Commission prior to
Commencement in accordance with Section 2.3 and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements,
information and other documents required to have been filed by the Company with the Commission pursuant to the reporting requirements
of the Exchange Act, including all material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act, prior
to Commencement shall have been filed with the Commission.
(vi)
No Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been suspended
by the Commission, the Trading Market or FINRA (except for any suspension of trading of limited duration agreed to by the Company, which
suspension shall be terminated prior to the Commencement Date), the Company shall not have received any final and non-appealable notice
that the listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior to such
date certain, the Common Stock is listed or quoted on any other Eligible Market), nor shall there have been imposed any suspension of,
or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to
the Common Stock that is continuing, the Company shall not have received any notice from DTC to the effect that a suspension of, or restriction
on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock
is being imposed or is contemplated (unless, prior to such suspension or restriction, DTC shall have notified the Company in writing
that DTC has determined not to impose any such suspension or restriction).
(vii)
Compliance with Laws. The Company shall have complied with all applicable Laws in connection with the execution, delivery
and performance of this Agreement and the other Transaction Documents to which it is a party and the consummation of the transactions
contemplated hereby and thereby, including, without limitation, the Company shall have obtained all permits and qualifications required
by any applicable state securities or “blue sky” Laws for the offer and sale of the Shares by the Company to the Investor
and the subsequent resale of the Registrable Securities by the Investor (or shall have the availability of exemptions therefrom).
(viii)
No Injunction. No Law or Order shall have been enacted, entered, promulgated, threatened or endorsed by any court or Governmental
Entity of competent jurisdiction which prohibits the consummation of or which would materially modify or delay any of the transactions
contemplated by the Transaction Documents.
(ix)
No Proceedings or Litigation. No Proceeding before any arbitrator or any court or Governmental Entity shall have been commenced,
and no inquiry or investigation by any Governmental Entity shall have been commenced, against the Company or any Subsidiary, or any of
the officers, directors or Affiliates of the Company or any Subsidiary, seeking to restrain, prevent or change the transactions contemplated
by the Transaction Documents, or seeking material damages in connection with such transactions.
39
(x)
Listing of Shares. All of the Shares that have been and may be issued pursuant to this Agreement shall have been approved
for listing or quotation on the Trading Market (or on an Eligible Market) as of the Commencement Date, subject only to notice of issuance.
(xi)
No Material Adverse Effect. No condition, occurrence, state of facts or event constituting a Material Adverse Effect shall
have occurred and be continuing.
(xii)
No Bankruptcy Proceedings. No Person shall have commenced a Proceeding against the Company pursuant to or within the meaning
of any Bankruptcy Law. The Company shall not have, pursuant to or within the meaning of any Bankruptcy Law, (a) commenced a voluntary
case, (b) consented to the entry of an Order for relief against it in an involuntary case, (c) consented to the appointment of a Custodian
of the Company or for all or substantially all of its property, or (d) made a general assignment for the benefit of its creditors. A
court of competent jurisdiction shall not have entered an Order or decree under any Bankruptcy Law that (I) is for relief against the
Company in an involuntary case, (II) appoints a Custodian of the Company or for all or substantially all of its property, or (III) orders
the liquidation of the Company.
(xiii)
Delivery of Commencement Irrevocable Transfer Agent Instructions and Notice of Effectiveness. The Commencement Irrevocable
Transfer Agent Instructions shall have been executed by the Company and delivered to and acknowledged in writing by the Company’s
transfer agent, and the Notice of Effectiveness relating to the Initial Registration Statement shall have been executed by the Company’s
outside counsel and delivered to the Company’s transfer agent, in each case directing such transfer agent to issue to the Investor
or its designated Broker-Dealer all of the Shares included in the Initial Registration Statement as DWAC Shares in accordance with this
Agreement and the Registration Rights Agreement.
(xiv)
Reservation of Shares. As of the Commencement Date, the Company shall have reserved out of its authorized and unissued
Common Stock, [●] shares of Common Stock solely for the purpose of issuing Shares pursuant to Purchases that may be effected by
the Company, in its sole discretion, from and after the Commencement Date under this Agreement.
(xv)
Opinions and Negative Assurances of Company Counsel. On the Commencement Date, the Investor shall have received the opinions
and negative assurances from outside counsel to the Company, dated the Commencement Date, in the forms mutually agreed to by the Company
and the Investor prior to the date of this Agreement.
(xvi)
Initial Comfort Letter of Company Auditor. On the Commencement Date, the Investor shall have received from the Accountant,
or a successor independent registered public accounting firm for the Company (as applicable), a letter dated the Commencement Date and
addressed to the Investor, in substantially the form, scope and substance mutually agreed to by the Company and the Investor at least
one (1) Trading Day prior to the date on which the Initial Registration Statement is first filed with the Commission, (i) confirming
that they are independent public accountants with respect to the Company within the meaning of the Securities Act and the Public Company
Accounting Oversight Board, and (ii) stating the conclusions and findings of such firm with respect to the audited and unaudited financial
statements and certain financial information contained or incorporated by reference in the Registration Statement and the Prospectus
(as supplemented by any Prospectus Supplement filed with the Commission on or prior to the Commencement Date), and certain other matters
customarily covered by auditor “comfort letters,” except that the specific date referred to therein for the carrying out
of procedures shall be no more than three (3) Trading Days prior to the Commencement Date (the “Initial Comfort Letter”).
40
(xvii)
FINRA No Objections. Prior to the Commencement Date, FINRA’s Corporate Financing Department shall have confirmed
in writing that it has determined not to raise any objection with respect to the fairness and reasonableness of the terms and arrangements
of the transactions contemplated by the Transaction Documents.
Section
7.3. Conditions Precedent to Purchases after Commencement Date. The right of the Company to deliver Purchase Notices under
this Agreement after the Commencement Date, and the obligation of the Investor to accept Purchase Notices timely delivered to the Investor
by the Company under this Agreement after the Commencement Date, are subject to the satisfaction of each of the conditions set forth
in this Section 7.3, (i) with respect to a Market Open Purchase Notice for a Market Open Purchase that is timely delivered by the Company
to the Investor in accordance with this Agreement, as of the Market Open Purchase Commencement Time of the applicable Market Open Purchase
Period for such Market Open Purchase to be effected pursuant to such Market Open Purchase Notice, (ii) with respect to an Intraday Purchase
Notice for an Intraday Purchase that is timely delivered by the Company to the Investor in accordance with this Agreement, as of the
Intraday Purchase Commencement Time of the applicable Intraday Purchase Period for such Intraday Purchase to be effected pursuant to
such Intraday Purchase Notice, (iii) with respect to a Pre-Market Purchase Notice for a Pre-Market Purchase that is timely delivered
by the Company to the Investor in accordance with this Agreement, as of the Pre-Market Purchase Commencement Time of the applicable Pre-Market
Purchase Period for such Pre-Market Purchase to be effected pursuant to such Pre-Market Purchase Notice, and (iv) with respect to a Post-Market
Purchase Notice for a Post-Market Purchase that is timely delivered by the Company to the Investor in accordance with this Agreement,
as of the Post-Market Purchase Commencement Time of the applicable Post-Market Purchase Period for such Post-Market Purchase to be effected
pursuant to such Post-Market Purchase Notice (each such Market Open Purchase Commencement Time, Intraday Purchase Commencement Time,
Pre-Market Purchase Commencement Time and Post-Market Purchase Commencement Time, at which time all such conditions must be satisfied,
a “Purchase Condition Satisfaction Time”).
(i)
Satisfaction of Certain Prior Conditions. Each of the conditions set forth in subsections (i), (ii), and (vii) through
(xii) set forth in Section 7.2 shall be satisfied at the applicable Purchase Condition Satisfaction Time after the Commencement Date
(with the terms “Commencement” and “Commencement Date” in the conditions set forth in subsections (i) and (ii)
of Section 7.2 replaced with “applicable Purchase Condition Satisfaction Time”); provided, however, that the
Company shall not be required to deliver the Compliance Certificate after the Commencement Date, except as provided in Section 6.17 and
Section 7.3(x).
41
(ii)
Initial Registration Statement Effective. The Initial Registration Statement covering the resale by the Investor of the
Registrable Securities included therein filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights
Agreement, and any post-effective amendment thereto required to be filed by the Company with the Commission after the Commencement Date
and prior to the applicable Purchase Date pursuant to the Registration Rights Agreement, in each case shall have been declared effective
under the Securities Act by the Commission and shall remain effective for the applicable Registration Period, and the Investor shall
be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell all of the Shares included in the Initial
Registration Statement, and any post-effective amendment thereto, that have been issued and sold to the Investor hereunder pursuant to
all Purchase Notices delivered by the Company to the Investor prior to such applicable Purchase Date and (c) all of the Shares included
in the Initial Registration Statement, and any post-effective amendment thereto, that are issuable pursuant to the applicable Purchase
Notice delivered by the Company to the Investor with respect to a Purchase to be effected hereunder on such applicable Purchase Date.
(iii)
Any Required New Registration Statement Effective. Any New Registration Statement covering the resale by the Investor of
the Registrable Securities included therein, and any post-effective amendment thereto, required to be filed by the Company with the Commission
pursuant to the Registration Rights Agreement after the Commencement Date and prior to the applicable Purchase Date for such Purchase,
in each case shall have been declared effective under the Securities Act by the Commission and shall remain effective for the applicable
Registration Period, and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to
resell all of the Shares included in such New Registration Statement, and any post-effective amendment thereto, that have been issued
and sold to the Investor hereunder pursuant to all Purchase Notices delivered by the Company to the Investor prior to such applicable
Purchase Date and (c) all of the Shares included in such new Registration Statement, and any post-effective amendment thereto, that are
issuable pursuant to the applicable Purchase Notice delivered by the Company to the Investor with respect to a Purchase to be effected
hereunder on such applicable Purchase Date.
(iv)
Delivery of Subsequent Irrevocable Transfer Agent Instructions and Notice of Effectiveness. With respect to any post-effective
amendment to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any New Registration
Statement, in each case declared effective by the Commission after the Commencement Date, the Company shall have delivered or caused
to be delivered to the Company’s transfer agent (a) irrevocable instructions in the form substantially similar to the Commencement
Irrevocable Transfer Agent Instructions executed by the Company and acknowledged in writing by its transfer agent and (b) the Notice
of Effectiveness, in each case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable
Securities included therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this
Agreement and the Registration Rights Agreement.
42
(v)
No Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request by
the Commission or any other Governmental Entity for any additional information relating to the Initial Registration Statement or any
post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement
or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other Governmental Entity of
any stop order suspending the effectiveness of the Initial Registration Statement or any post-effective amendment thereto, any New Registration
Statement or any post-effective amendment thereto, or prohibiting or suspending the use of the Prospectus contained in any of the foregoing
or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification of the Shares for offering
or sale in any jurisdiction, or the initiation or contemplated initiation of any Proceeding for such purpose; (c) the objection of FINRA
to the terms of the transactions contemplated by the Transaction Documents or (d) the occurrence of any event or the existence of any
condition or state of facts, which makes any statement of a material fact made in the Initial Registration Statement or any post-effective
amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the
foregoing or any Prospectus Supplement thereto untrue or which requires the making of any additions to or changes to the statements then
made in the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective
amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto in order to state a material
fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case
of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were made) not misleading, or which requires
an amendment to the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective
amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto to comply with the Securities
Act, any applicable state securities or “blue sky” Laws or any other Law (other than the transactions contemplated by the
applicable Purchase Notice delivered by the Company to the Investor with respect to a Purchase to be effected hereunder on such applicable
Purchase Date and the settlement thereof). The Company shall have no Knowledge of any event that could reasonably be expected to have
the effect of causing the suspension of the effectiveness of the Initial Registration Statement or any post-effective amendment thereto,
any New Registration Statement or any post-effective amendment thereto, or the prohibition or suspension of the use of the Prospectus
contained in any of the foregoing or any Prospectus Supplement thereto in connection with the resale of the Registrable Securities by
the Investor.
(vi)
Other Commission Filings. The final Prospectus included in any post-effective amendment to the Initial Registration Statement,
and any Prospectus Supplement thereto, required to be filed by the Company with the Commission pursuant to Section 2.3 and the Registration
Rights Agreement after the Commencement Date and prior to the applicable Purchase Date for such Purchase, shall have been filed with
the Commission in accordance with Section 2.3 and the Registration Rights Agreement. The final Prospectus included in any New Registration
Statement and in any post-effective amendment thereto, and any Prospectus Supplement thereto, required to be filed by the Company with
the Commission pursuant to Section 2.3 and the Registration Rights Agreement after the Commencement Date and prior to the applicable
Purchase Date for such Purchase, shall have been filed with the Commission in accordance with Section 2.3 and the Registration Rights
Agreement. All reports, schedules, registrations, forms, statements, information and other documents required to have been filed by the
Company with the Commission pursuant to the reporting requirements of the Exchange Act, including all material required to have been
filed pursuant to Section 13(a) or 15(d) of the Exchange Act, after the Commencement Date and prior to the applicable Purchase Date for
such Purchase, shall have been filed with the Commission and, if any Registrable Securities are covered by a Registration Statement on
Form S-3, such filings shall have been made within the applicable time period prescribed for such filing under the Exchange Act.
43
(vii)
No Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been suspended
by the Commission, the Trading Market (or Eligible Market, as applicable) or FINRA (except for any suspension of trading of limited duration
agreed to by the Company, which suspension shall be terminated prior to the applicable Purchase Date for such Purchase), the Company
shall not have received any final and non-appealable notice that the listing or quotation of the Common Stock on the Trading Market (or
Eligible Market, as applicable) shall be terminated on a date certain (unless, prior to such date certain, the Common Stock is listed
or quoted on any other Eligible Market), nor shall there have been imposed any suspension of, or restriction on, accepting additional
deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock that is continuing, the
Company shall not have received any notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits
of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated
(unless, prior to such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined not to impose
any such suspension or restriction).
(viii)
Certain Limitations. The issuance and sale of the Shares issuable pursuant to the applicable Purchase Notice shall not
(a) exceed, in the case of a Market Open Purchase Notice, the Market Open Purchase Maximum Amount applicable to such Market Open Purchase
Notice, in the case of an Intraday Purchase Notice, the Intraday Purchase Maximum Amount applicable to such Intraday Purchase Notice,
in the case of a Pre-Market Purchase Notice, the Pre-Market Purchase Maximum Amount applicable to such Pre-Market Purchase Notice, and
in the case of a Post-Market Purchase Notice, the Post-Market Purchase Maximum Amount applicable to such Post-Market Purchase Notice,
(b) cause the aggregate number of shares of Common Stock issued pursuant to this Agreement to exceed the Aggregate Limit, (c) cause the
Investor to beneficially own (under Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder) shares of Common Stock in
excess of the Beneficial Ownership Limitation, or (d) if and to the extent the Exchange Cap is then applicable under Section 3.5, cause
the aggregate number of shares of Common Stock issued pursuant to this Agreement to exceed the Exchange Cap, unless in the case of this
clause (d), the Company’s stockholders have theretofore approved the issuance of such shares of Common Stock in excess of the Exchange
Cap in accordance with the applicable rules of the Trading Market.
(ix)
Shares Authorized and Delivered. All of the Shares issuable pursuant to the applicable Purchase Notice shall have been
duly authorized by all necessary corporate action of the Company. All Shares relating to all prior Purchase Notices required to have
been received by the Investor as DWAC Shares under this Agreement prior to the applicable Purchase Condition Satisfaction Time for the
applicable Purchase shall have been delivered to the Investor as DWAC Shares in accordance with this Agreement.
44
(x)
Bring-Down Negative Assurance Letters; Bring-Down Comfort Letters and Compliance Certificates. The Investor shall have
received (a) all Bring-Down Negative Assurance Letters from outside counsel to the Company, which the Company was obligated to instruct
its outside counsel to deliver to the Investor prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase,
(b) all Bring-Down Comfort Letters from the Accountant, or a successor independent registered public accounting firm for the Company
(as applicable), which the Company was obligated to instruct such firm to deliver to the Investor prior to the applicable Purchase Condition
Satisfaction Time for the applicable Purchase, and (c) all Compliance Certificates from the Company that the Company was obligated to
deliver to the Investor prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase, in each case in accordance
with Section 6.17.
(xi)
QIU Fee Reimbursement and Additional Investor Legal Fee Expense Reimbursement. The Company shall have paid, by wire transfer
of immediately available funds to an account designated by the Investor, or the Investor shall have withheld from amounts otherwise payable
to the Company pursuant to and in accordance with Section 10.1(i), as applicable, (a) all or any portion of the QIU Fee Reimbursement
that the Company was obligated to pay to the Investor, either through the Investor’s withholding of amounts otherwise payable to
the Company or by cash payment directly to the Investor, as applicable, pursuant to, at such time(s) and in such manner as set forth
in Section 10.1(i), prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase, which QIU Fee Reimbursement
shall be fully earned by the Investor and non-refundable as of the date of such withholding by the Investor and/or such payment by the
Company to the Investor (as the case may be), regardless of whether any subsequent Purchases are made or settled hereunder or any subsequent
termination of this Agreement, and (b) all or any portion of the Additional Investor Legal Fee Expense Reimbursement that the Company
was obligated to pay to the Investor, either through the Investor’s withholding of amounts otherwise payable to the Company or
by cash payment directly to the Investor, as applicable, pursuant to, at such time(s) and in such manner as set forth in Section 10.1(i),
prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase, which Additional Investor Legal Fee Expense
Reimbursement shall be fully earned by the Investor and non-refundable as of the date of such withholding by the Investor and/or such
payment by the Company to the Investor (as the case may be), regardless of whether any subsequent Purchases are made or settled hereunder
or any subsequent termination of this Agreement.
(xii)
Payment of Commitment Fee and Subsequent Investor Legal Fee Expense Reimbursement. The Company shall have (a) paid, by
wire transfer of immediately available funds to an account designated by the Investor, or the Investor shall have withheld from amounts
otherwise payable to the Company pursuant to and in accordance with Section 10.1(i), as applicable, all of the Commitment Fee (or earned
portion thereof) that the Company was obligated to pay to the Investor, either through the Investor’s withholding of amounts otherwise
payable to the Company or by cash payment directly to the Investor, as applicable, pursuant to, at such time(s) and in such manner as
set forth in Section 10.1(ii), prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase, which Commitment
Fee (or earned portion thereof) shall be fully earned by the Investor and non-refundable as of the date of such withholding by the Investor
or such cash payment directly to the Investor (as the case may be), regardless of whether any subsequent Purchases are made or settled
hereunder or any subsequent termination of this Agreement, and (b) paid, by wire transfer of immediately available funds to an account
designated by the Investor (or the Investor’s counsel), all Subsequent Investor Legal Fee Expense Reimbursement payments that the
Company was obligated to pay to the Investor prior to the applicable Purchase Condition Satisfaction Time for the applicable Purchase
in accordance with Section 10.1(i), each of which Subsequent Investor Legal Fee Expense Reimbursement payments shall be fully earned
and non-refundable as of the date such payments are made by the Company to the Investor (or the Investor’s counsel), regardless
of whether any additional Purchases are made or settled hereunder or any subsequent termination of this Agreement.
45
Article
VIII
TERMINATION
Section
8.1. Automatic Termination. Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically
on the earliest to occur of (i) the first day of the month next following the 36-month anniversary of the Commencement Date, (ii) the
date on which the Investor shall have purchased from the Company, pursuant to all Purchases that have occurred and fully settled pursuant
to this Agreement, an aggregate number of Shares for a total aggregate gross purchase price to the Company equal to the Total Commitment,
(iii) the date on which the Common Stock shall have failed to be listed or quoted on the Trading Market or any Eligible Market for a
period of one (1) Trading Day, (iv) the thirtieth (30th) Trading Day next following the date on which, pursuant to or within
the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a Proceeding against the Company, in
each case that is not discharged or dismissed prior to such thirtieth (30th) Trading Day, and (v) the date on which, pursuant
to or within the meaning of any Bankruptcy Law, a Custodian is appointed for the Company or for all or substantially all of its property,
or the Company makes a general assignment for the benefit of its creditors.
Section
8.2. Other Termination. Subject to Section 8.3, the Company may terminate this Agreement after the Commencement Date effective
upon ten (10) Trading Days’ prior written notice to the Investor in accordance with Section 10.4; provided, however,
that (i) the Company shall have (A) paid or caused to be paid all of the Commitment Fee (or earned portion thereof) required to be paid
to the Investor, either through the Investor’s withholding of amounts otherwise payable to the Company or by cash payment directly
to the Investor, as applicable, pursuant to, at such time(s) and in such manner as set forth in Section 10.1(ii), and (B) paid or caused
to be paid all of the QIU Fee Reimbursement, all of the Additional Investor Legal Fee Expense Reimbursement and all of the Subsequent
Investor Legal Fee Expense Reimbursement payments required to be paid to the Investor either through the Investor’s withholding
of amounts otherwise payable to the Company or by cash payment directly to the Investor, as applicable, pursuant to, at such time(s)
and in such manner as set forth in Section 10.1(i), in each case in this clause (i) prior to such termination, and (ii) prior to issuing
any press release, or making any public statement or announcement, with respect to such termination, the Company shall consult with the
Investor and its counsel on the form and substance of such press release or other disclosure. Subject to Section 8.3, this Agreement
may be terminated at any time by the mutual written consent of the parties, effective as of the date of such mutual written consent unless
otherwise provided in such written consent. Subject to Section 8.3, the Investor shall have the right to terminate this Agreement effective
upon ten (10) Trading Days’ prior written notice to the Company in accordance with Section 10.4, if: (a) any condition, occurrence,
state of facts or event constituting a Material Adverse Effect has occurred and is continuing; (b) a Fundamental Transaction shall have
occurred; (c) the Initial Registration Statement and any New Registration Statement is not filed by the applicable Filing Deadline therefor
or declared effective by the Commission by the applicable Effectiveness Deadline (as defined in the Registration Rights Agreement) therefor,
or the Company is otherwise in breach or default in any material respect under any of the other provisions of the Registration Rights
Agreement, and, if such failure, breach or default is capable of being cured, such failure, breach or default is not cured within ten
(10) Trading Days after notice of such failure, breach or default is delivered to the Company pursuant to Section 10.4; (d) while a Registration
Statement, or any post-effective amendment thereto, is required to be maintained effective pursuant to the terms of the Registration
Rights Agreement and the Investor holds any Registrable Securities, the effectiveness of such Registration Statement, or any post-effective
amendment thereto, lapses for any reason (including, without limitation, the issuance of a stop order by the Commission) or such Registration
Statement or any post-effective amendment thereto, the Prospectus contained therein or any Prospectus Supplement thereto otherwise becomes
unavailable to the Investor for the resale of all of the Registrable Securities included therein in accordance with the terms of the
Registration Rights Agreement, and such lapse or unavailability continues for a period of twenty (20) consecutive Trading Days or for
more than an aggregate of sixty (60) Trading Days in any 365-day period, other than due to acts of the Investor; (e) trading in the Common
Stock on the Trading Market (or if the Common Stock is then listed on any Eligible Market, trading in the Common Stock on any such Eligible
Market) shall have been suspended and such suspension continues for a period of five (5) consecutive Trading Days; or (f) the Company
is in material breach or default of this Agreement, and, if such breach or default is capable of being cured, such breach or default
is not cured within ten (10) Trading Days after notice of such breach or default is delivered to the Company pursuant to Section 10.4.
Unless notification thereof is required elsewhere in this Agreement (in which case such notification shall be provided in accordance
with such other provision), the Company shall promptly (but in no event later than twenty-four (24) hours) notify the Investor (and,
if required under applicable Law, including, without limitation, Regulation FD promulgated by the Commission, or under the applicable
rules and regulations of the Trading Market (or Eligible Market, as applicable), the Company shall publicly disclose such information
in accordance with Regulation FD and the applicable rules and regulations of the Trading Market (or Eligible Market, as applicable))
upon becoming aware of any of the events set forth in the immediately preceding sentence.
Section
8.3. Effect of Termination. In the event of termination by the Company or the Investor (other than by mutual termination)
pursuant to Section 8.2, written notice thereof shall forthwith be given to the other party as provided in Section 10.4 and the transactions
contemplated by this Agreement shall be terminated without further action by either party. If this Agreement is terminated as provided
in Section 8.1 or Section 8.2, this Agreement shall become void and of no further force and effect, except that (i) the provisions of
Article V (Representations, Warranties and Covenants of the Company), Article IX (Indemnification), Article X (Miscellaneous) and this
Article VIII (Termination) shall remain in full force and effect indefinitely notwithstanding such termination, and, (ii) so long as
the Investor owns any Shares, the covenants and agreements of the Company contained in Article VI (Additional Covenants) shall remain
in full force and notwithstanding such termination for a period of six (6) months following such termination. Notwithstanding anything
in this Agreement to the contrary, no termination of this Agreement by any party shall (i) become effective prior to the fifth (5th)
Trading Day immediately following the settlement date related to any pending Purchase that has not been fully settled in accordance with
the terms and conditions of this Agreement (it being hereby acknowledged and agreed that no termination of this Agreement shall limit,
alter, modify, change or otherwise affect any of the Company’s or the Investor’s rights or obligations under the Transaction
Documents with respect to any pending Purchase, and that the parties shall fully perform their respective obligations with respect to
any such pending Purchase under the Transaction Documents), (ii) limit, alter, modify, change or otherwise affect the Company’s
or the Investor’s rights or obligations under the Registration Rights Agreement, all of which shall survive any such termination,
(iii) affect any Commitment Fee (or earned portion thereof) paid or payable to the Investor pursuant to Section 10.1(ii), which Commitment
Fee (or earned portion thereof) shall be fully earned by the Investor and non-refundable when withheld by, or paid by the Company directly
to, the Investor in accordance with Section 10.1(ii), regardless of whether any subsequent Purchases are made or settled hereunder or
any subsequent termination of this Agreement, (iv) affect the Initial Investor Legal Fee Expense Reimbursement paid to the Investor (or
the Investor’s counsel, as applicable), all of which Initial Investor Legal Fee Expense Reimbursement shall be fully earned by
the Investor and shall be non-refundable as of the Closing Date pursuant to Section 10.1(i), regardless of whether the Commencement shall
have occurred, whether any Purchases are made or settled hereunder or any subsequent termination of this Agreement, and (v) affect the
QIU Fee Reimbursement, the Additional Investor Legal Fee Expense Reimbursement or the Subsequent Investor Legal Fee Expense Reimbursement
payments paid or payable to the Investor (or the Investor’s counsel, as applicable) pursuant to Section 10.1(i), which QIU Fee
Reimbursement, Additional Investor Legal Fee Expense Reimbursement and Subsequent Investor Legal Fee Expense Reimbursement payments,
in each case, shall be fully earned by the Investor and non-refundable when withheld by, or paid by the Company directly to, the Investor
in accordance with Section 10.1(i), regardless of whether any subsequent Purchases are made or settled hereunder or any subsequent termination
of this Agreement. Nothing in this Section 8.3 shall be deemed to release the Company or the Investor from any liability for any breach
or default under this Agreement or any of the other Transaction Documents to which it is a party, or to impair the rights of the Company
and the Investor to compel specific performance by the other party of its obligations under the Transaction Documents to which it is
a party.
46
Article
IX
INDEMNIFICATION
Section
9.1. Indemnification of Investor. In consideration of the Investor’s execution and delivery of this Agreement and acquiring
the Shares hereunder and in addition to all of the Company’s other obligations under the Transaction Documents to which it is a
party, subject to the provisions of this Section 9.1, the Company shall indemnify and hold harmless the Investor, its Broker-Dealer,
each of their respective directors, officers, shareholders, members, partners, employees, representatives, agents and advisors (and any
other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other
title), each Person, if any, who controls the Investor or its Broker-Dealer (within the meaning of Section 15 of the Securities Act or
Section 20(a) of the Exchange Act), and the respective directors, officers, stockholders, members, partners, employees, representatives,
agents and advisors (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack
of such title or any other title) of such controlling Persons (each, an “Investor Party”), from and against
all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses (including all judgments, amounts paid in settlement,
court costs, reasonable and documented attorneys’ fees and costs of defense and investigation) (collectively, “Damages”)
that any Investor Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement, the Registration Rights Agreement or in the other Transaction Documents to which
it is a party or (b) any Proceeding (including for these purposes a derivative action brought on behalf of the Company) instituted against
such Investor Party arising out of or resulting from the execution, delivery, performance or enforcement of the Transaction Documents,
other than claims for indemnification within the scope of Section 6 of the Registration Rights Agreement; provided, however,
that (x) the foregoing indemnity shall not apply to any Damages to the extent, but only to the extent, that such Damages resulted directly
and primarily from a breach of any of the Investor’s representations, warranties, covenants or agreements contained in this Agreement
or the Registration Rights Agreement, and (y) the Company shall not be liable under subsection (b) of this Section 9.1 to the extent,
but only to the extent, that a court of competent jurisdiction shall have determined by a final judgment (from which no further appeals
are available) that such Damages resulted directly and primarily from any acts or failures to act, undertaken or omitted to be taken
by such Investor Party through its fraud, bad faith, gross negligence, or willful or reckless misconduct.
The
Company shall reimburse any Investor Party promptly upon demand (with accompanying presentation of sufficiently detailed documentary
evidence) for all reasonable and documented legal and other costs and expenses reasonably incurred by such Investor Party in connection
with (i) any Proceeding, whether at law or in equity, to enforce compliance by the Company with any provision of the Transaction Documents
or (ii) any other Proceeding, whether at law or in equity, with respect to which it is entitled to indemnification under this Section
9.1; provided that the Investor shall promptly reimburse the Company for all such legal and other costs and expenses to the extent
a court of competent jurisdiction determines that any Investor Party was not entitled to such reimbursement.
An
Investor Party’s right to indemnification or other remedies based upon the representations, warranties, covenants and agreements
of the Company set forth in the Transaction Documents shall not in any way be affected by any investigation or knowledge of such Investor
Party. Such representations, warranties, covenants and agreements shall not be affected or deemed waived by reason of the fact that an
Investor Party knew or should have known that any representation or warranty might be inaccurate or that the Company failed to comply
with any agreement or covenant. Any investigation by such Investor Party shall be for its own protection only and shall not affect or
impair any right or remedy hereunder.
To
the extent that the foregoing undertakings by the Company set forth in this Section 9.1 may be unenforceable for any reason, the Company
shall make the maximum contribution to the payment and satisfaction of each of the Damages which is permissible under applicable law.
Section
9.2. Indemnification Procedures. Promptly after an Investor Party receives notice of a claim or the commencement of an action
for which the Investor Party intends to seek indemnification under Section 9.1, the Investor Party will notify the Company in writing
of the claim or commencement of the Proceeding; provided, however, that failure to notify the Company will not relieve
the Company from liability under Section 9.1, except to the extent it has been materially prejudiced by the failure to give notice. The
Company will be entitled to participate in the defense of any Proceeding as to which indemnification is being sought, and if the Company
acknowledges in writing the obligation to indemnify the Investor Party against whom the Proceeding is brought, the Company may (but will
not be required to) assume the defense against the Proceeding with counsel satisfactory to it. After the Company notifies the Investor
Party that the Company wishes to assume the defense of a Proceeding, the Company will not be liable for any further legal or other expenses
incurred by the Investor Party in connection with the defense against the Proceeding except that if, in the opinion of counsel to the
Investor Party, it would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent
both the Company and such Investor Party. In such event, the Company will pay the reasonable and documented fees and expenses of no more
than one separate counsel for all such Investor Parties promptly as such fees and expenses are incurred. Each Investor Party, as a condition
to receiving indemnification as provided in Section 9.1, will cooperate in all reasonable respects with the Company in the defense of
any action or claim as to which indemnification is sought. The Company will not be liable for any settlement of any action effected without
its prior written consent, which consent shall not be unreasonably withheld, delayed or conditioned. The Company will not, without the
prior written consent of the Investor Party, which consent shall not be unreasonably withheld, delayed or conditioned, effect any settlement
of a pending or threatened action with respect to which an Investor Party is, or is informed that it may be, made a party and for which
it would be entitled to indemnification, unless the settlement includes an unconditional release of the Investor Party from all liability
and claims which are the subject matter of the pending or threatened action.
The
remedies provided for in this Article IX are not exclusive and shall not limit any rights or remedies which may otherwise be available
to any Investor Party at law or in equity.
47
Article
X
MISCELLANEOUS
Section
10.1. Certain Fees and Expenses; Commitment Fee; Commencement Irrevocable Transfer Agent Instructions.
(i)
Certain Fees and Expenses. Each party shall bear its own fees and expenses related to the transactions contemplated by
this Agreement; provided, however, that (1) on or prior to the Closing Date, the Company shall have paid to the Investor
(or to the Investor’s legal counsel), by wire transfer of immediately available funds to an account designated by the Investor
(or the Investor’s legal counsel) on or prior to the Closing Date, $25,000 as reimbursement for the reasonable and documented fees
and disbursements of the Investor’s legal counsel incurred by the Investor prior to the Closing (the “Initial Investor
Legal Fee Expense Reimbursement”), (2) on or prior to the earliest of (a) the ninetieth (90th) day following
the Effective Date of the Initial Registration Statement, (b) the one hundred twentieth (120th) day following the Closing
Date and (c) the effective date of any termination by the Company of this Agreement (it being acknowledged and agreed that no termination
of this Agreement shall become effective unless and until all amounts payable to the Investor under this Section 10.1(i) have been paid
to the Investor pursuant to and in accordance with this Section 10.1(i)), the Company shall have paid to the Investor, by wire transfer
of immediately available funds to an account designated by the Investor, on or prior to the earliest of such dates referenced in this
clause (2), the difference, if any, between (i) $100,000 (representing the sum of (x) the full amount of the Additional Investor Legal
Fee Expense Reimbursement and (y) the full amount of the QIU Fee Reimbursement) and (ii) the Withheld Reimbursement Amount (as defined
below), and (3) within ten (10) Business Days after each Representation Date (provided a Future Purchase Suspension is not then in effect),
shall have paid to the Investor, by wire transfer of immediately available funds to an account designated by the Investor, an additional
amount capped at $7,500 per fiscal quarter (subject to an aggregate cap of $30,000 for all such quarterly reimbursements) as reimbursement
for the reasonable fees and disbursements of the Investor’s legal counsel incurred by the Investor in connection with the Investor’s
ongoing due diligence and review of deliverables subject to Section 6.17 (the “Subsequent Investor Legal Fee Expense Reimbursement”),
in each case in connection with the transactions contemplated by this Agreement and the Registration Rights Agreement. The Company and
the Investor acknowledge and agree that, prior to any other withholding pursuant to Section 10.1(ii) in respect of the Commitment Fee
and prior to any payment of any portion of any of the Purchase Price(s) to the Company in connection with any Purchase hereunder, the
Investor shall withhold an aggregate amount in cash from the Purchase Price payable by the Investor to the Company for the Market Open
Purchase Share Amount, Intraday Purchase Share Amount, Pre-Market Purchase Share Amount and/or Post-Market Purchase Share Amount, as
applicable, in connection with each Market Open Purchase, Intraday Purchase, Pre-Market Purchase and/or Post-Market Purchase, respectively,
effected by the Company pursuant to this Agreement (the “Withheld Reimbursement Amount”), until the Investor
shall have received from such cash withholding(s) a total aggregate amount in cash equal to $100,000, representing the sum of (X) the
full amount of the QIU Fee Reimbursement and (Y) the full amount of the Additional Investor Legal Fee Expense Reimbursement payable to
the Investor pursuant to this Agreement, and upon the Investor’s receipt of a total aggregate amount in cash of $100,000 from such
withholdings, the Investor shall not withhold any additional cash amounts in respect of the QIU Fee Reimbursement and the Additional
Investor Legal Fee Expense Reimbursement from the Purchase Price(s) payable by the Investor to the Company in connection with any Purchase(s)
effected pursuant to this Agreement (it being acknowledged and agreed that upon the Investor’s receipt of a total aggregate amount
in cash of $100,000 from such withholdings in respect of the QIU Fee Reimbursement and the Additional Investor Legal Fee Expense Reimbursement,
the Investor may then effect additional withholdings pursuant to and in accordance with Section 10.1(ii) in respect of the Commitment
Fee, including from the same Purchase Price(s) for such Purchases from which the withholdings pursuant to this Section 10.1(i) have been
made). For the avoidance of doubt, (1) the Initial Investor Legal Fee Expense Reimbursement shall be fully earned by the Investor and
shall be non-refundable as of the Closing Date, regardless of whether the Commencement shall have occurred, pursuant to the limitations
set forth in Section 10.1(i), any Purchases are effected by the Company or settled hereunder or any subsequent termination of this Agreement,
(2) each amount withheld by the Investor or paid by the Company to the Investor (as the case may be) in respect of the QIU Fee Reimbursement
in accordance with this Section 10.1(i), shall be fully earned by the Investor and non-refundable as of the date of such withholding
by the Investor or such payment by the Company to the Investor (as the case may be), regardless of whether any subsequent Purchases are
made or settled hereunder or any subsequent termination of this Agreement, (3) each amount withheld by the Investor or paid by the Company
to the Investor (as the case may be) in respect of the Additional Investor Legal Fee Expense Reimbursement in accordance with this Section
10.1(i), shall be fully earned by the Investor and non-refundable as of the date of such withholding by the Investor or such payment
by the Company to the Investor (as the case may be), regardless of whether any subsequent Purchases are made or settled hereunder or
any subsequent termination of this Agreement, and (4) each Subsequent Investor Legal Fee Expense Reimbursement payment shall be fully
earned by the Investor and shall be non-refundable following Commencement when paid by the Company in accordance with this Section 10.1(i),
regardless of whether any additional Purchases are effected by the Company or settled hereunder or any subsequent termination of this
Agreement. The Company shall pay all U.S. federal, state and local stamp and other similar transfer and other taxes and duties levied
in connection with issuance of the Shares pursuant hereto. The parties acknowledge that the Initial Investor Legal Fee Expense Reimbursement,
the Additional Investor Legal Fee Expense Reimbursement and the Subsequent Investor Legal Fee Expense Reimbursement payable in connection
with the Investor’s ongoing due diligence and review of deliverables (subject to Section 6.17), collectively, are a reasonable
estimate of, and are not disproportionate to, the probable costs of preparing the Transaction Documents and are less than or equal to
the probable transaction costs of organizing a debt facility or capital raising in the amount of the Total Commitment.
48
(ii)
Commitment Fee. In consideration for the Investor’s execution and delivery of this Agreement, the Company shall pay
or shall cause to be paid to the Investor the Commitment Fee solely pursuant to, at such time(s) and in such manner as set forth in this
Section 10.1(ii). Except as otherwise provided in this Section 10.1(ii), the parties acknowledge and agree that the Commitment Fee shall
be paid and satisfied exclusively through the Investor’s withholding of amounts from the Purchase Price otherwise payable to the
Company as provided below, that the Company shall have no obligation to pay any portion of the Commitment Fee by any other means or in
any other manner, and that the Investor shall be entitled to the Commitment Fee only to the extent of amounts actually so withheld. The
Company and the Investor acknowledge and agree that, upon the Investor’s receipt of a total aggregate amount in cash of $100,000
in respect of the QIU Fee Reimbursement and the Additional Investor Legal Fee Expense Reimbursement pursuant to, at such time(s) and
in such manner as set forth in Section 10.1(i), the Investor shall withhold an additional amount in cash equal to five percent (5%) from
the Purchase Price payable by the Investor to the Company (including from the same Purchase Price(s) from which the withholdings pursuant
to this Section 10.1(i) have been made) for the Market Open Purchase Share Amount, Intraday Purchase Share Amount, Pre-Market Purchase
Share Amount and/or Post-Market Purchase Share Amount, as applicable, in connection with each Market Open Purchase, Intraday Purchase,
Pre-Market Purchase and/or Post-Market Purchase, respectively, effected by the Company pursuant to this Agreement (the “Withheld
Commitment Fee Amount”), until the Investor shall have received from such cash withholding(s) a total aggregate amount
in cash equal to $500,000 (exclusive of any Withheld Reimbursement Amount pursuant to Section 10.1(i)), representing the maximum aggregate
Commitment Fee that may be earned by and paid to the Investor pursuant to this Agreement, it being understood that, except in the event
of a Limited Commitment Fee Make-Whole (defined below), if the withholdings actually made hereunder in respect of the Commitment Fee
total less than $500,000, the Investor shall be entitled to such lesser amount only and the Company shall have no obligation in respect
of the difference, and upon the Investor’s receipt of a total aggregate amount in cash of $500,000 from such withholdings in respect
of the Commitment Fee, the Investor shall not withhold any additional cash amounts in respect of the Commitment Fee from the Purchase
Price payable by the Investor to the Company in connection with any Purchase effected pursuant to this Agreement. Notwithstanding the
foregoing, in the event this Agreement is terminated by the Company at any time prior to the ninetieth (90th) day following
the Effective Date of the Initial Registration Statement, the aggregate amount of the Commitment Fee shall be due in full and the Company
shall pay or cause to be paid to the Investor, in cash, the difference, if any, between (i) $500,000 and (ii) the Withheld Commitment
Fee Amount (the “Limited Commitment Fee Make-Whole”), within three (3) Business Days after written notice of
such termination by the Company pursuant to Section 8.2 is provided to the Investor in accordance with Section 10.4, and no termination
of this Agreement by the Company shall become effective unless and until the entire Limited Commitment Fee Make-Whole has been paid in
cash by the Company to the Investor pursuant to and in accordance with this Section 10.1(ii). For the avoidance of doubt, each amount
withheld by the Investor or paid by the Company to the Investor (as the case may be) in respect of the Commitment Fee in accordance with
this Section 10.1(ii), shall be fully earned by the Investor and non-refundable as of the date of such withholding by the Investor or
such payment by the Company to the Investor (as the case may be), regardless of whether any subsequent Purchases are made or settled
hereunder or any subsequent termination of this Agreement.
(iii)
No Legends. All Shares to be issued in respect of each Purchase Notice delivered to the Investor pursuant to this Agreement
shall be issued to the Investor in accordance with Section 3.4 by crediting the Investor’s or its designees’ account at DTC
as DWAC Shares, and the Company shall not take any action or give instructions to any transfer agent of the Company otherwise.
(iv)
Irrevocable Transfer Agent Instructions; Notice of Effectiveness. On the Effective Date of the Initial Registration Statement
and prior to Commencement, the Company shall deliver or cause to be delivered to its transfer agent (and thereafter, shall deliver or
cause to be delivered to any subsequent transfer agent of the Company), (i) irrevocable instructions executed by the Company and acknowledged
in writing by the Company’s transfer agent (the “Commencement Irrevocable Transfer Agent Instructions”)
and (ii) the notice of effectiveness in the form attached as an exhibit to the Registration Rights Agreement (the “Notice
of Effectiveness”) relating to the Initial Registration Statement executed by the Company’s outside counsel, in each
case directing the Company’s transfer agent to issue to the Investor or its designee all of the Shares included in the Initial
Registration Statement as DWAC Shares in accordance with this Agreement and the Registration Rights Agreement. With respect to any post-effective
amendment to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any New Registration
Statement, in each case declared effective by the Commission after the Commencement Date, the Company shall deliver or cause to be delivered
to its transfer agent (and thereafter, shall deliver or cause to be delivered to any subsequent transfer agent of the Company) (i) irrevocable
instructions in the form substantially similar to the Commencement Irrevocable Transfer Agent Instructions executed by the Company and
acknowledged in writing by the Company’s transfer agent and (ii) the Notice of Effectiveness, in each case modified as necessary
to refer to such Registration Statement or post-effective amendment and the Registrable Securities included therein, to issue the Registrable
Securities included therein as DWAC Shares, in each case in accordance with the terms of this Agreement and the Registration Rights Agreement.
For the avoidance of doubt, all Shares to be issued and delivered from and after Commencement to or for the benefit of the Investor pursuant
to this Agreement shall be issued and delivered to the Investor or its designee only as DWAC Shares. The Company represents and warrants
to the Investor that, while this Agreement is effective, no instruction other than those referred to in this Section 10.1(iv) will be
given by the Company to its transfer agent, or any successor transfer agent of the Company, with respect to the Shares from and after
Commencement, and the Shares covered by the Initial Registration Statement or any post-effective amendment thereof, or any New Registration
Statement or post-effective amendment thereof, as applicable, shall otherwise be freely transferable on the books and records of the
Company and no stop transfer instructions shall be maintained against the transfer thereof. The Company agrees that if the Company fails
to fully comply with the provisions of this Section 10.1(iv) within three (3) Trading Days after the date on which the Investor has provided
the deliverables referred to above that the Investor is required to provide to the Company or its transfer agent, the Company shall,
at the Investor’s written instruction, purchase from the Investor all Shares acquired by the Investor pursuant to this Agreement
that contain any restrictive legend, or that have any stop transfer orders maintained that prohibit or impede the transfer thereof in
any respect, at the greater of (i) the Purchase Price paid by the Investor for such Shares in the applicable Purchase effected by the
Company under this Agreement and (ii) the Closing Sale Price of the Common Stock on the date of the Investor’s written instruction.
49
Section
10.2. Specific Enforcement, Consent to Jurisdiction, Waiver of Jury Trial.
(i)
The Company and the Investor acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that either
party shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement by the other
party and to enforce specifically the terms and provisions hereof (without the necessity of showing economic loss and without any bond
or other security being required), this being in addition to any other remedy to which either party may be entitled by law or equity.
(ii)
Each of the Company and the Investor (a) hereby irrevocably submits to the jurisdiction of the U.S. District Court and other courts of
the United States sitting in The City of New York, Borough of Manhattan, State of New York for the purposes of any Proceeding arising
out of or relating to this Agreement, and (b) hereby waives, and agrees not to assert in any such Proceeding, any claim that it is not
personally subject to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum or that the venue of the
Proceeding is improper. Each of the Company and the Investor consents to process being served in any such Proceeding by mailing a copy
thereof to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing in this Section 10.2 shall affect or limit any right to serve process in
any other manner permitted by Law.
(iii)
EACH OF THE COMPANY AND THE INVESTOR HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY IN RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR DISPUTES RELATING HERETO. EACH OF THE COMPANY AND THE INVESTOR (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR
ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK
TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTY HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.2.
Section
10.3. Entire Agreement. The Transaction Documents set forth the entire agreement and understanding of the parties with respect
to the subject matter hereof and supersede all prior and contemporaneous agreements, negotiations and understandings between the parties,
both oral and written, with respect to such matters. There are no promises, undertakings, representations or warranties by either party
relative to the subject matter hereof not expressly set forth in the Transaction Documents. The Disclosure Schedule and all exhibits
to this Agreement are hereby incorporated by reference in, and made a part of, this Agreement as if set forth in full herein.
50
Section
10.4. Notices. Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall
be in writing and shall be effective (a) upon hand delivery or electronic mail delivery at the address or number designated below (if
delivered on a business day during normal business hours where such notice is to be received), or the first business day following such
delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second
business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt
of such mailing, whichever shall first occur. The address for such communications shall be:
If
to the Company:
Polar
Power, Inc.
249
E. Gardena Boulevard
Gardena,
CA 90248
Telephone
Number: (310) 830-9153
Email:
asams@polarpowerinc.com
Attention:
Arthur Sams, Chief Executive Officer
With
a copy (which shall not constitute notice) to:
Loeb
& Loeb LLP
345
Park Avenue
New
York, NY 10154
Telephone
Number: (212) 407-4000
Email:
mnussbaum@loeb.com
Attention:
Mitchell Nussbaum
If
to the Investor:
Roth
Principal Investments, LLC
2340
Collins Avenue, Suite 402
Miami
Beach, Florida 33139
Telephone
Number: (612) 791-5927
Email:
jtonnos@roth.com
Attention:
Joe Tonnos
Co-President
51
With
a copy (which shall not constitute notice) to:
Reed
Smith LLP
599
Lexington Avenue
New
York, NY 10022
Telephone
Number: (212) 521-5400
Email:
amarsico@reedsmith.com
Attention:
Anthony J. Marsico, Esq.
Either
party hereto may from time to time change its address for notices by giving at least five (5) days’ advance written notice of such
changed address to the other party hereto.
Section
10.5. Waivers. No provision of this Agreement may be waived by the parties from and after the date that is one (1) Trading
Day immediately preceding the date on which the Initial Registration Statement is initially filed with the Commission. Subject to the
immediately preceding sentence, no provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate
as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercises
thereof or of any other right, power or privilege.
Section
10.6. Amendments. No provision of this Agreement may be amended by the parties from and after the date that is one (1) Trading
Day immediately preceding the date on which the Initial Registration Statement is initially filed with the Commission. Subject to the
immediately preceding sentence, no provision of this Agreement may be amended other than by a written instrument signed by both parties
hereto.
Section
10.7. Headings. The article, section and subsection headings in this Agreement are for convenience only and shall not constitute
a part of this Agreement for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. Unless the context
clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms
thereof. The terms “including,” “includes,” “include” and words of like import shall be construed
broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,” “hereof”
and words of like import refer to this entire Agreement instead of just the provision in which they are found.
Section
10.8. Construction. The parties agree that each of them and their respective counsel has reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents. In addition, each and every reference
to share prices (other than the Threshold Price) and number of shares of Common Stock in any Transaction Document shall, in all cases,
be subject to adjustment for any stock splits, stock combinations, stock dividends, recapitalizations, reorganizations and other similar
transactions that occur on or after the date of this Agreement. Any reference in this Agreement to “Dollars” or “$”
shall mean the lawful currency of the United States of America. Any references to “Section” or “Article” in this
Agreement shall, unless otherwise expressly stated herein, refer to the applicable Section or Article of this Agreement. Unless the context
clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms
thereof. The terms “including,” “includes,” “include” and words of like import shall be construed
broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,” “hereof”
and words of like import refer to this entire Agreement instead of just the provision in which they are found.
52
Section
10.9. Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors. Neither the Company nor the Investor may assign this Agreement or any of their respective rights or obligations hereunder
to any Person.
Section
10.10. No Third Party Beneficiaries. Except as expressly provided in Article IX, this Agreement is intended only for the benefit
of the parties hereto and their respective successors, and is not for the benefit of, nor may any provision hereof be enforced by, any
other Person.
Section
10.11. Governing Law. This Agreement shall be governed by and construed in accordance with the internal procedural and substantive
Laws of the State of New York, without giving effect to any Laws of such state that would cause the application of the Laws of any other
jurisdiction.
Section
10.12. Survival. The representations, warranties, covenants and agreements of the Company and the Investor contained
in this Agreement shall survive the execution and delivery hereof until the termination of this Agreement; provided, however,
that (i) the provisions of Article V (Representations, Warranties and Covenants of the Company), Article VIII (Termination), Article
IX (Indemnification) and this Article X (Miscellaneous) shall remain in full force and effect indefinitely notwithstanding such termination,
and, (ii) so long as the Investor owns any Shares, the covenants and agreements of the Company and the Investor contained in Article
VI (Additional Covenants), shall remain in full force and effect notwithstanding such termination for a period of six (6) months following
such termination.
Section
10.13. Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party;
provided that a facsimile signature or signature delivered by e-mail in a “.pdf” format data file, including any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered
due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.
Section
10.14. Publicity. The Company shall afford the Investor and its counsel with a reasonable opportunity to review and comment
upon, shall consult with the Investor and its counsel on the form and substance of, and shall give due consideration to all such comments
from the Investor or its counsel on, any press release, Commission filing or any other public disclosure made by or on behalf of the
Company relating to the Investor, its Purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated
thereby, including any press release disclosing the execution of this Agreement and the Registration Rights Agreement by the Company,
prior to the issuance, filing or public disclosure thereof. For the avoidance of doubt, the Company shall not be required to submit for
review any such disclosure (i) contained in periodic reports filed with the Commission under the Exchange Act if it shall have previously
provided substantially the same disclosure to the Investor or its counsel for review in connection with a previous filing or (ii) any
Prospectus Supplement if it contains disclosure that does not reference the Investor, its Purchases hereunder or any aspect of the Transaction
Documents or the transactions contemplated thereby.
Section
10.15. Severability. The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction
shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be
held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other
provision or part of a provision of this Agreement, and this Agreement shall be reformed and construed as if such invalid or illegal
or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal
and enforceable to the maximum extent possible.
Section
10.16. Further Assurances. From and after the Closing Date, upon the request of the Investor or the Company, each of the Company
and the Investor shall execute and deliver such instrument, documents and other writings as may be reasonably necessary or desirable
to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.
[Signature
Page Follows]
53
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized
officer as of the date first above written.
THE COMPANY:
POLAR POWER, INC.
By:
Name:
Title:
THE INVESTOR:
ROTH PRINCIPAL INVESTMENTS, LLC
By:
Name:
Joe
Tonnos
Title:
Co-President
ANNEX
I TO THE
COMMON
STOCK PURCHASE AGREEMENT
DEFINITIONS
“2025
Form 10-K” shall have the meaning assigned to such term in the definition of Commission Documents.
“Accountant”
shall have the meaning assigned to such term in Section 5.6(d).
“Additional
Investor Legal Fee Expense Reimbursement” means an amount in cash equal to $50,000, which the Company shall pay or cause
to be paid to the Investor as reimbursement for the fees and disbursements of the Investor’s legal counsel in connection with the
transactions contemplated by this Agreement, pursuant to, at such time(s) and in such manner as set forth in Section 10.1(i) of this
Agreement.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control
with a Person, as such terms are used in and construed under Rule 144.
“Aggregate
Limit” shall have the meaning assigned to such term in Section 2.1.
“Agreement”
shall have the meaning assigned to such term in the preamble of this Agreement.
“Allowable
Grace Period” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Average
Price” means a price per Share (rounded to the nearest tenth of a cent) equal to the quotient obtained by dividing (i)
the aggregate gross Purchase Price paid by the Investor for all Shares purchased pursuant to this Agreement, by (ii) the aggregate number
of Shares issued pursuant to this Agreement.
“Bankruptcy
Law” means Title 11, U.S. Code, or any similar U.S. federal or state bankruptcy Law or any Law for the relief of debtors.
“Base
Price” means a price per Share equal to the sum of (i) the Minimum Price and (ii) $0.0847 (subject to adjustment for any
reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or
after the date of this Agreement).
“Beneficial
Ownership Limitation” shall have the meaning assigned to such term in Section 3.6.
“Bloomberg”
means Bloomberg, L.P.
“Bring-Down
Comfort Letter” shall have the meaning assigned to such term in Section 6.17.
“Bring-Down
Negative Assurance Letter” shall have the meaning assigned to such term in Section 6.17.
“Broker-Dealer”
shall have the meaning assigned to such term in Section 6.13.
“Bylaws”
shall have the meaning assigned to such term in Section 5.3.
“Charter”
shall have the meaning assigned to such term in Section 5.3.
“Closing”
shall have the meaning assigned to such term in Section 2.2.
“Closing
Date” means the date of this Agreement.
“Closing
Sale Price” means, for the Common Stock as of any date, the last closing trade price for the Common Stock on the Trading
Market (or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market), as reported by Bloomberg, or, if the
Trading Market (or such Eligible Market, as applicable) begins to operate on an extended hours basis and does not designate the closing
trade price for the Common Stock, then the last trade price for the Common Stock prior to 4:00 p.m., New York City time, as reported
by Bloomberg. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations
or other similar transactions during such period.
“Code”
shall have the meaning assigned to such term in Section 5.38.
“Commencement”
shall have the meaning assigned to such term in Section 3.1.
“Commencement
Date” shall have the meaning assigned to such term in Section 3.1.
“Commencement
Irrevocable Transfer Agent Instructions” shall have the meaning assigned to such term in Section 10.1(iv).
“Commission”
means the U.S. Securities and Exchange Commission or any successor entity.
“Commission
Documents” shall mean (1) all reports, schedules, registrations, forms, statements, information and other documents filed
with or furnished to the Commission by the Company pursuant to the reporting requirements of the Exchange Act, including all material
filed with or furnished to the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, since January 1, 2025 and
prior to the date of this Agreement, including, without limitation, the Company’s Annual Report on Form 10-K for its fiscal year
ended December 31, 2025 filed by the Company with the Commission on April 15, 2026 (the “2025 Form 10-K”),
and which hereafter shall be filed with or furnished to the Commission by the Company, including, without limitation, the Current Report,
(2) each Registration Statement, as the same may be amended from time to time, the Prospectus contained therein and each Prospectus Supplement
thereto and (3) all information contained in such filings and all documents and disclosures that have been and heretofore shall be incorporated
by reference therein.
“Commitment
Fee” means an amount in cash, not to exceed $500,000 in the aggregate, which the Company shall pay or cause to be paid
to the Investor, pursuant to, at such time(s) and in such manner as set forth in Section 10.1(ii) of this Agreement.
“Common
Stock” shall have the meaning assigned to such term in the recitals of this Agreement.
“Common
Stock Equivalents” means any securities of the Company which entitle the holder thereof to acquire at any time Common Stock,
including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Company”
shall have the meaning assigned to such term in the preamble of this Agreement.
“Compliance
Certificate” shall have the meaning assigned to such term in Section 7.2(ii).
“Contracts”
means any legally binding contracts, agreements, subcontracts, leases, and purchase orders.
“Cover
Price” shall have the meaning assigned to such term in Section 3.4.
“Current
Report” shall have the meaning assigned to such term in Section 2.3.
“Custodian”
shall mean any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.
“Damages”
shall have the meaning assigned to such term in Section 9.1.
“Disclosure
Schedule” shall have the meaning assigned to such term in the preamble to Article V.
“Disqualification
Event” shall have the meaning assigned to such term in Section 5.44.
“DTC”
means The Depository Trust Company, a subsidiary of The Depository Trust & Clearing Corporation, or any successor thereto.
“DWAC”
shall have the meaning assigned to such term in Section 5.33.
“DWAC
Shares” means shares of Common Stock issued pursuant to this Agreement that are (i) issued in electronic form, (ii) freely
tradable and transferable in the United States and without restriction on resale and without stop transfer instructions maintained against
the transfer thereof and (iii) timely credited by the Company’s transfer agent to the Investor’s (or its designated Broker-Dealer
at which the account or accounts to be credited with the Shares being purchased or acquired by Investor are maintained) specified DWAC
account with DTC under its Fast Automated Securities Transfer (FAST) Program, or any similar program hereafter adopted by DTC performing
substantially the same function.
“EDGAR”
means the Commission’s Electronic Data Gathering, Analysis and Retrieval System.
“Effective
Date” means, with respect to the Initial Registration Statement filed pursuant to Section 2(a) of the Registration Rights
Agreement (or any post-effective amendment thereto) or any New Registration Statement filed pursuant to Section 2(c) of the Registration
Rights Agreement (or any post-effective amendment thereto), as applicable, the date on which the Initial Registration Statement (or any
post-effective amendment thereto) or any New Registration Statement (or any post-effective amendment thereto) is declared effective by
the Commission.
“Effectiveness
Deadline” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Eligible
Market” means The Nasdaq Global Select Market, The Nasdaq Global Market, the New York Stock Exchange or the NYSE American
(or any nationally recognized successor to any of the foregoing).
“Environmental
Laws” shall have the meaning assigned to such term in Section 5.18.
“ERISA”
shall have the meaning assigned to such term in Section 5.38.
“ERISA
Affiliate” shall have the meaning assigned to such term in Section 5.38.
“Evaluation
Date” shall have the meaning assigned to such term in Section 5.6(c).
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.
“Exchange
Cap” shall have the meaning assigned to such term in Section 3.5(a).
“Exempt
Issuance” means the issuance of (a) Common Stock, options or other equity incentive awards to employees, officers, directors
or vendors of the Company pursuant to any equity incentive plan duly adopted for such purpose, by the Company’s Board of Directors
or a majority of the members of a committee of the Board of Directors established for such purpose, (b) (1) any Shares issued to the
Investor (or its designee) pursuant to the Transaction Documents, (2) any securities issued upon the exercise or exchange of or conversion
of any shares of Common Stock or Common Stock Equivalents held by the Investor or an Affiliate of the Investor at any time, or (3) any
securities issued upon the exercise or exchange of or conversion of any Common Stock Equivalents issued and outstanding on the date of
this Agreement, provided that such securities referred to in this clause (3) have not been amended since the date of this Agreement to
increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, (c)
securities issued pursuant to acquisitions, divestitures, licenses, partnerships, collaborations or strategic transactions approved by
the Company’s Board of Directors or a majority of the members of a committee of directors established for such purpose, which acquisitions,
divestitures, licenses, partnerships, collaborations or strategic transactions can have a Variable Rate Transaction component, provided
that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company or an asset in a business synergistic with the business of the Company and shall provide to the Company additional
benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities, (d) shares of Common Stock issued
by the Company to the Investor (or its designee) or an Affiliate of the Investor in connection with any “equity line of credit”
or other continuous offering or similar offering of Common Stock (other than the transactions contemplated by the Transaction Documents)
pursuant to one or more written agreements between the Company and the Investor executed after the date of this Agreement (if any) or
an Affiliate of the Investor (including RCP) executed prior to or after the date of this Agreement (if any), whereby the Company may
sell shares of Common Stock to the Investor or an Affiliate of the Investor (including RCP) at a future determined price, (e) shares
of Common Stock issued by the Company in any “at the market offering” or “equity distribution program” or similar
offering of Common Stock exclusively to or through RCP pursuant to one or more written agreements between the Company and RCP, or
(f) any of the following (collectively, the “Permitted Company Financings”), in each case notwithstanding that the terms
thereof may constitute or include a Variable Rate Transaction: (1) the issuance and sale by the Company of shares of its Series A Convertible
Preferred Stock (A) pursuant to that certain Securities Purchase Agreement between the Company and the purchasers party thereto (as amended,
restated, supplemented or otherwise modified from time to time, the “Series A Securities Purchase Agreement”), and (B) in
one or more additional closings after the date of this Agreement, whether pursuant to the Series A Securities Purchase Agreement or one
or more additional securities purchase agreements entered into by the Company on substantially the same terms (each, a “Series
A Second Closing”), provided that the aggregate stated value of all shares of Series A Convertible Preferred Stock issued and sold
pursuant to the foregoing clauses (A) and (B), taken together, shall not exceed $1,800,000, together with the issuance of shares of Common
Stock upon conversion of, or in payment of dividends (including “payment-in-kind” dividends) on, such Series A Convertible
Preferred Stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred
Stock filed with the Secretary of State of the State of Delaware on July 10, 2026 (as the same may be corrected by any certificate of
correction or amended in accordance with its terms and applicable Law, the “Certificate of Designation”); (2) the Convertible
Promissory Note issued by the Company to Mayers Ventures LLC, dated June 30, 2026 (the “Mayers Note”), together with the
issuance of shares of Common Stock upon conversion of, or in payment of interest (including “payment-in-kind” interest) on,
the Mayers Note; and (3) the common stock purchase warrants issued or issuable to the purchasers under the Series A Securities Purchase
Agreement and to the holder of the Mayers Note (collectively, the “Related Warrants”), together with the issuance of shares
of Common Stock upon exercise thereof. For the avoidance of doubt, the entry into, and performance by the Company of its obligations
under, each of the Series A Securities Purchase Agreement (including any Series A Second Closing), the Certificate of Designation, the
Mayers Note and the Related Warrants, and each issuance of Common Stock or Common Stock Equivalents thereunder (including any issuance
resulting from the operation of the conversion, exercise, dividend, interest or anti-dilution provisions thereof), shall constitute an
Exempt Issuance and shall not be deemed a breach of Section 6.6(ii) or any other provision of this Agreement.
“FCPA”
shall have the meaning assigned to such term in Section 5.35.
“Filing
Deadline” shall have the meaning assigned to such term in the Registration Rights Agreement.
“FINRA”
means the Financial Industry Regulatory Authority, Inc.
“FINRA
Filing” shall have the meaning assigned to such term in Section 6.14.
“Fundamental
Transaction” means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving corporation) another Person, with the result that the holders of the
Company’s capital stock immediately prior to such consolidation or merger together beneficially own less than 50% of the outstanding
voting power of the surviving or resulting corporation, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of
all or substantially all of the properties or assets of the Company to another Person, or (3) take action to facilitate a purchase, tender
or exchange offer by another Person that is accepted by the holders of more than 50% of the outstanding shares of Common Stock (excluding
any shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party
to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or
other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination), or (5) reorganize, recapitalize or reclassify its Common Stock, or (ii) any “person”
or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the
“beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary
voting power represented by issued and outstanding Common Stock.
“Future
Purchase Suspension” shall have the meaning assigned to such term in Section 6.17.
“GAAP”
shall have the meaning assigned to such term in Section 5.6(b).
“Governmental
Entity” shall mean any arbitrator, court, governmental body, regulatory body, administrative agency or other authority,
body or agency (whether foreign or domestic) having jurisdiction over the Company or any of its Subsidiaries or any of their respective
properties, assets or operations.
“Hazardous
Materials” shall have the meaning assigned to such term in Section 5.18.
“Indebtedness”
means, with respect to any Person as of any time, without duplication, (a) any liabilities for borrowed money or amounts owed (other
than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements, indemnities and other contingent
obligations in respect of Indebtedness of others, whether or not the same are or should be reflected in the Company’s balance sheet
(or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions
in the ordinary course of business; and (c) the present value of any lease payments due under leases required to be capitalized in accordance
with GAAP.
“Initial
Comfort Letter” shall have the meaning assigned to such term in Section 7.2(xvi).
“Initial
Investor Legal Fee Expense Reimbursement” shall have the meaning assigned to such term in Section 10.1(i).
“Initial
Registration Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Intellectual
Property” shall have the meaning assigned to such term in Section 5.19.
“Intraday
Purchase” shall have the meaning assigned to such term in Section 3.2.
“Intraday
Purchase Commencement Time” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the time on the Purchase
Date for such Intraday Purchase that is the latest of: (i) the Market Open Purchase Ending Time of the Market Open Purchase Period
for the Market Open Purchase preceding the Intraday Purchase Period for such Intraday Purchase occurring on the same Purchase Date as
such earlier Market Open Purchase, if the Company has timely delivered a Market Open Purchase Notice to the Investor for a Market Open
Purchase on such Purchase Date, (ii) the Intraday Purchase Ending Time of the Intraday Purchase Period for the most recent prior Intraday
Purchase, if any, occurring on the same Purchase Date as such Intraday Purchase, and (iii) the Investor’s timely receipt (acknowledged
by email correspondence to each of the individual notice recipients of the Company set forth in the applicable Intraday Purchase Notice,
other than via auto-reply) from the Company of the applicable Intraday Purchase Notice for such Intraday Purchase on the applicable Purchase
Date therefor.
“Intraday
Purchase Ending Time” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the time on the Purchase
Date for such Intraday Purchase that is the earliest of: (i) 3:59 p.m., New York City time, on the applicable Purchase Date for
such Intraday Purchase, or such earlier time publicly announced by the Trading Market (or, if the Common Stock is then listed on an Eligible
Market, by such Eligible Market) as the official close of the primary (or “regular”) trading session on the Trading Market
(or on such Eligible Market, as applicable) on such Purchase Date; (ii) immediately at such time following the Intraday Purchase Commencement
Time of the Intraday Purchase Period for such Intraday Purchase that the total number (or volume) of shares of Common Stock traded on
the Trading Market (or on such Eligible Market, as applicable) during such Intraday Purchase Period has exceeded the applicable Intraday
Purchase Share Volume Maximum for such Intraday Purchase (taking into account the Intraday Purchase Percentage specified by the Company
in the applicable Intraday Purchase Notice for such Intraday Purchase); provided, however, that the calculation of the
total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such
Intraday Purchase Period shall exclude from such calculation all shares of Common Stock traded in any of the following transactions,
to the extent they occur during such Intraday Purchase Period (as applicable): (A) the opening or first purchase of Common Stock at or
following the official open of such primary (or “regular”) trading session that is reported in the consolidated system on
such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official close of such primary (or “regular”)
trading session that is reported in the consolidated system on such Purchase Date (as applicable), and (C) provided the Company shall
have specified in the applicable Intraday Purchase Notice that clause (iii) below shall not trigger the Intraday Purchase Ending Time
for such Intraday Purchase (such specification by the Company, whether in an Intraday Purchase Notice or in a Market Open Purchase Notice,
a “Limit Order Continue Election”), all sales of Common Stock on the Trading Market (or on such Eligible Market,
as applicable) during such Intraday Purchase Period at a Sale Price that is less than the applicable Intraday Purchase Minimum Price
Threshold; and (iii) provided the Company shall have specified in the applicable Intraday Purchase Notice that this clause (iii) shall
trigger the Intraday Purchase Ending Time for such Intraday Purchase (such specification by the Company, whether in an Intraday Purchase
Notice or in a Market Open Purchase Notice, a “Limit Order Discontinue Election”), immediately at such time
following the Intraday Purchase Commencement Time of the Intraday Purchase Period for such Intraday Purchase that the Sale Price of any
share of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such Intraday Purchase Period is
less than the applicable Intraday Purchase Minimum Price Threshold; provided, however, that the determination of whether
the Sale Price of any share of Common Stock traded during such Intraday Purchase Period is less than the applicable Intraday Purchase
Minimum Price Threshold shall exclude (A) the opening or first purchase of Common Stock at or following the official open of such primary
(or “regular”) trading session that is reported in the consolidated system on such Purchase Date and (B) the last or closing
sale of Common Stock at or prior to the official close of such primary (or “regular”) trading session that is reported in
the consolidated system on such Purchase Date (as applicable). All such calculations shall be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Intraday
Purchase Maximum Amount” means, with respect to an Intraday Purchase made pursuant to Section 3.2, such number of shares
of Common Stock equal to the lesser of: (i) two (2) million shares, and (ii) the product of (A) the Intraday Purchase Percentage specified
by the Company in the applicable Intraday Purchase Notice for such Intraday Purchase, multiplied by (B) the total number (or volume)
of shares of Common Stock traded on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on such Eligible
Market) during the Intraday Purchase Period for such Intraday Purchase; provided, however, that the calculation of the
total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such
Intraday Purchase Period referred to in clause (ii)(B) above shall exclude from such calculation all shares of Common Stock traded in
any of the following transactions, to the extent they occur during such Intraday Purchase Period (as applicable): (1) the opening or
first purchase of Common Stock at or following the official open of such primary (or “regular”) trading session that is reported
in the consolidated system on such Purchase Date, (2) the last or closing sale of Common Stock at or prior to the official close of such
primary (or “regular”) trading session that is reported in the consolidated system on such Purchase Date (as applicable),
and (3) provided the Company shall have specified a Limit Order Continue Election in the applicable Intraday Purchase Notice for such
Intraday Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Intraday Purchase
Period at a Sale Price that is less than the applicable Intraday Purchase Minimum Price Threshold. All such calculations shall be appropriately
adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Intraday
Purchase Minimum Price Threshold” means, with respect to an Intraday Purchase made pursuant to Section 3.2, either (a)
the dollar amount specified by the Company in the applicable Intraday Purchase Notice for such Intraday Purchase as the per share minimum
Sale Price threshold to be used in determining whether the event in clause (iii) of the definition of “Intraday Purchase Ending
Time” shall have occurred during the applicable Intraday Purchase Period for such Intraday Purchase, if the Company shall have
specified a Limit Order Discontinue Election in the applicable Intraday Purchase Notice for such Intraday Purchase, or (b) the dollar
amount specified by the Company in the applicable Intraday Purchase Notice for such Intraday Purchase as the per share minimum Sale Price
threshold to be used in determining the sales of Common Stock during the applicable Intraday Purchase Period that shall be excluded from
the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as
applicable) during such Intraday Purchase Period, if the Company shall have specified a Limit Order Continue Election in the applicable
Intraday Purchase Notice for such Intraday Purchase; provided, however, that in each case if the Company has not specified
any such dollar amount as the per share minimum Sale Price threshold in the applicable Intraday Purchase Notice for such Intraday Purchase,
then the per share minimum Sale Price threshold to be used in such Intraday Purchase shall be such dollar amount equal to the product
of (a) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the Purchase Date for such Intraday Purchase,
multiplied by (b) 0.75. All such calculations shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend,
stock split, reverse stock split or other similar transaction.
“Intraday
Purchase Notice” means, with respect to an Intraday Purchase made pursuant to Section 3.2, an irrevocable written notice
from the Company to the Investor, specifying the Intraday Purchase Percentage that shall apply to such Intraday Purchase and whether
a Limit Order Continue Election or a Limit Order Discontinue Election shall apply to such Intraday Purchase, and directing the Investor
to subscribe for and purchase a specified Intraday Purchase Share Amount (such specified Intraday Purchase Share Amount subject to automatic
adjustment as set forth in Section 3.2 as necessary to give effect to the applicable Intraday Purchase Maximum Amount for such Intraday
Purchase), at the applicable Intraday Purchase Price therefor on the Purchase Date for such Intraday Purchase in accordance with this
Agreement, that is delivered by the Company to the Investor and received by the Investor (i) after the latest of (X) 10:00 a.m.,
New York City time, on such Purchase Date, if the Company has not timely delivered a Market Open Purchase Notice to the Investor for
a Market Open Purchase on such Purchase Date, (Y) the Market Open Purchase Ending Time of the Market Open Purchase Period for the Market
Open Purchase preceding the Intraday Purchase Period for such Intraday Purchase occurring on the same Purchase Date as such earlier Market
Open Purchase, if the Company has timely delivered a Market Open Purchase Notice to the Investor for a Market Open Purchase on such Purchase
Date, and (Z) the Intraday Purchase Ending Time of the Intraday Purchase Period for the most recent prior Intraday Purchase, if any,
occurring on the same Purchase Date as such Intraday Purchase, and (ii) prior to the earlier of (X) 2:00 p.m., New York City time,
on such Purchase Date and (Y) such time that is exactly two (2) hours immediately prior to the official close of the primary (or “regular”)
trading session on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market) on such
Purchase Date, if the Trading Market (or such Eligible Market, as applicable) has theretofore publicly announced that the official close
of the primary (or “regular”) trading session on the Trading Market (or on such Eligible Market, as applicable) on such Purchase
Date shall be earlier than 4:00 p.m., New York City time, on such Purchase Date.
“Intraday
Purchase Percentage” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the percentage specified
by the Company in the applicable Intraday Purchase Notice for such Intraday Purchase, which shall not exceed 25.0%, for purposes of calculating,
among other things, the Intraday Purchase Maximum Amount, the Intraday Purchase Share Amount and the Intraday Purchase Share Volume Maximum,
in each case applicable to such Intraday Purchase.
“Intraday
Purchase Period” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the period on the Purchase Date
for such Intraday Purchase, beginning at the applicable Intraday Purchase Commencement Time and ending at the applicable Intraday Purchase
Ending Time on such Purchase Date for such Intraday Purchase.
“Intraday
Purchase Price” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the purchase price per Share
to be purchased by the Investor in such Intraday Purchase, equal to the product of (i) 0.97, multiplied by (ii) the VWAP of the Common
Stock for the applicable Intraday Purchase Period on the applicable Purchase Date for such Intraday Purchase; provided, however,
that the calculation of the VWAP for the Common Stock for the Intraday Purchase Period for an Intraday Purchase shall exclude each of
the following transactions, to the extent they occur during such Intraday Purchase Period (as applicable): (A) the opening or first purchase
of Common Stock at or following the official open of such primary (or “regular”) trading session that is reported in the
consolidated system on such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official close of such primary
(or “regular”) trading session that is reported in the consolidated system on such Purchase Date (as applicable), and (C)
provided the Company shall have specified a Limit Order Continue Election in the applicable Intraday Purchase Notice for such Intraday
Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Intraday Purchase Period
at a Sale Price that is less than the applicable Intraday Purchase Minimum Price Threshold for such Intraday Purchase. All such calculations
shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction.
“Intraday
Purchase Share Amount” means, with respect to an Intraday Purchase made pursuant to Section 3.2, the total number of Shares
to be purchased by the Investor in such Intraday Purchase as specified by the Company in the applicable Intraday Purchase Notice for
such Intraday Purchase, which total number of Shares shall not exceed the Intraday Purchase Maximum Amount applicable to such Intraday
Purchase, taking into account the Intraday Purchase Percentage specified by the Company in the applicable Intraday Purchase Notice for
such Intraday Purchase (and such number of Shares specified by the Company in the applicable Intraday Purchase Notice for such Intraday
Purchase shall be subject to automatic adjustment in accordance with Section 3.2 as necessary to give effect to the Intraday Purchase
Maximum Amount limitation applicable to such Intraday Purchase, taking into account the Intraday Purchase Percentage specified by the
Company in the applicable Intraday Purchase Notice for such Intraday Purchase, as set forth in this Agreement).
“Intraday
Purchase Share Volume Maximum” means, with respect to an Intraday Purchase made pursuant to Section 3.2, a number of shares
of Common Stock equal to the quotient obtained by dividing (i) the Intraday Purchase Share Amount to be purchased by the Investor in
such Intraday Purchase, by (ii) the Intraday Purchase Percentage specified by the Company in the applicable Intraday Purchase Notice
for such Intraday Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction).
“Investment
Period” means the period commencing on the Commencement Date and expiring on the date this Agreement is subsequently terminated
pursuant to Article VIII.
“Investor”
shall have the meaning assigned to such term in the preamble of this Agreement.
“Investor
Party” shall have the meaning assigned to such term in Section 9.1.
“Issuer
Covered Person” shall have the meaning assigned to such term in Section 5.44.
“IT
Systems” shall have the meaning assigned to such term in Section 5.39.
“Knowledge”
means the actual knowledge of any of (i) the Company’s Chief Executive Officer, President and Secretary and (ii) the Company’s
Chief Financial Officer, in each case after reasonable inquiry of all officers, directors and employees of the Company under such Person’s
direct supervision who would reasonably be expected to have knowledge or information with respect to the matter in question.
“Law”
means any federal, state, provincial, local, foreign, national or supranational statute, law (including common law), act, statute, ordinance,
treaty, rule, code, regulation or other binding directive issued, promulgated or enforced by a Governmental Entity having jurisdiction
over a given matter.
“Limit
Order Continue Election” shall have the meaning assigned to such term in the definition of “Intraday Purchase Ending
Time,” which election shall be applicable to any Purchase effected by the Company contemplated under Article III of this Agreement,
if such election is specified by the Company in the applicable Purchase Notice for such Purchase.
“Limit
Order Discontinue Election” shall have the meaning assigned to such term in the definition of “Intraday Purchase
Ending Time,” which election shall be applicable to any Purchase effected by the Company contemplated under Article III of this
Agreement, if such election is specified by the Company in the applicable Purchase Notice for such Purchase.
“Limited
Commitment Fee Make-Whole” shall have the meaning assigned to such term in Section 10.1(ii).
“Market
Open Purchase” shall have the meaning assigned to such term in Section 3.1.
“Market
Open Purchase Commencement Time” means, with respect to a Market Open Purchase made pursuant to Section 3.1, 9:30:01 a.m.,
New York City time, on the Purchase Date for such Market Open Purchase, or such later time on such Purchase Date publicly announced by
the Trading Market (or, if the Common Stock is then listed on an Eligible Market, by such Eligible Market) as the official open of the
primary (or “regular”) trading session on the Trading Market (or on such Eligible Market, as applicable) on such Purchase
Date.
“Market
Open Purchase Ending Time” means, with respect to a Market Open Purchase made pursuant to Section 3.1, the time on the
Purchase Date for such Market Open Purchase that is the earliest of: (i) 3:59 p.m., New York City time, on the applicable Purchase
Date for such Market Open Purchase, or such earlier time publicly announced by the Trading Market (or, if the Common Stock is then listed
on an Eligible Market, by such Eligible Market) as the official close of the primary (or “regular”) trading session on the
Trading Market (or on such Eligible Market, as applicable) on such Purchase Date; (ii) immediately at such time following the Market
Open Purchase Commencement Time of the Market Open Purchase Period for such Market Open Purchase that the total number (or volume) of
shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such Market Open Purchase Period
has exceeded the applicable Market Open Purchase Share Volume Maximum for such Market Open Purchase (taking into account the Market Open
Purchase Percentage specified by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase); provided,
however, that the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such
Eligible Market, as applicable) during such Market Open Purchase Period shall exclude from such calculation all shares of Common Stock
traded in any of the following transactions, to the extent they occur during such Market Open Purchase Period (as applicable): (A) the
opening or first purchase of Common Stock at or following the official open of such primary (or “regular”) trading session
that is reported in the consolidated system on such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official
close of such primary (or “regular”) trading session that is reported in the consolidated system on such Purchase Date (as
applicable), and (C) provided the Company shall have specified a Limit Order Continue Election in the applicable Market Open Purchase
Notice for such Market Open Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during
such Market Open Purchase Period at a Sale Price that is less than the applicable Market Open Purchase Minimum Price Threshold; and (iii)
provided the Company shall have specified a Limit Order Discontinue Election in the applicable Market Open Purchase Notice for such Market
Open Purchase, immediately at such time following the Market Open Purchase Commencement Time of the Market Open Purchase Period for such
Market Open Purchase that the Sale Price of any share of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable)
during such Market Open Purchase Period is less than the applicable Market Open Purchase Minimum Price Threshold; provided, however,
that the determination of whether the Sale Price of any share of Common Stock traded during such Market Open Purchase Period is less
than the applicable Market Open Purchase Minimum Price Threshold shall exclude (A) the opening or first purchase of Common Stock at or
following the official open of such primary (or “regular”) trading session that is reported in the consolidated system on
such Purchase Date and (B) the last or closing sale of Common Stock at or prior to the official close of such primary (or “regular”)
trading session that is reported in the consolidated system on such Purchase Date (as applicable). All such calculations shall be appropriately
adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Market
Open Purchase Maximum Amount” means, with respect to a Market Open Purchase made pursuant to Section 3.1, such number of
shares of Common Stock equal to the lesser of: (i) two (2) million shares, and (ii) the product of (A) the Market Open Purchase Percentage
specified by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase, multiplied by (B) the total number
(or volume) of shares of Common Stock traded on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on
such Eligible Market) during the Market Open Purchase Period for such Market Open Purchase; provided, however, that the
calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable)
during such Market Open Purchase Period referred to in clause (ii)(B) above shall exclude from such calculation all shares of Common
Stock traded in any of the following transactions, to the extent they occur during such Market Open Purchase Period (as applicable):
(1) the opening or first purchase of Common Stock at or following the official open of such primary (or “regular”) trading
session that is reported in the consolidated system on such Purchase Date, (2) the last or closing sale of Common Stock at or prior to
the official close of such primary (or “regular”) trading session that is reported in the consolidated system on such Purchase
Date (as applicable), and (3) provided the Company shall have specified a Limit Order Continue Election in the applicable Market Open
Purchase Notice for such Market Open Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable)
during such Market Open Purchase Period at a Sale Price that is less than the applicable Market Open Purchase Minimum Price Threshold.
All such calculations shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction.
“Market
Open Purchase Minimum Price Threshold” means, with respect to a Market Open Purchase made pursuant to Section 3.1, either
(a) the dollar amount specified by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase as the per
share minimum Sale Price threshold to be used in determining whether the event in clause (iii) of the definition of “Market Open
Purchase Ending Time” shall have occurred during the applicable Market Open Purchase Period for such Market Open Purchase, if the
Company shall have specified a Limit Order Discontinue Election in the applicable Market Open Purchase Notice for such Market Open Purchase,
or (b) the dollar amount specified by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase as the
per share minimum Sale Price threshold to be used in determining the sales of Common Stock during the applicable Market Open Purchase
Period that shall be excluded from the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market
(or on such Eligible Market, as applicable) during such Market Open Purchase Period, if the Company shall have specified a Limit Order
Continue Election in the applicable Market Open Purchase Notice for such Market Open Purchase; provided, however, that
in each case if the Company has not specified any such dollar amount as the per share minimum Sale Price threshold in the applicable
Market Open Purchase Notice for such Market Open Purchase, then the per share minimum Sale Price threshold to be used in such Market
Open Purchase shall be such dollar amount equal to the product of (a) the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding the Purchase Date for such Market Open Purchase, multiplied by (b) 0.75. All such calculations shall be appropriately adjusted
for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Market
Open Purchase Notice” means, with respect to a Market Open Purchase made pursuant to Section 3.1, an irrevocable written
notice delivered by the Company to the Investor, and received by the Investor, after 7:30 a.m., New York City time, and prior to 9:00
a.m., New York City time, on the Purchase Date for such Market Open Purchase, specifying the Market Open Purchase Percentage that shall
apply to such Market Open Purchase and whether a Limit Order Continue Election or a Limit Order Discontinue Election shall apply to such
Market Open Purchase, and directing the Investor to subscribe for and purchase a specified Market Open Purchase Share Amount (such specified
Market Open Purchase Share Amount subject to automatic adjustment as set forth in Section 3.1 as necessary to give effect to the applicable
Market Open Purchase Maximum Amount for such Market Open Purchase), at the applicable Market Open Purchase Price therefor on such Purchase
Date for such Market Open Purchase in accordance with this Agreement.
“Market
Open Purchase Percentage” means, with respect to a Market Open Purchase made pursuant to Section 3.1, the percentage specified
by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase, which shall not exceed 25.0%, for purposes
of calculating, among other things, the Market Open Purchase Maximum Amount, the Market Open Purchase Share Amount and the Market Open
Purchase Share Volume Maximum, in each case applicable to such Market Open Purchase.
“Market
Open Purchase Period” means, with respect to a Market Open Purchase made pursuant to Section 3.1, the period on the Purchase
Date for such Market Open Purchase, beginning at the applicable Market Open Purchase Commencement Time and ending at the applicable Market
Open Purchase Ending Time on such Purchase Date for such Market Open Purchase.
“Market
Open Purchase Price” means, with respect to a Market Open Purchase made pursuant to Section 3.1, the purchase price per
Share to be purchased by the Investor in such Market Open Purchase, equal to the product of (i) 0.97, multiplied by (ii) the VWAP of
the Common Stock for the applicable Market Open Purchase Period on the applicable Purchase Date for such Market Open Purchase; provided,
however, that the calculation of the VWAP for the Common Stock for the Market Open Purchase Period for a Market Open Purchase
shall exclude each of the following transactions, to the extent they occur during such Market Open Purchase Period (as applicable): (A)
the opening or first purchase of Common Stock at or following the official open of such primary (or “regular”) trading session
that is reported in the consolidated system on such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official
close of such primary (or “regular”) trading session that is reported in the consolidated system on such Purchase Date (as
applicable), and (C) provided the Company shall have specified a Limit Order Continue Election in the applicable Market Open Purchase
Notice for such Market Open Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during
such Market Open Purchase Period at a Sale Price that is less than the applicable Market Open Purchase Minimum Price Threshold for such
Market Open Purchase. All such calculations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization
or other similar transaction.
“Market
Open Purchase Share Amount” means, with respect to a Market Open Purchase made pursuant to Section 3.1, the total number
of Shares to be purchased by the Investor in such Market Open Purchase as specified by the Company in the applicable Market Open Purchase
Notice for such Market Open Purchase, which total number of Shares shall not exceed the Market Open Purchase Maximum Amount applicable
to such Market Open Purchase, taking into account the Market Open Purchase Percentage specified by the Company in the applicable Market
Open Purchase Notice for such Market Open Purchase (and such number of Shares specified by the Company in the applicable Market Open
Purchase Notice for such Market Open Purchase shall be subject to automatic adjustment in accordance with Section 3.1 as necessary to
give effect to the Market Open Purchase Maximum Amount limitation applicable to such Market Open Purchase, taking into account the Market
Open Purchase Percentage specified by the Company in the applicable Market Open Purchase Notice for such Market Open Purchase, as set
forth in this Agreement).
“Market
Open Purchase Share Volume Maximum” means, with respect to a Market Open Purchase made pursuant to Section 3.1, a number
of shares of Common Stock equal to the quotient obtained by dividing (i) the Market Open Purchase Share Amount to be purchased by the
Investor in such Market Open Purchase, by (ii) the Market Open Purchase Percentage specified by the Company in the applicable Market
Open Purchase Notice for such Market Open Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend,
stock split, reverse stock split or other similar transaction).
“Material
Adverse Effect” means (i) any condition, occurrence, state of facts or event having, or insofar as reasonably can be foreseen
would likely have, any effect on the business, operations, properties or financial condition of the Company as set forth in the Commission
Documents that is material and adverse to the Company and its Subsidiaries, taken as a whole, excluding any facts, circumstances, changes
or effects, individually or in the aggregate, exclusively and directly resulting from, relating to or arising out of any of the following:
(a) changes in conditions in the U.S. or global capital, credit or financial markets generally, including changes in the availability
of capital or currency exchange rates, provided such changes shall not have affected the Company in a materially disproportionate manner
as compared to other similarly situated companies, (b) changes generally affecting the industries in which the Company and its Subsidiaries
operate, provided such changes shall not have affected the Company and its Subsidiaries, taken as a whole, in a materially disproportionate
manner as compared to other similarly situated companies, (c) any effect of the announcement of, or the consummation of the transactions
contemplated by, this Agreement and the Registration Rights Agreement on the Company’s or any of its Subsidiaries’ relationships,
contractual or otherwise, with customers, suppliers, vendors, bank lenders, strategic venture partners or employees, (d) changes arising
in connection with earthquakes, hostilities, acts of war, sabotage or terrorism or military actions or any escalation or material worsening
of any such hostilities, acts of war, sabotage or terrorism or military actions existing as of the date hereof, (e) any action taken
by the Investor, any of its officers, its sole member or the Investor’s Broker-Dealer, or any of such Person’s successors
with respect to the transactions contemplated by this Agreement and the Registration Rights Agreement, and (f) the effect of any changes
in applicable Laws or accounting rules, provided such changes shall not have affected the Company and its Subsidiaries, taken as a whole,
in a materially disproportionate manner as compared to other similarly situated companies; (ii) any condition, occurrence, state of facts
or event having, or insofar as reasonably can be foreseen would likely have, any material adverse effect on the legality, validity or
enforceability of any of the Transaction Documents or the transactions contemplated thereby; or (iii) any condition, occurrence, state
of facts or event that would, or insofar as reasonably can be foreseen would likely, prohibit or otherwise materially interfere with
or delay the ability of the Company to perform any of its obligations under any of the Transaction Documents to which it is a party.
“Material
Permits” shall have the meaning assigned to such term in Section 5.17.
“Minimum
Price” means $1.61, representing [the Nasdaq official closing price of the Common Stock on the Trading Market (as reflected
on Nasdaq.com) on [the Trading Day immediately preceding] 3 the date of this Agreement] [the average Nasdaq official
closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com) for the five (5) consecutive Trading Days ending
on [the Trading Day immediately preceding]4 the date of this Agreement]5 (subject to adjustment for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of
this Agreement).
“Money
Laundering Laws” shall have the meaning assigned to such term in Section 5.37.
“MPA
Period” means: (i) with respect to the first publication or distribution of a research report (as such term is defined
in Rule 500 of Regulation AC) concerning the Company by any Affiliate of the Investor, including, without limitation, RCP, the period
commencing at 5:00 p.m., New York City time, on the eleventh (11th) Trading Day immediately preceding the Trading Day on which
any Affiliate of the Investor, including, without limitation, RCP, shall have published or distributed any research report (as such term
is defined in Rule 500 of Regulation AC) concerning the Company, and ending at 6:00 a.m., New York City time, on the eleventh (11th)
Trading Day immediately following the Trading Day on which any Affiliate of the Investor, including, without limitation, RCP, shall have
published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company; (ii) with
respect to any subsequent publication or distribution of a research report (as such term is defined in Rule 500 of Regulation AC) concerning
the Company by any Affiliate of the Investor, including, without limitation, RCP, the period commencing at 5:00 p.m., New York City time,
on the fourth (4th) Trading Day immediately preceding the Trading Day on which any Affiliate of the Investor, including, without
limitation, RCP, shall have published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning
the Company, and ending at 6:00 a.m., New York City time, on the fourth (4th) Trading Day immediately following the Trading
Day on which any Affiliate of the Investor, including, without limitation, RCP, shall have published or distributed any research report
(as such term is defined in Rule 500 of Regulation AC) concerning the Company; and (iii) with respect to any non-deal road show or investor
conference, investor marketing event or pre-scheduled series of investor meetings (either in person or virtual) that is hosted (or substantially
coordinated, organized, arranged or facilitated) by any Affiliate of the Investor, including without limitation RCP, at which the Company
shall have agreed to participate (a “Scheduled Investor Marketing Event”), the period commencing at 5:00 p.m.,
New York City time, on the fourth (4th) Trading Day immediately preceding the first Trading Day on which the Scheduled Investor
Marketing Event occurred, and ending at 6:00 a.m., New York City time, on the fourth (4th) Trading Day immediately following
the last Trading Day on which such Scheduled Investor Marketing Event had occurred, provided that a Scheduled Investor Marketing
Event shall not include any event at which an Affiliate of the Investor merely attends as a participant or provides de minimis administrative
assistance.
3
Use if Agreement is signed prior to market close at 4:00 p.m., Eastern Standard Time.
4
Use if Agreement is signed prior to market close at 4:00 p.m., Eastern Standard Time.
5
Use the lower of the two.
“New
Registration Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Non-Affiliate
Shares” shall have the meaning assigned to such term in Section 5.45.
“Notice
of Effectiveness” shall have the meaning assigned to such term in Section 10.1(iv).
“OFAC”
shall have the meaning assigned to such term in Section 5.36.
“Order”
means any outstanding writ, order, judgment, injunction, binding decision or determination, award, ruling, subpoena, verdict or decree
entered, issued or rendered by any Governmental Entity.
“PEA
Period” means the period commencing at 9:30 a.m., New York City time, on the fifth (5th) Trading Day immediately
prior to the filing of (i) any post-effective amendment to the Initial Registration Statement or any New Registration Statement or (ii)
any New Registration Statement, as applicable, and ending at 9:30 a.m., New York City time, on the Trading Day immediately following,
the Effective Date of such post-effective amendment or New Registration Statement, as applicable.
“Permits”
means all franchises, grants, authorizations, licenses, permits, easements, consents, certificates, exemptions, waivers and Orders of
any Governmental Entity required for the conduct of the business conducted by the Company and its Subsidiaries.
“Person”
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture or Governmental Entity.
“Personal
Data” shall have the meaning assigned to such term in Section 5.39.
“Policies”
shall have the meaning assigned to such term in Section 5.40.
“Post-Market
Purchase” shall have the meaning assigned to such term in Section 3.3(b).
“Post-Market
Purchase Commencement Time” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), such time after
4:05 p.m., New York City time, on the Purchase Date for such Post-Market Purchase that the Investor shall have timely received from the
Company a valid Post-Market Purchase Notice for such Post-Market Purchase, as acknowledged by email correspondence from the Investor
to each of the individual notice recipients of the Company set forth in the applicable Post-Market Purchase Notice, other than via auto-reply,
such email correspondence confirming the applicable commencement time of the Post-Market Purchase Period for such Post-Market Purchase
on such Purchase Date therefor.
“Post-Market
Purchase Ending Time” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), the time on the Purchase
Date for such Post-Market Purchase that is the earliest of: (i) 6:00:00 p.m., New York City time, on the Purchase Date for such
Post-Market Purchase; (ii) immediately at such time following the Post-Market Purchase Commencement Time of the Post-Market Purchase
Period for such Post-Market Purchase that the total number (or volume) of shares of Common Stock traded on the Trading Market (or on
such Eligible Market, as applicable) during such Post-Market Purchase Period has exceeded the applicable Post-Market Purchase Share Volume
Maximum for such Post-Market Purchase (taking into account the Post-Market Purchase Percentage specified by the Company in the applicable
Post-Market Purchase Notice for such Post-Market Purchase); provided, however, that, if the Company shall have specified
a Limit Order Continue Election in the applicable Post-Market Purchase Notice for such Post-Market Purchase, the calculation of the total
number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such Post-Market
Purchase Period shall exclude from such calculation all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable)
during such Post-Market Purchase Period at a Sale Price that is less than the applicable Post-Market Purchase Minimum Price Threshold;
and (iii) provided the Company shall have specified a Limit Order Discontinue Election in the applicable Post-Market Purchase Notice
for such Post-Market Purchase, immediately at such time following the Post-Market Purchase Commencement Time of the Post-Market Purchase
Period for such Post-Market Purchase that the Sale Price of any share of Common Stock traded on the Trading Market (or on such Eligible
Market, as applicable) during such Post-Market Purchase Period is less than the applicable Post-Market Purchase Minimum Price Threshold.
All such calculations shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction.
“Post-Market
Purchase Maximum Amount” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), such number of
shares of Common Stock equal to the lesser of: (i) one (1) million shares, and (ii) the product of (A) the Post-Market Purchase Percentage
specified by the Company in the applicable Post-Market Purchase Notice for such Post-Market Purchase, multiplied by (B) the total number
(or volume) of shares of Common Stock traded on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on
such Eligible Market) during the Post-Market Purchase Period for such Post-Market Purchase; provided, however, that, if
the Company shall have specified a Limit Order Continue Election in the applicable Post-Market Purchase Notice for such Post-Market Purchase,
the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as
applicable) during such Post-Market Purchase Period referred to in clause (ii)(B) above shall exclude from such calculation all sales
of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Post-Market Purchase Period at a Sale Price
that is less than the applicable Post-Market Purchase Minimum Price Threshold. All such calculations shall be appropriately adjusted
for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Post-Market
Purchase Minimum Price Threshold” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), either
(a) the dollar amount specified by the Company in the applicable Post-Market Purchase Notice for such Post-Market Purchase as the per
share minimum Sale Price threshold to be used in determining whether the event in clause (iii) of the definition of “Post-Market
Purchase Ending Time” shall have occurred during the applicable Post-Market Purchase Period for such Post-Market Purchase, if the
Company shall have specified a Limit Order Discontinue Election in the applicable Post-Market Purchase Notice for such Post-Market Purchase,
or (b) the dollar amount specified by the Company in the applicable Post-Market Purchase Notice for such Post-Market Purchase as the
per share minimum Sale Price threshold to be used in determining the sales of Common Stock during the applicable Post-Market Purchase
Period that shall be excluded from the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market
(or on such Eligible Market, as applicable) during such Post-Market Purchase Period, if the Company shall have specified a Limit Order
Continue Election in the applicable Post-Market Purchase Notice for such Post-Market Purchase; provided, however, that
in each case if the Company has not specified any such dollar amount as the per share minimum Sale Price threshold in the applicable
Post-Market Purchase Notice for such Post-Market Purchase, then the per share minimum Sale Price threshold to be used in such Post-Market
Purchase shall be such dollar amount equal to the product of (a) the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding the Purchase Date for such Post-Market Purchase, multiplied by (b) 0.75. All such calculations shall be appropriately adjusted
for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Post-Market
Purchase Notice” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), an irrevocable written
notice delivered by the Company to the Investor, and received by the Investor, after 4:05 p.m., New York City time, and prior to 5:00
p.m., New York City time, on the Purchase Date for such Post-Market Purchase, specifying the Post-Market Purchase Percentage that shall
apply to such Post-Market Purchase and whether a Limit Order Continue Election or a Limit Order Discontinue Election shall apply to such
Post-Market Purchase, and directing the Investor to purchase a specified Post-Market Purchase Share Amount (such specified Post-Market
Purchase Share Amount subject to automatic adjustment as set forth in Section 3.3(b) as necessary to give effect to the applicable Post-Market
Purchase Maximum Amount for such Post-Market Purchase), at the applicable Post-Market Purchase Price therefor on such Purchase Date for
such Post-Market Purchase in accordance with this Agreement.
“Post-Market
Purchase Percentage” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), the percentage specified
by the Company in the applicable Post-Market Purchase Notice for such Post-Market Purchase, which shall not exceed 20.0%, for purposes
of calculating, among other things, the Post-Market Purchase Maximum Amount, the Post-Market Purchase Share Amount and the Post-Market
Purchase Share Volume Maximum, in each case applicable to such Post-Market Purchase.
“Post-Market
Purchase Period” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), the period on the Purchase
Date for such Post-Market Purchase, beginning at the applicable Post-Market Purchase Commencement Time and ending at the applicable Post-Market
Purchase Ending Time on such Purchase Date for such Post-Market Purchase.
“Post-Market
Purchase Price” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), the purchase price per Share
to be purchased by the Investor in such Post-Market Purchase, equal to the product of (i) 0.95, multiplied by (ii) the VWAP of the Common
Stock for the applicable Post-Market Purchase Period on the applicable Purchase Date for such Post-Market Purchase; provided,
however, that, if the Company shall have specified a Limit Order Continue Election in the applicable Post-Market Purchase Notice
for such Post-Market Purchase, the calculation of the VWAP for the Common Stock for the Post-Market Purchase Period for a Post-Market
Purchase shall exclude from such calculation all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable)
during such Post-Market Purchase Period at a Sale Price that is less than the applicable Post-Market Purchase Minimum Price Threshold
for such Post-Market Purchase. All such calculations shall be appropriately adjusted for any stock dividend, stock split, stock combination,
recapitalization or other similar transaction.
“Post-Market
Purchase Share Amount” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), the total number
of Shares to be purchased by the Investor in such Post-Market Purchase as specified by the Company in the applicable Post-Market Purchase
Notice for such Post-Market Purchase, which total number of Shares shall not exceed the Post-Market Purchase Maximum Amount applicable
to such Post-Market Purchase, taking into account the Post-Market Purchase Percentage specified by the Company in the applicable Post-Market
Purchase Notice for such Post-Market Purchase (and such number of Shares specified by the Company in the applicable Post-Market Purchase
Notice for such Post-Market Purchase shall be subject to automatic adjustment in accordance with Section 3.3(b) as necessary to give
effect to the Post-Market Purchase Maximum Amount limitation applicable to such Post-Market Purchase, taking into account the Post-Market
Purchase Percentage specified by the Company in the applicable Post-Market Purchase Notice for such Post-Market Purchase, as set forth
in this Agreement).
“Post-Market
Purchase Share Volume Maximum” means, with respect to a Post-Market Purchase made pursuant to Section 3.3(b), a number
of shares of Common Stock equal to the quotient obtained by dividing (i) the Post-Market Purchase Share Amount to be purchased by the
Investor in such Post-Market Purchase, by (ii) the Post-Market Purchase Percentage specified by the Company in the applicable Post-Market
Purchase Notice for such Post-Market Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend,
stock split, reverse stock split or other similar transaction).
“Pre-Market
Purchase” shall have the meaning assigned to such term in Section 3.3(a).
“Pre-Market
Purchase Commencement Time” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), such time after
7:00 a.m., New York City time, on the Purchase Date for such Pre-Market Purchase that the Investor shall have timely received from the
Company a valid Pre-Market Purchase Notice for such Pre-Market Purchase, as acknowledged by email correspondence from the Investor to
each of the individual notice recipients of the Company set forth in the applicable Pre-Market Purchase Notice, other than via auto-reply,
such email correspondence confirming the applicable commencement time of the Pre-Market Purchase Period for such Pre-Market Purchase
on such Purchase Date therefor.
“Pre-Market
Purchase Ending Time” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), the time on the Purchase
Date for such Pre-Market Purchase that is the earliest of: (i) 9:10:00 a.m., New York City time, on the Purchase Date for such
Market Open Purchase; (ii) immediately at such time following the Pre-Market Purchase Commencement Time of the Pre-Market Purchase Period
for such Pre-Market Purchase that the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible
Market, as applicable) during such Pre-Market Purchase Period has exceeded the applicable Pre-Market Purchase Share Volume Maximum for
such Pre-Market Purchase (taking into account the Pre-Market Purchase Percentage specified by the Company in the applicable Pre-Market
Purchase Notice for such Pre-Market Purchase); provided, however, that, if the Company shall have specified a Limit Order
Continue Election in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, the calculation of the total number (or
volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during such Pre-Market Purchase
Period shall exclude from such calculation all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable)
during such Pre-Market Purchase Period at a Sale Price that is less than the applicable Pre-Market Purchase Minimum Price Threshold;
and (iii) provided the Company shall have specified a Limit Order Discontinue Election in the applicable Pre-Market Purchase Notice for
such Pre-Market Purchase, immediately at such time following the Pre-Market Purchase Commencement Time of the Pre-Market Purchase Period
for such Pre-Market Purchase that the Sale Price of any share of Common Stock traded on the Trading Market (or on such Eligible Market,
as applicable) during such Pre-Market Purchase Period is less than the applicable Pre-Market Purchase Minimum Price Threshold. All such
calculations shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock
split or other similar transaction.
“Pre-Market
Purchase Maximum Amount” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), such number of shares
of Common Stock equal to the lesser of: (i) one (1) million shares, and (ii) the product of (A) the Pre-Market Purchase Percentage specified
by the Company in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, multiplied by (B) the total number (or volume)
of shares of Common Stock traded on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on such Eligible
Market) during the Pre-Market Purchase Period for such Pre-Market Purchase; provided, however, that, if the Company shall
have specified a Limit Order Continue Election in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, the calculation
of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on such Eligible Market, as applicable) during
such Pre-Market Purchase Period referred to in clause (ii)(B) above shall exclude from such calculation all sales of Common Stock on
the Trading Market (or on such Eligible Market, as applicable) during such Pre-Market Purchase Period at a Sale Price that is less than
the applicable Pre-Market Purchase Minimum Price Threshold. All such calculations shall be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Pre-Market
Purchase Minimum Price Threshold” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), either
(a) the dollar amount specified by the Company in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase as the per share
minimum Sale Price threshold to be used in determining whether the event in clause (iii) of the definition of “Pre-Market Purchase
Ending Time” shall have occurred during the applicable Pre-Market Purchase Period for such Pre-Market Purchase, if the Company
shall have specified a Limit Order Discontinue Election in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, or
(b) the dollar amount specified by the Company in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase as the per share
minimum Sale Price threshold to be used in determining the sales of Common Stock during the applicable Pre-Market Purchase Period that
shall be excluded from the calculation of the total number (or volume) of shares of Common Stock traded on the Trading Market (or on
such Eligible Market, as applicable) during such Pre-Market Purchase Period, if the Company shall have specified a Limit Order Continue
Election in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase; provided, however, that in each case
if the Company has not specified any such dollar amount as the per share minimum Sale Price threshold in the applicable Pre-Market Purchase
Notice for such Pre-Market Purchase, then the per share minimum Sale Price threshold to be used in such Pre-Market Purchase shall be
such dollar amount equal to the product of (a) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the
Purchase Date for such Pre-Market Purchase, multiplied by (b) 0.75. All such calculations shall be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
“Pre-Market
Purchase Notice” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), an irrevocable written notice
delivered by the Company to the Investor, and received by the Investor, after 7:00 a.m., New York City time, and prior to 8:30 a.m.,
New York City time, on the Purchase Date for such Pre-Market Purchase, specifying the Pre-Market Purchase Percentage that shall apply
to such Pre-Market Purchase and whether a Limit Order Continue Election or a Limit Order Discontinue Election shall apply to such Pre-Market
Purchase, and directing the Investor to purchase a specified Pre-Market Purchase Share Amount (such specified Pre-Market Purchase Share
Amount subject to automatic adjustment as set forth in Section 3.3(a) as necessary to give effect to the applicable Pre-Market Purchase
Maximum Amount for such Pre-Market Purchase), at the applicable Pre-Market Purchase Price therefor on such Purchase Date for such Pre-Market
Purchase in accordance with this Agreement.
“Pre-Market
Purchase Percentage” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), the percentage specified
by the Company in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, which shall not exceed 20.0%, for purposes
of calculating, among other things, the Pre-Market Purchase Maximum Amount, the Pre-Market Purchase Share Amount and the Pre-Market Purchase
Share Volume Maximum, in each case applicable to such Pre-Market Purchase.
“Pre-Market
Purchase Period” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), the period on the Purchase
Date for such Pre-Market Purchase, beginning at the applicable Pre-Market Purchase Commencement Time and ending at the applicable Pre-Market
Purchase Ending Time on such Purchase Date for such Pre-Market Purchase.
“Pre-Market
Purchase Price” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), the purchase price per Share
to be purchased by the Investor in such Pre-Market Purchase, equal to the product of (i) 0.95, multiplied by (ii) the VWAP of the Common
Stock for the applicable Pre-Market Purchase Period on the applicable Purchase Date for such Pre-Market Purchase; provided, however,
that, if the Company shall have specified a Limit Order Continue Election in the applicable Pre-Market Purchase Notice for such Pre-Market
Purchase, the calculation of the VWAP for the Common Stock for the Pre-Market Purchase Period for a Pre-Market Purchase shall exclude
from such calculation all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Pre-Market
Purchase Period at a Sale Price that is less than the applicable Pre-Market Purchase Minimum Price Threshold for such Pre-Market Purchase.
All such calculations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other
similar transaction.
“Pre-Market
Purchase Share Amount” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), the total number of
Shares to be purchased by the Investor in such Pre-Market Purchase as specified by the Company in the applicable Pre-Market Purchase
Notice for such Pre-Market Purchase, which total number of Shares shall not exceed the Pre-Market Purchase Maximum Amount applicable
to such Pre-Market Purchase, taking into account the Pre-Market Purchase Percentage specified by the Company in the applicable Pre-Market
Purchase Notice for such Pre-Market Purchase (and such number of Shares specified by the Company in the applicable Pre-Market Purchase
Notice for such Pre-Market Purchase shall be subject to automatic adjustment in accordance with Section 3.3(a) as necessary to give effect
to the Pre-Market Purchase Maximum Amount limitation applicable to such Pre-Market Purchase, taking into account the Pre-Market Purchase
Percentage specified by the Company in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase, as set forth in this Agreement).
“Pre-Market
Purchase Share Volume Maximum” means, with respect to a Pre-Market Purchase made pursuant to Section 3.3(a), a number of
shares of Common Stock equal to the quotient obtained by dividing (i) the Pre-Market Purchase Share Amount to be purchased by the Investor
in such Pre-Market Purchase, by (ii) the Pre-Market Purchase Percentage specified by the Company in the applicable Pre-Market Purchase
Notice for such Pre-Market Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock
split, reverse stock split or other similar transaction).
“Privacy
Laws” shall have the meaning assigned to such term in Section 5.40.
“Proceeding”
means any lawsuit, litigation, action, audit, examination or investigation, claim, complaint, charge, proceeding, suit or arbitration
(in each case, whether civil, criminal or administrative and whether public or private) pending in court or arbitration or by, before
or otherwise involving any Governmental Entity.
“Prospectus”
shall have the meaning assigned to such term in the Registration Rights Agreement.
“Prospectus
Supplement” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Purchase”
or “Purchases” means any one or more of the following (given the context in which it is used in this Agreement):
(i) Market Open Purchase(s) made pursuant to Section 3.1, (ii) Intraday Purchase(s) made pursuant to Section 3.2, (iii) Pre-Market Purchase(s)
made pursuant to Section 3.3(a) and/or (iv) Post-Market Purchase(s) made pursuant to Section 3.3(b).
“Purchase
Condition Satisfaction Time” shall have the meaning assigned to such term in Section 7.3.
“Purchase
Date” means: (i) with respect to a Market Open Purchase made pursuant to Section 3.1, the Trading Day on which the Investor
timely receives, (A) after 7:30 a.m., New York City time, and (B) prior to 9:00 a.m., New York City time, on such Trading Day, a valid
Market Open Purchase Notice for such Market Open Purchase in accordance with this Agreement; (ii) with respect to an Intraday Purchase
made pursuant to Section 3.2, the Trading Day on which the Investor timely receives a valid Intraday Purchase Notice for such Intraday
Purchase in accordance with this Agreement, (A) after the latest of (X) 10:00 a.m., New York City time, on such Trading Day, if
the Company has not timely delivered a valid Market Open Purchase Notice to the Investor for a Market Open Purchase on such Trading Day,
(Y) the Market Open Purchase Ending Time of the Market Open Purchase Period for the Market Open Purchase preceding the applicable Intraday
Purchase Period for such Intraday Purchase occurring on the same Trading Day as such earlier Market Open Purchase, if the Company has
timely delivered a valid Market Open Purchase Notice to the Investor for a Market Open Purchase on such Trading Day, and (Z) the Intraday
Purchase Ending Time of the Intraday Purchase Period for the most recent prior Intraday Purchase, if any, occurring on the same Trading
Day as such Intraday Purchase, and (B) prior to the earlier of (X) 2:00 p.m., New York City time, on such Trading Day for such
Intraday Purchase and (Y) such time that is exactly two (2) hours immediately prior to the official close of the primary (or “regular”)
trading session on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market) on such
Trading Day, if the Trading Market (or such Eligible Market, as applicable) has publicly announced that the official close of the primary
(or “regular”) trading session shall be earlier than 4:00 p.m., New York City time, on such Trading Day; (iii) with respect
to a Pre-Market Purchase made pursuant to Section 3.3(a), the Trading Day on which the Investor timely receives, (A) after 7:00 a.m.,
New York City time, and (B) prior to 8:30 a.m., New York City time, on such Trading Day, a valid Pre-Market Purchase Notice for such
Pre-Market Purchase in accordance with this Agreement; and (iv) with respect to a Post-Market Purchase made pursuant to Section 3.3(b),
the Trading Day on which the Investor timely receives, (A) after 4:05 p.m., New York City time, and (B) prior to 5:00 p.m., New York
City time, on such Trading Day, a valid Post-Market Purchase Notice for such Post-Market Purchase in accordance with this Agreement.
“Purchase
Notice” or “Purchase Notices” means any one or more of the following (given the context in which
it is used in this Agreement): (i) Market Open Purchase Notice(s) with respect to Market Open Purchase(s) made pursuant to Section 3.1,
(ii) Intraday Purchase Notice(s) with respect to Intraday Purchase(s) made pursuant to Section 3.2, (iii) Pre-Market Purchase Notice(s)
with respect to Pre-Market Purchase(s) made pursuant to Section 3.3(a) and/or (iv) Post-Market Purchase Notice(s) with respect to Post-Market
Purchase(s) made pursuant to Section 3.3(b).
“Purchase
Price” means any one or more of the following (given the context in which it is used in this Agreement): (i) the applicable
Market Open Purchase Price for the Shares purchased by the Investor in a Market Open Purchase effected by the Company pursuant to Section
3.1, (ii) the applicable Intraday Purchase Price for the Shares purchased by the Investor in an Intraday Purchase effected by the Company
pursuant to Section 3.2, (iii) the applicable Pre-Market Purchase Price for the Shares purchased by the Investor in a Pre-Market Purchase
effected by the Company pursuant to Section 3.3(a) and/or (iv) the applicable Post-Market Purchase Price for the Shares purchased by
the Investor in a Post-Market Purchase effected by the Company pursuant to Section 3.3(b).
“Purchase
Share Delivery Date” shall have the meaning assigned to such term in Section 3.4.
“QIU
Fee Reimbursement” means an amount in cash equal to $50,000, representing all fees required to be paid to the Qualified
Independent Underwriter engaged by the Company pursuant to Section 6.15 of this Agreement in connection with the transactions contemplated
by this Agreement and the Registration Rights Agreement, which cash amount (i) the Investor shall pay directly to the Qualified Independent
Underwriter on or prior to the Commencement Date and (ii) the Company shall reimburse or cause to be reimbursed to the Investor, pursuant
to, at such time(s) and in such manner as set forth in Section 10.1(i) of this Agreement.
“Qualified
Independent Underwriter” shall have the meaning assigned to such term in FINRA Rule 5121(f)(12).
“RCP”
shall have the meaning assigned to such term in the Recitals.
“Registrable
Securities” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Registration
Period” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Registration
Rights Agreement” shall have the meaning assigned to such term in the recitals hereof.
“Registration
Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.
“Regulation
D” shall have the meaning assigned to such term in the recitals hereof.
“Representation
Date” shall have the meaning assigned to such term in Section 6.17.
“Restricted
Period” shall have the meaning assigned to such term in Section 6.9(i).
“Restricted
Person” shall have the meaning assigned to such term in Section 6.9(i).
“Restricted
Persons” shall have the meaning assigned to such term in Section 6.9(i).
“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect.
“Sale
Price” means any trade price for a share of Common Stock on the Trading Market, or if the Common Stock is then traded on
an Eligible Market, on such Eligible Market, as reported by Bloomberg.
“Sarbanes-Oxley
Act” shall have the meaning assigned to such term in Section 5.6(c).
“Section
4(a)(2)” shall have the meaning assigned to such term in the recitals of this Agreement.
“Securities
Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.
“Shares”
shall mean the shares of Common Stock that may be purchased by the Investor under this Agreement pursuant to one or more Purchase Notices.
“Short
Sales” shall mean “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange
Act.
“Subsequent
Investor Legal Fee Expense Reimbursement” shall have the meaning assigned to such term in Section 10.1(i).
“Subsidiary”
shall mean any corporation or other entity of which at least a majority of the securities or other ownership interest having ordinary
voting power for the election of directors or other persons performing similar functions are at the time owned directly or indirectly
by the Company and/or any of its other Subsidiaries.
“Threshold
Price” means $0.50, which shall not be adjusted (proportionally or otherwise) for any forward stock split, reverse stock
split, stock combination, stock dividend, recapitalization, reorganization or other similar transaction involving the capital stock of
the Company that occurs on or after the date of the Agreement.
“Total
Commitment” shall have the meaning assigned to such term in Section 2.1.
“Trading
Day” shall mean any day on which the Trading Market or, if the Common Stock is then listed on an Eligible Market, such
Eligible Market is open for “regular” trading, including any day on which the Trading Market (or such Eligible Market, as
applicable) is open for “regular” trading for a period of time less than the customary “regular” trading period.
“Trading
Market” means The Nasdaq Capital Market (or any nationally recognized successor thereto).
“Transaction
Documents” means, collectively, this Agreement (as qualified by the Disclosure Schedule) and the exhibits hereto, the Registration
Rights Agreement, and the exhibits thereto, and each of the other agreements, documents, certificates and instruments entered into or
furnished by the parties hereto in connection with the transactions contemplated hereby and thereby.
“Variable
Rate Transaction” means a transaction in which the Company (i) issues or sells any equity or debt securities that are convertible
into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents
either (A) at a conversion price, exercise price, exchange rate or other price that is based upon and/or varies with the trading prices
of or quotations for the Common Stock at any time after the initial issuance of such equity or debt securities, or (B) with a conversion,
exercise or exchange price that is subject to being reset at some future date after the initial issuance of such equity or debt security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market
for the Common Stock (including, without limitation, any “full ratchet” or “weighted average” anti-dilution provisions,
but not including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other
similar transaction), or (ii) issues or sells any equity or debt securities, including, without limitation, Common Stock or Common Stock
Equivalents, either (A) at a price that is subject to being reset at some future date after the initial issuance of such debt or equity
security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the
market for the Common Stock (other than standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend,
stock split or other similar transaction), or (B) that are subject to or contain any put, call, redemption, buy-back, price-reset or
other similar provision or mechanism (including, without limitation, a “Black-Scholes” put or call right, other than in connection
with a “fundamental transaction”) that provides for the issuance of additional equity securities of the Company or the payment
of cash by the Company or (iii) enters into any agreement, including, but not limited to, an “equity line of credit” or “at
the market offering” or other continuous offering or similar offering of Common Stock or Common Stock Equivalents, whereby the
Company may sell Common Stock or Common Stock Equivalents at a future determined price.
“VWAP”
means, for the Common Stock for a specified period, the dollar volume-weighted average price for the Common Stock on the Trading Market
(or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market), for such period, as reported by Bloomberg through
its “AQR” function; provided, however, that (i) the calculation of the dollar volume-weighted average price
for the Common Stock for the Market Open Purchase Period for each Market Open Purchase shall exclude each of the following transactions,
to the extent they occur during such Market Open Purchase Period (as applicable): (A) the opening or first purchase of Common Stock at
or following the official open of such primary (or “regular”) trading session that is reported in the consolidated system
on such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official close of such primary (or “regular”)
trading session that is reported in the consolidated system on such Purchase Date (as applicable), and (C) provided the Company shall
have specified a Limit Order Continue Election in the applicable Market Open Purchase Notice for such Market Open Purchase, all sales
of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Market Open Purchase Period at a Sale Price
that is less than the applicable Market Open Purchase Minimum Price Threshold for such Market Open Purchase; (ii) the calculation of
the dollar volume-weighted average price for the Common Stock for the Intraday Purchase Period for each Intraday Purchase shall exclude
each of the following transactions, to the extent they occur during such Intraday Purchase Period (as applicable): (A) the opening or
first purchase of Common Stock at or following the official open of such primary (or “regular”) trading session that is reported
in the consolidated system on such Purchase Date, (B) the last or closing sale of Common Stock at or prior to the official close of such
primary (or “regular”) trading session that is reported in the consolidated system on such Purchase Date (as applicable),
and (C) provided the Company shall have specified a Limit Order Continue Election in the applicable Intraday Purchase Notice for such
Intraday Purchase, all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Intraday Purchase
Period at a Sale Price that is less than the applicable Intraday Purchase Minimum Price Threshold for such Intraday Purchase; (iii) provided
the Company shall have specified a Limit Order Continue Election in the applicable Pre-Market Purchase Notice for such Pre-Market Purchase,
the calculation of the dollar volume-weighted average price for the Common Stock for the Pre-Market Purchase Period for each Pre-Market
Purchase shall exclude all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable) during such Pre-Market
Purchase Period at a Sale Price that is less than the applicable Pre-Market Purchase Minimum Price Threshold for such Pre-Market Purchase;
and (iv) provided the Company shall have specified a Limit Order Continue Election in the applicable Post-Market Purchase Notice for
such Post-Market Purchase, the calculation of the dollar volume-weighted average price for the Common Stock for the Post-Market Purchase
Period for each Post-Market Purchase shall exclude all sales of Common Stock on the Trading Market (or on such Eligible Market, as applicable)
during such Post-Market Purchase Period at a Sale Price that is less than the applicable Post-Market Purchase Minimum Price Threshold
for such Post-Market Purchase. All such calculations shall be appropriately adjusted for any stock dividend, stock split, stock combination,
recapitalization or other similar transaction.
“Withheld
Commitment Fee Amount” shall have the meaning assigned to such term in Section 10.1(ii).
“Withheld
Reimbursement Amount” shall have the meaning assigned to such term in Section 10.1(i).
EXHIBIT
A
FORM
OF REGISTRATION RIGHTS AGREEMENT
[TO
BE FURNISHED SEPARATELY]
EXHIBIT
B
CLOSING
CERTIFICATE
[●],
2026
The
undersigned, the [●] of Polar Power, Inc., a Delaware corporation (the “Company”), delivers this certificate
in connection with the Common Stock Purchase Agreement, dated as of July 27, 2026 (the “Agreement”),
by and between the Company and Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”),
and hereby certifies on the date hereof that (capitalized terms used herein without definition have the meanings assigned to them in
the Agreement):
1.
Attached hereto as Exhibit A is a true, complete and correct copy of the Certificate of Incorporation of the Company, as amended
through the date hereof, as filed with the Secretary of State of the State of Delaware (the “Certificate of Incorporation”).
The Certificate of Incorporation of the Company has not been further amended or restated, and no document with respect to any amendment
to the Certificate of Incorporation of the Company has been filed in the office of the Secretary of State of the State of Delaware since
the date shown on the face of the state certification relating to the Company’s Certificate of Incorporation, which is in full
force and effect on the date hereof, and no action has been taken by the Company in contemplation of any such amendment or the dissolution,
merger or consolidation of the Company.
2.
Attached hereto as Exhibit B is a true and complete copy of the Bylaws of the Company, as amended through, and as in full force
and effect on, the date hereof (the “Bylaws”), and no proposal for any amendment, repeal or other modification
to the Bylaws of the Company has been taken or is currently pending before the Board of Directors or stockholders of the Company.
3.
The Board of Directors of the Company has approved the transactions contemplated by the Transaction Documents; said approval has not
been amended, rescinded or modified and remains in full force and effect as of the date hereof. Attached hereto as Exhibit C are
true, correct and complete copies of the resolutions duly adopted by the Board of Directors of the Company on [●], 2026.
4.
Each person who, as an officer of the Company, or as attorney-in-fact of an officer of the Company, signed the Transaction Documents
to which the Company is a party, was duly elected, qualified and acting as such officer or duly appointed and acting as such attorney-in-fact,
and the signature of each such person appearing on any such document is his genuine signature.
IN
WITNESS WHEREOF, I have signed my name as of the date first above written.
Name:
Title:
EXHIBIT C
COMPLIANCE
CERTIFICATE
The
undersigned, the [●] of Polar Power, Inc., a Delaware corporation (the “Company”), delivers this certificate
in connection with the Common Stock Purchase Agreement, dated as of July 27, 2026 (the “Agreement”),
by and between the Company and Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”),
and hereby certifies on the date hereof that, to the best of his knowledge after reasonable investigation, on behalf of the Company (capitalized
terms used herein without definition have the meanings assigned to them in the Agreement):
1.
The undersigned is the duly appointed [●] of the Company.
2.
Except as set forth in the attached Disclosure Schedule, the representations and warranties of the Company set forth in Article V of
the Agreement (i) that are not qualified by “materiality” or “Material Adverse Effect” are true and correct in
all material respects as of [the Commencement Date] [the date hereof] with the same force and effect as if made on [the Commencement
Date] [the date hereof], except to the extent such representations and warranties are as of another date, in which case, such representations
and warranties are true and correct in all material respects as of such other date and (ii) that are qualified by “materiality”
or “Material Adverse Effect” are true and correct as of [the Commencement Date] [the date hereof] with the same force and
effect as if made on [the Commencement Date] [the date hereof], except to the extent such representations and warranties are as of another
date, in which case, such representations and warranties are true and correct as of such other date.
3.
The Company has performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
the Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company [at or prior to Commencement][on
or prior to the date hereof].
4.
The Shares issuable in respect of each Purchase Notice effected pursuant to the Agreement shall be delivered to the Investor electronically
as DWAC Shares, and shall be freely tradable and transferable and without restriction on resale and without any stop transfer instructions
maintained against such Shares.
5.
As of [the Commencement Date][the date hereof], the Company does not possess any material non-public information.
6.
As of [the Commencement Date][the date hereof], the Company has reserved out of its authorized and unissued Common Stock, [●] shares
of Common Stock solely for the purpose of issuing Shares pursuant to Purchases effected under the Agreement.
7.
No stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus under the Securities Act has been
issued and no proceedings for such purpose or pursuant to Section 8A of the Securities Act are pending before or, to the Knowledge of
the Company, threatened by the Commission.
The
undersigned has executed this Certificate this [●] day of [●], 202[●].
By:
Name:
Title:
DISCLOSURE
SCHEDULE
RELATING
TO THE COMMON STOCK
PURCHASE
AGREEMENT, DATED AS OF July 27, 2026
BETWEEN
POLAR POWER, INC. AND ROTH PRINCIPAL INVESTMENTS, LLC
This
disclosure schedule is made and given pursuant to Article V of the Common Stock Purchase Agreement, dated as of July 27, 2026
(the “Agreement”), by and between Polar Power, Inc., a Delaware corporation (the “Company”),
and Roth Principal Investments, LLC, a Delaware limited liability company. Unless the context otherwise requires, all capitalized terms
are used herein as defined in the Agreement. The numbers below correspond to the section numbers of representations and warranties in
the Agreement most directly modified by the below exceptions.
FORM
OF OPINION OF OUTSIDE COUNSEL TO BE DELIVERED PURSUANT TO
SECTION
7.1(iv)
[Company
Counsel’s Letterhead]
Capitalized
terms herein not otherwise defined herein will have the meaning given to such terms in the Common Stock Purchase Agreement, dated
as of July 27, 2026, by and between Polar Power, Inc. and Roth Principal Investments, LLC (the “Purchase Agreement”).
1.
The
Company has been duly incorporated and is validly existing and in good standing under the laws of the State of Delaware, with full
corporate power and authority to own its properties and to conduct its business as such business is presently conducted. The Company
is duly qualified to do business as a foreign corporation and is in good standing in the State of California.
2.
The
Company has the requisite corporate power and authority to execute, deliver and perform its obligations under the Purchase Agreement
and the Registration Rights Agreement. The execution and delivery by the Company of the Purchase Agreement and the Registration Rights
Agreement, and the consummation by the Company of the transactions contemplated thereby (including, without limitation, the reservation
for issuance and the issuance of the Shares) have been duly and validly authorized by all necessary corporate action.
3.
Each
of the Purchase Agreement and the Registration Rights Agreement has been duly executed and delivered by the Company and constitutes
a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its respective terms, subject
to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’
rights and remedies generally, and subject, as to enforceability, to general principles of equity, including principles of commercial
reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).
4.
The
execution, delivery and performance by the Company of the Purchase Agreement and the Registration Rights Agreement and the consummation
by the Company of the transactions contemplated thereby (including, without limitation, the reservation for issuance and the issuance
of the Shares) do not: (i) violate the Company’s Certificate of Incorporation, as in effect as of the date hereof, or the Company’s
Bylaws, as in effect as of the date hereof (together, the “Governing Documents”); (ii) violate the Delaware
General Corporation Law, as amended (“DGCL”) or any U.S. federal, California state or New York state statute,
rule or regulation applicable to the Company; (iii) require any consents, approvals, or authorizations to be obtained by the Company,
or any registrations, declarations or filings to be made by the Company, in each case, under the DGCL or any U.S. federal, California
state or New York state statute, rule or regulation applicable to the Company that have not been obtained or made (other than any
filings required to be made by the Company after the Closing Date with the Commission in order to enable the Company to perform its
obligations under the Purchase Agreement and the Registration Rights Agreement); (iv) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument
or obligation to which the Company is a party or is bound that has been filed as an exhibit to any Commission Document filed with
the Commission prior to the date on which this opinion is given (an “Existing SEC-Filed Material Agreement”);
(v) create or impose a lien, charge or encumbrance on any property of the Company under the terms of any Existing SEC-Filed Material
Agreement; or (vi) result in a violation of any U.S. federal, California state or New York state order, judgment or decree applicable
to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries are bound or
affected.
5.
Assuming
the accuracy of the representations and warranties made by you in the Purchase Agreement, the offering, sale and issuance of the
Shares by the Company to you under the Purchase Agreement do not require registration under the Securities Act.
6.
When
issued and paid for in accordance with the Purchase Agreement, the Shares will be duly authorized and validly issued, fully paid
and non-assessable, free and clear of all liens, charges, taxes, security interests, encumbrances, rights of first refusal, preemptive
or similar rights and other encumbrances under the Governing Documents, the DGCL or any Existing SEC-Filed Material Agreement.
7.
The
execution and delivery of the Purchase Agreement and the Registration Rights Agreement by the Company do not, and the performance
by the Company of its obligations thereunder shall not, give rise to any rights of any other person that exist and are in effect
as of the date of the Closing, for the registration under the Securities Act of any shares of Common Stock or other securities of
the Company which have not been waived.
8.
We
are not representing the Company in any pending litigation in which it is a named defendant that challenges the validity or enforceability
of, or seeks to enjoin the performance of, the Purchase Agreement or the Registration Rights Agreement.
9.
The
Company is not, and after giving effect to the issuance and sale of the Shares under the Purchase Agreement and the application of
the proceeds therefrom as described in the Current Report, will not be, an “investment company,” as that term is defined
in the Investment Company Act of 1940, as amended.
FORM
OF OPINION AND NEGATIVE ASSURANCE OF OUTSIDE COUNSEL TO BE DELIVERED ON THE COMMENCEMENT DATE PURSUANT TO SECTION 7.2(xv)
[Company
Counsel’s Letterhead]
Capitalized
terms herein not otherwise defined herein will have the meaning given to such terms in the Common Stock Purchase Agreement, dated
as of July 27, 2026, by and between Polar Power, Inc. and Roth Principal Investments, LLC (the “Purchase Agreement”).
1.
Any
required filing of the Prospectus pursuant to Rule 424(b) has been made in the manner and within the time period required by such
Rule.
2.
The
statements under the caption “Description of Capital Stock” included in the Registration Statement and the Prospectus,
and under the caption “Item 14. Indemnification of Directors and Officers” included in the Registration Statement, insofar
as such statements constitute summaries of the legal matters, agreements, documents or proceedings referred to therein, fairly summarize,
in all material respects, the matters referred to therein, subject to the qualifications and assumptions stated therein.
3.
No
facts have come to our attention that cause us to believe that any of the opinions expressed in our opinion letter to you dated [●],
2026 are not true and correct as of the date hereof.
In
acting as counsel to the Company in connection with the transactions described in the first paragraph above, we have participated in
conferences with officers and other representatives of the Company, the independent public accountants for the Company, your counsel
and your representatives, at which conferences certain contents of the Registration Statement and the Prospectus and related matters
were discussed. Although we are not passing upon or assuming responsibility for the accuracy, completeness or fairness of the statements
included or incorporated by reference in or omitted from the Registration Statement or the Prospectus and have made no independent check
or verification thereof (except as provided in paragraph 2 above), based upon our participation in such conferences, we confirm to you
that the Registration Statement, as of its effective date, and the Prospectus, as of its date and as of the date hereof (except in each
case as to the financial statements, schedules and other financial and accounting data, as to which we make no comment), appeared or
appears on its face to be appropriately responsive in all material respects to the applicable requirements of the Securities Act and
Form S-1.
Furthermore,
subject to the foregoing, nothing came to our attention that caused us to believe that (i) the Registration Statement, as of its effective
date, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; or (ii) the Prospectus, as of its date or as of the date hereof, contained or contains
any untrue statement of a material fact or omitted or omits to state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided, however, that we do not express any belief
with respect to the financial statements, schedules, notes, other financial and accounting information derived therefrom, contained in
the Registration Statement or the Prospectus, as the case may be, at the respective times as of which the advisements set forth in this
paragraph are provided.
Based
solely on our review of the Commission’s EDGAR website, we advise you that the Registration Statement became effective under the
Securities Act on [●], 202[●]. In addition, based solely on our review of the information made available by the Commission
at http://www.sec.gov/litigation/stoporders.shtml, we confirm that the Commission has not issued any stop order suspending the effectiveness
of the Registration Statement, and no proceedings for that purpose are pending or, to our knowledge, have been threatened by the Commission.
FORM
OF BRING-DOWN NEGATIVE ASSURANCE LETTER TO BE DELIVERED PURSUANT TO SECTION 6.17 AND SECTION 7.3(x)
[Company
Counsel’s Letterhead]
Capitalized
terms herein not otherwise defined herein will have the meaning given to such terms in the Common Stock Purchase Agreement, dated
as of July 27, 2026, by and between Polar Power, Inc. and Roth Principal Investments, LLC (the “Purchase Agreement”).
1.
Any
required filing of the Prospectus pursuant to Rule 424(b) has been made in the manner and within the time period required by such
Rule.
2.
The
statements under the caption “Description of Capital Stock” included in the Registration Statement and the Prospectus,
and under the caption “Item 14. Indemnification of Directors and Officers” included in the Registration Statement, insofar
as such statements constitute summaries of the legal matters, agreements, documents or proceedings referred to therein, fairly summarize,
in all material respects, the matters referred to therein, subject to the qualifications and assumptions stated therein.
In
acting as counsel to the Company in connection with the transactions described in the first paragraph above, we have participated in
conferences with officers and other representatives of the Company, the independent public accountants for the Company, your counsel
and your representatives, at which conferences certain contents of the Registration Statement and the Prospectus and related matters
were discussed. Although we are not passing upon or assuming responsibility for the accuracy, completeness or fairness of the statements
included or incorporated by reference in or omitted from the Registration Statement or the Prospectus and have made no independent check
or verification thereof (except as provided in paragraph 2 above), based upon our participation in such conferences, we confirm to you
that the Registration Statement, as of its effective date, and the Prospectus, as of its date and as of the date hereof (except in each
case as to the financial statements, schedules and other financial and accounting data, as to which we make no comment), appeared or
appears on its face to be appropriately responsive in all material respects to the applicable requirements of the Securities Act and
Form S-1.
Furthermore,
subject to the foregoing, nothing came to our attention that caused us to believe that (i) the Registration Statement, as of its effective
date, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; or (ii) the Prospectus, as of its date or as of the date hereof, contained or contains
any untrue statement of a material fact or omitted or omits to state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided, however, that we do not express any belief
with respect to the financial statements, schedules, notes, other financial and accounting information derived therefrom, contained in
the Registration Statement or the Prospectus, as the case may be, at the respective times as of which the advisements set forth in this
paragraph are provided.
Based
solely on our review of the Commission’s EDGAR website, we advise you that the Registration Statement became effective under the
Securities Act on [●], 202[●]. In addition, based solely on our review of the information made available by the Commission
at http://www.sec.gov/litigation/stoporders.shtml, we confirm that the Commission has not issued any stop order suspending the effectiveness
of the Registration Statement, and no proceedings for that purpose are pending or, to our knowledge, have been threatened by the Commission.
EX-10.2
EX-10.2
Filename: ex10-2.htm · Sequence: 3
Exhibit
10.2
REGISTRATION
RIGHTS AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 27, 2026, is by and between
Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”), and Polar Power, Inc.,
a Delaware corporation (the “Company”).
RECITALS
A.
The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase
Agreement”), pursuant to which the Company may issue, from time to time, to the Investor up to the lesser of (i) $25,000,000
in aggregate gross purchase price of newly issued shares of the Company’s common stock, par value $0.0001 per share (“Common
Stock”), and (ii) the Exchange Cap (to the extent applicable under Section 3.5 of the Purchase Agreement), as provided
for therein.
B.
Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to
execute and deliver the Purchase Agreement, the Company has agreed to provide the Investor with certain registration rights with respect
to the Registrable Securities (as defined herein) as set forth herein.
AGREEMENT
NOW,
THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound
hereby, the Company and the Investor hereby agree as follows:
1.
Definitions.
Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in
this Agreement, the following terms shall have the following meanings:
(a)
“Agreement” shall have the meaning assigned to such term in the preamble of this Agreement.
(b)
“Allowable Grace Period” shall have the meaning assigned to such term in Section 3(p).
(c)
“Blue Sky Filing” shall have the meaning assigned to such term in Section 6(a).
(d)
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in New
York, New York are authorized or required by law to remain closed.
(e)
“Claims” shall have the meaning assigned to such term in Section 6(a).
(f)
“Commission” means the U.S. Securities and Exchange Commission or any successor entity.
(g)
“Common Stock” shall have the meaning assigned to such term in the recitals to this Agreement.
(h)
“Company” shall have the meaning assigned to such term in the preamble of this Agreement.
(i)
“Company Party” shall have the meaning assigned to such term in Section 6(b).
(j)
“Effective Date” means the date that the applicable Registration Statement has been declared effective by the
Commission.
(k)
“Effectiveness Deadline” means (i) with respect to the Initial Registration Statement required to be filed
pursuant to Section 2(a), the earlier of (A) the sixtieth (60th) calendar day immediately after the Filing Deadline with respect
to the Initial Registration Statement, if the Initial Registration Statement is subject to review by the Commission, and (B) if the Company
is notified (orally or in writing) by the Commission that the Initial Registration Statement will not be reviewed by the Commission,
the fifth (5th) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission
that the Initial Registration Statement will not be reviewed by the Commission, and (ii) with respect to any New Registration Statements
that may be required to be filed by the Company pursuant to this Agreement, the earlier of (A) the sixtieth (60th) calendar
day immediately after the Filing Deadline with respect to such New Registration Statement, if such New Registration Statement is subject
to review by the Commission, and (B) if the Company is notified (orally or in writing) by the Commission that such New Registration Statement
will not be reviewed by the Commission, the fifth (5th) Business Day after the date the Company is notified (orally or in
writing, whichever is earlier) by the Commission that such New Registration Statement will not be reviewed by the Commission.
(l)
“Filing Deadline” means (i) with respect to the Initial Registration Statement required to be filed pursuant
to Section 2(a), the tenth (10th) Business Day after the date of this Agreement and (ii) with respect to any New Registration
Statements that may be required to be filed by the Company pursuant to this Agreement, the tenth (10th) Business Day following
the sale of substantially all of the Registrable Securities included in the Initial Registration Statement or the most recent prior New
Registration Statement, as applicable, or such other date as permitted by the Commission.
(m)
“FINRA Filing” shall have the meaning assigned to such term in the Purchase Agreement.
(n)
“Indemnified Damages” shall have the meaning assigned to such term in Section 6(a).
(o)
“Initial Registration Statement” shall have the meaning assigned to such term in Section 2(a).
2
(p)
“Investor” shall have the meaning assigned to such term in the preamble of this Agreement.
(q)
“Investor Party” and “Investor Parties” shall have the meaning assigned to such terms in Section
6(a).
(r)
“Legal Counsel” shall have the meaning assigned to such term in Section 2(b).
(s)
“New Registration Statement” shall have the meaning assigned to such term in Section 2(c).
(t)
“Person” means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership,
limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.
(u)
“Prospectus” means the prospectus in the form included in the Registration Statement at the applicable Effective
Date of the Registration Statement, as supplemented from time to time by any Prospectus Supplement, including the documents incorporated
by reference therein.
(v)
“Prospectus Supplement” means any prospectus supplement to the Prospectus filed with the Commission from time
to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.
(w)
“Purchase Agreement” shall have the meaning assigned to such term in the recitals to this Agreement.
(x)
“register,” “registered,” and “registration” refer to a
registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant
to Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.
(y)
“Registrable Securities” means all of (i) the Shares and (ii) any capital stock of the Company issued or issuable
with respect to such Shares, including, without limitation, (1) as a result of any stock split, stock dividend, recapitalization, exchange
or similar event or otherwise and (2) shares of capital stock of the Company into which the shares of Common Stock are converted or exchanged
and shares of capital stock of a successor entity into which the shares of Common Stock are converted or exchanged, in each case until
such time as such securities cease to be Registrable Securities pursuant to Section 2(f).
(z)
“Registration Statement” means a registration statement or registration statements of the Company filed under
the Securities Act covering the resale by the Investor of Registrable Securities, as such registration statement or registration statements
may be amended and supplemented from time to time, including all documents filed as part thereof or incorporated by reference therein.
(aa)
“Registration Period” shall have the meaning assigned to such term in Section 3(a).
3
(bb)
“Rule 144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration.
(cc)
“Rule 415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on a delayed
or continuous basis.
(dd)
“Staff” shall have the meaning assigned to such term in Section 2(c).
(ee)
“Suspension” shall have the meaning assigned to such term in Section 3(g)(i).
(ff)
“Violations” shall have the meaning assigned to such term in Section 6(a).
2.
Registration.
(a)
Mandatory Registration. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,
file with the Commission the Initial Registration Statement on Form S-1 (or any successor form) covering the resale by the Investor of
the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance with applicable Commission rules,
regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor under Rule 415 under the Securities
Act at then prevailing market prices (and not fixed prices) (the “Initial Registration Statement”). The Initial
Registration Statement shall contain the “Selling Stockholder” and “Plan of Distribution” sections in substantially
the form attached hereto as Exhibit B. The Company shall use its commercially reasonable efforts to have the Initial Registration
Statement declared effective by the Commission as soon as reasonably practicable, but in no event later than the applicable Effectiveness
Deadline.
(b)
Legal Counsel. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review, solely on
its behalf, any registration pursuant to this Section 2 (“Legal Counsel”), which shall be Reed Smith LLP, or
such other counsel as thereafter designated by the Investor. Except as provided under Section 10.1(i) of the Purchase Agreement, the
Company shall have no obligation to reimburse the Investor for any and all legal fees and expenses of the Legal Counsel incurred in connection
with the transactions contemplated hereby.
(c)
Sufficient Number of Shares Registered. If at any time all Registrable Securities are not covered by the Initial Registration
Statement filed pursuant to Section 2(a) as a result of Section 2(e) or otherwise, the Company shall use its commercially reasonable
efforts to file with the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not
covered by the Initial Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of
the Commission (“Staff”) with respect to the date on which the Staff will permit such additional Registration
Statement(s) to be filed with the Commission and the rules and regulations of the Commission) (each such additional Registration Statement,
a “New Registration Statement”), but in no event later than the applicable Filing Deadline for such New Registration
Statement(s). The Company shall use its commercially reasonable efforts to cause each such New Registration Statement to become effective
as soon as reasonably practicable following the filing thereof with the Commission, but in no event later than the applicable Effectiveness
Deadline for such New Registration Statement.
4
(d)
No Inclusion of Other Securities. In no event shall the Company include any securities other than Registrable Securities on any
Registration Statement pursuant to Section 2(a) or Section 2(c); provided, however, that nothing in this Agreement shall prohibit
or restrict the Company from granting registration rights with respect to, or from filing or maintaining a separate registration statement
(other than a Registration Statement hereunder) covering the resale of, any securities issued or issuable in connection with the Permitted
Company Financings (as defined in the Purchase Agreement), so long as no such securities are included on any Registration Statement filed
pursuant to Section 2(a) or Section 2(c).
(e)
Offering. If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant
to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become effective and
be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices),
or if after the filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required by the
Staff or the Commission to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall
reduce the number of Registrable Securities to be included in such Registration Statement (after consultation with the Investor and Legal
Counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the Commission shall so permit
such Registration Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary,
if after giving effect to the actions referred to in the immediately preceding sentence, the Staff or the Commission does not permit
such Registration Statement to become effective and be used for resales by the Investor on a delayed or continuous basis under Rule 415
at then-prevailing market prices (and not fixed prices), the Company shall not request acceleration of the Effective Date of such Registration
Statement, the Company shall promptly (but in no event later than 48 hours) request the withdrawal of such Registration Statement pursuant
to Rule 477 under the Securities Act, and the Effectiveness Deadline shall automatically be deemed to have elapsed with respect to such
Registration Statement at such time as the Staff or the Commission has made a final and non-appealable determination that the Commission
will not permit such Registration Statement to be so utilized (unless prior to such time the Company has received assurances from the
Staff or the Commission that a New Registration Statement filed by the Company with the Commission promptly thereafter may be so utilized).
In the event of any reduction in Registrable Securities pursuant to this paragraph, the Company shall use its commercially reasonable
efforts to file one or more New Registration Statements with the Commission in accordance with Section 2(c) until such time as all Registrable
Securities have been included in Registration Statements that have been declared effective and the Prospectuses contained therein are
available for use by the Investor.
(f)
Any Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i) when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by the Company
or one of its Subsidiaries; and (iii) the date that is the later of (A) the first (1st) anniversary of the effective date
of termination of the Purchase Agreement in accordance with Article VIII of the Purchase Agreement and (B) the first (1st)
anniversary of the date of the last sale of any Registrable Securities by the Company to the Investor pursuant to the Purchase Agreement.
5
3.
Related Obligations.
The
Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the
intended method of disposition thereof, and, pursuant thereto, during the term of this Agreement, the Company shall have the following
obligations:
(a)
The Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant to Section 2(a) hereof and
one or more New Registration Statements pursuant to Section 2(c) hereof with respect to the Registrable Securities, but in no event later
than the applicable Filing Deadline therefor, and the Company shall use its commercially reasonable efforts to cause each such Registration
Statement to become effective as soon as practicable after such filing, but in no event later than the applicable Effectiveness Deadline
therefor. Subject to Allowable Grace Periods, the Company shall keep each Registration Statement effective (and the Prospectus contained
therein available for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at then-prevailing market prices (and
not fixed prices) at all times until the earlier of (i) the date on which the Investor shall have sold all of the Registrable Securities
covered by such Registration Statement and (ii) the date of termination of the Purchase Agreement if as of such termination date the
Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable Securities after
the date of termination of the Purchase Agreement) (the “Registration Period”). Notwithstanding anything to
the contrary contained in this Agreement (but subject to the provisions of Section 3(p) hereof), the Company shall ensure that, when
filed and at all times while effective, each Registration Statement (including, without limitation, all amendments and supplements thereto)
and the Prospectus (including, without limitation, all amendments and supplements thereto) used in connection with such Registration
Statement shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or
necessary to make the statements therein (in the case of Prospectuses, in the light of the circumstances in which they were made) not
misleading. The Company shall submit to the Commission, as soon as reasonably practicable after the date that the Company learns that
no review of a particular Registration Statement will be made by the Staff or that the Staff has no further comments on a particular
Registration Statement (as the case may be), a request for acceleration of effectiveness of such Registration Statement to a time and
date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.
6
(b)
Subject to Section 3(p) of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the Commission
such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement and the Prospectus
used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated under the
Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein current
and available for use) at all times during the Registration Period for such Registration Statement, and, during such period, comply with
the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required to be covered
by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the
intended methods of disposition by the Investor. Without limiting the generality of the foregoing, the Company covenants and agrees that
(i) at or before 8:30 a.m. (New York City time) on the Trading Day immediately following the Effective Date of the Initial Registration
Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall file with the Commission in
accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant to such Registration
Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated by any one or more Purchases are material
to the Company (individually or collectively), the material terms of which have not previously been described in the Prospectus or any
Prospectus Supplement filed with the Commission under Rule 424(b) under the Securities Act (or in any periodic report, statement, schedule
or other document filed by the Company with the Commission under the Exchange Act and incorporated by reference in the Registration Statement
and the Prospectus), or if otherwise required under the Securities Act (or the public written interpretive guidance of the Staff of the
Commission relating thereto), in each case as reasonably and mutually determined by the Company and the Investor, then, no later than
(i) 9:00 a.m., New York City time, on the Purchase Date for any such Market Open Purchase and/or Pre-Market Purchase (as applicable)
and (ii) as soon as reasonably practicable on the Purchase Date for any such Intraday Purchase(s) and/or Post-Market Purchase (as applicable),
the Company shall file with the Commission a Prospectus Supplement pursuant to Rule 424(b) under the Securities Act with respect to such
Purchase(s) requiring such filing, disclosing the total number of Shares that are to be issued and sold to the Investor pursuant to such
Purchase(s), the total Purchase Price for the Shares subject thereto, the applicable Purchase Price(s) for such Shares and the estimated
net proceeds to be received by the Company from the sale of such Shares. To the extent not previously disclosed in the Prospectus or
a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and in its Annual Reports on Form 10-K the
information described in the immediately preceding sentence relating to all Purchases effected and settled during the relevant fiscal
quarter (as applicable) and shall file such Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K with the Commission within
the applicable time period prescribed for such report under the Exchange Act. In the case of amendments and supplements to any Registration
Statement on Form S-1 or Prospectus related thereto which are required to be filed pursuant to this Agreement (including, without limitation,
pursuant to this Section 3(b)) by reason of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under
the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement and Prospectus, if applicable,
or shall promptly file such amendments or supplements to the Registration Statement or Prospectus with the Commission, for the purpose
of including or incorporating such report into such Registration Statement and Prospectus. The Company consents to the use of the Prospectus
(including, without limitation, any supplement thereto) included in each Registration Statement in accordance with the provisions of
the Securities Act and with the securities or “Blue Sky” laws of the jurisdictions in which the Registrable Securities may
be sold by the Investor, in connection with the resale of the Registrable Securities and for such period of time thereafter as such Prospectus
(including, without limitation, any supplement thereto) (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities
Act) is required by the Securities Act to be delivered in connection with resales of Registrable Securities.
7
(c)
The Company shall (A) permit Legal Counsel an opportunity to review and comment upon (i) each Registration Statement at least two (2)
Business Days prior to its filing with the Commission and (ii) all amendments and supplements to each Registration Statement (including,
without limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the contents of which is limited to that set forth
in such reports) within a reasonable number of days prior to their filing with the Commission, and (B) shall reasonably consider any
comments of the Investor and Legal Counsel on any such Registration Statement or amendment or supplement thereto or to any Prospectus
contained therein. The Company shall promptly furnish to Legal Counsel, without charge, (i) electronic copies of any correspondence from
the Commission or the Staff to the Company or its representatives relating to each Registration Statement (which correspondence shall
be redacted to exclude any material, non-public information regarding the Company or any of its Subsidiaries), (ii) after the same is
prepared and filed with the Commission, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s)
thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested
by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of the Prospectus
included in such Registration Statement and all amendments and supplements thereto; provided, however, the Company shall not be required
to furnish any document (other than the Prospectus, which may be provided in .PDF format) to Legal Counsel to the extent such document
is available on EDGAR.
(d)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without
charge, (i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration Statement
and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated
therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration Statement,
one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto (or such
other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation,
copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request from time to time in order
to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the Company shall not be required
to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the extent such document
is available on EDGAR.
(e)
The Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration and
qualification applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other
securities or “Blue Sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions,
such amendments (including, without limitation, post-effective amendments) and supplements to such registrations and qualifications as
may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably
necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all
other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in
any jurisdiction where it would not otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation
in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify
Legal Counsel and the Investor of the receipt by the Company of any notification with respect to the suspension of the registration or
qualification of any of the Registrable Securities for sale under the securities or “Blue Sky” laws of any jurisdiction in
the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.
8
(f)
The Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable
after becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain
any material, non-public information regarding the Company or any of its Subsidiaries), and, subject to Section 3(p), promptly prepare
a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct such untrue statement or omission
and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and the Investor (or such other number of copies
as Legal Counsel or the Investor may reasonably request). The Company shall also promptly notify Legal Counsel and the Investor in writing
(i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective
amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel and the Investor by facsimile
or e-mail on the same day of such effectiveness), and when the Company receives written notice from the Commission that a Registration
Statement or any post-effective amendment will be reviewed by the Commission, (ii) of any request by the Commission for amendments or
supplements to a Registration Statement or related Prospectus or related information, (iii) of the Company’s reasonable determination
that a post-effective amendment to a Registration Statement would be appropriate and (iv) of the receipt of any request by the Commission
or any other federal or state governmental authority for any additional information relating to the Registration Statement or any amendment
or supplement thereto or any related Prospectus. The Company shall also advise the Investor promptly (but in no event later than 24 hours)
and shall confirm such advice in writing of the Company becoming aware of the happening of any event, which makes any statement made
in the FINRA Filing untrue or which requires the making of any additions to or changes to the statements then made in the FINRA Filing
in order to comply with FINRA Rules 5110 and 5121. The Company shall respond as promptly as reasonably practicable to any comments received
from the Commission with respect to a Registration Statement or any amendment thereto. Nothing in this Section 3(f) shall limit any obligation
of the Company under the Purchase Agreement.
(g)
The Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued (each, a “Suspension”), to obtain the withdrawal of such order or suspension as soon as practicable
and (ii) notify Legal Counsel and the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice
of the initiation or threat of any proceeding.
(h)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in
such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or
other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made
generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company
agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.
9
(i)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts
either to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market, or (ii)
secure designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible Market.
The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(i).
(j)
The Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of Registrable
Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such denominations
or amounts (as the case may be) as the Investor may reasonably request from time to time and registered in such names as the Investor
may request. Investor hereby agrees that it shall cooperate with the Company, its counsel and its transfer agent in connection with any
issuances of DWAC Shares, and hereby represents, warrants and covenants to the Company that it will resell such DWAC Shares only pursuant
to the Registration Statement in which such DWAC Shares are included, in a manner described under the caption “Plan of Distribution”
in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations,
including, without limitation, any applicable prospectus delivery requirements of the Securities Act. At the time such DWAC Shares are
offered and sold pursuant to the Registration Statement, such DWAC Shares shall be free from all restrictive legends and may be transmitted
by the Company’s transfer agent to the Investor by crediting an account at DTC as directed in writing by the Investor.
(k)
Upon the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor
and subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information as the Investor
reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being offered or sold, the Purchase Price being paid therefor and any
other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such Prospectus
Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement or post-effective
amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained therein if reasonably requested
by the Investor.
(l)
The Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to
be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of
such Registrable Securities.
10
(m)
The Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form
complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period beginning
not later than the first day of the Company’s fiscal quarter next following the applicable Effective Date of each Registration
Statement.
(n)
The Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.
(o)
Within one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the Commission,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the Commission in substantially
the form attached hereto as Exhibit A or such form as shall be reasonably acceptable to the transfer agent.
(p)
Notwithstanding anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after
the Effective Date of a particular Registration Statement, the Company may, upon written notice to Investor, suspend Investor’s
use of any prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable
Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of Registrable
Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other similar transaction
and the Company determines in good faith that (A) the Company’s ability to pursue or consummate such a transaction would be materially
adversely affected by any required disclosure of such transaction in such Registration Statement or other registration statement or (B)
such transaction renders the Company unable to comply with Commission requirements, in each case under circumstances that would make
it impractical or inadvisable to cause any Registration Statement (or such filings) to be used by Investor or to promptly amend or supplement
any Registration Statement contemplated by this Agreement on a post effective basis, as applicable, or (y) has experienced some other
material non-public event the disclosure of which at such time, in the good faith judgment of the Company, would materially adversely
affect the Company (each, an “Allowable Grace Period”); provided, however, that in no event shall the
Investor be suspended from selling Registrable Securities pursuant to any Registration Statement for a period that exceeds twenty (20)
consecutive Trading Days or an aggregate of sixty (60) Trading Days in any 365-day period; and provided, further, the Company
shall not effect any such suspension during (A) the first ten (10) consecutive Trading Days after the Effective Date of the particular
Registration Statement or (B) the five-Trading Day period commencing on the Purchase Date for each Purchase under the Purchase Agreement.
Upon disclosure of such information or the termination of the condition described above, the Company shall provide prompt notice, but
in any event within one Business Day of such disclosure or termination, to the Investor and shall promptly terminate any suspension of
sales it has put into effect and shall take such other reasonable actions to permit registered sales of Registrable Securities as contemplated
in this Agreement (including as set forth in the first sentence of Section 3(f) with respect to the information giving rise thereto unless
such material, non-public information is no longer applicable). Notwithstanding anything to the contrary contained in this Section 3(p),
the Company shall cause its transfer agent to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the
Purchase Agreement in connection with any sale of Registrable Securities with respect to which (i) the Company has made a sale to Investor
and (ii) the Investor has entered into a contract for sale, and delivered a copy of the Prospectus included as part of the particular
Registration Statement to the extent applicable, in each case prior to the Investor’s receipt of the notice of an Allowable Grace
Period and for which the Investor has not yet settled.
11
4.
Obligations of the Investor.
(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period to
which the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor
with respect to such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of the Investor that the Investor shall furnish to the Company
such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities
held by it, as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities
and shall execute such documents in connection with such registration as the Company may reasonably request.
(b)
The Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company
in writing of the Investor’s election to exclude all of the Investor’s Registrable Securities from such Registration Statement.
(c)
The Investor agrees that, upon receipt of any notice from the Company of the occurrence of any Suspension or happening of any event of
the kind described in Section 3(p) or the first sentence of 3(f), the Investor shall immediately discontinue disposition of Registrable
Securities pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies
of the supplemented or amended Prospectus contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that
no supplement or amendment is required or notice from the Company of the withdrawal or lifting of such Suspension, as applicable. Notwithstanding
anything to the contrary in this Section 4(c), the Company shall cause its transfer agent to deliver DWAC Shares to a transferee of the
Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to
which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of the occurrence
of any Suspension or happening of any event of the kind described in Section 3(p) or the first sentence of Section 3(f) and for which
the Investor has not yet settled.
(d)
The Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.
12
5.
Expenses of Registration.
Each
party shall bear its own fees and expenses related to the transactions contemplated by this Agreement. For the avoidance of doubt, the
Company shall pay for all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of
counsel for the Company; and the Investor shall pay any sales or brokerage commissions and fees and disbursements of counsel for, and
other expenses of, the Investor incurred in connection with the registrations, filings or qualifications pursuant to Section 2 and 3,
and all U.S. federal, state and local stamp and other similar transfer and other taxes and duties levied in connection with the sale
of the Securities pursuant hereto.
6.
Indemnification.
(a)
In the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent permitted
by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, its Broker-Dealer, each of their respective
directors, officers, stockholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who
controls the Investor or its Broker-Dealer within the meaning of the Securities Act or the Exchange Act and each of the directors, officers,
stockholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an “Investor
Party” and collectively, the “Investor Parties”), against any losses, obligations, claims, damages,
liabilities, contingencies, judgments, fines, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys’
fees, costs of defense and investigation), amounts paid in settlement or expenses, joint or several, (collectively, “Claims”)
reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken
from the foregoing by or before any court or governmental, administrative or other regulatory agency, body or the Commission, whether
pending or threatened, whether or not an Investor Party is or may be a party thereto (“Indemnified Damages”),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement
or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities
or other “Blue Sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (as amended or
supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any material fact necessary to make
the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading (the matters
in the foregoing clauses (i) and (ii) being, collectively, “Violations”). Subject to Section 6(e), the Company
shall reimburse the Investor Parties, promptly as such expenses are incurred and are due and payable, for any reasonable and documented
out-of-pocket legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.
Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not
apply to a Claim by an Investor Party arising out of or based upon a Violation which occurs in reliance upon and in conformity with information
furnished in writing to the Company by such Investor Party for such Investor Party expressly for use in connection with the preparation
of such Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby
acknowledged and agreed that the written information set forth on Exhibit C attached hereto is the only written information furnished
to the Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement);
(ii) shall not be available to the Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to
be delivered the Prospectus (as amended or supplemented) made available by the Company (to the extent applicable), including, without
limitation, a corrected Prospectus, if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available
by the Company pursuant to Section 3(d) and then only if, and to the extent that, following the receipt of the corrected Prospectus no
grounds for such Claim would have existed; and (iii) shall not apply to amounts paid in settlement of any Claim if such settlement is
effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of the Investor Party and shall survive the
transfer of any of the Registrable Securities by the Investor pursuant to Section 9.
13
(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of
its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the
meaning of the Securities Act or the Exchange Act (each, a “Company Party”), against any Claim or Indemnified
Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified
Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs
in reliance upon and in conformity with written information relating to the Investor furnished to the Company by the Investor expressly
for use in connection with such Registration Statement, the Prospectus included therein or any Prospectus Supplement thereto (it being
hereby acknowledged and agreed that the written information set forth on Exhibit C attached hereto is the only written information
furnished to the Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement);
and, subject to Section 6(e) and the below provisos in this Section 6(b), the Investor shall reimburse a Company Party any reasonable,
documented out-of-pocket legal or other expenses reasonably incurred by such Company Party in connection with investigating or defending
any such Claim; provided, however, the indemnity agreement contained in this Section 6(b) and the agreement with respect
to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Investor, which consent shall not be unreasonably withheld or delayed; and provided, further
that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the
net proceeds to the Investor as a result of the applicable sale of Registrable Securities pursuant to such Registration Statement, Prospectus
or Prospectus Supplement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of
such Company Party and shall survive the transfer of any of the Registrable Securities by the Investor pursuant to Section 9.
(c)
Promptly after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section
6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to
assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company
Party (as the case may be); provided, however, an Investor Party or Company Party (as the case may be) shall have the right
to retain its own counsel with the reasonable and documented out-of-pocket fees and expenses of such counsel to be paid by the indemnifying
party if: (i) the indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed
promptly to assume the defense of such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company Party (as
the case may be) in any such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties)
include both such Investor Party or Company Party (as the case may be) and the indemnifying party, and such Investor Party or such Company
Party (as the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were
to represent such Investor Party or such Company Party and the indemnifying party (in which case, if such Investor Party or such Company
Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the
indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof on behalf of the indemnified party
and such counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii) above the
indemnifying party shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for all
Investor Parties or Company Parties (as the case may be). The Company Party or Investor Party (as the case may be) shall reasonably cooperate
with the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall
furnish to the indemnifying party all information reasonably available to the Company Party or Investor Party (as the case may be) which
relates to such action or Claim. The indemnifying party shall keep the Company Party or Investor Party (as the case may be) reasonably
apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall
be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however,
the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Company Party
or Investor Party (as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall
not include any admission as to fault on the part of the Company Party. For the avoidance of doubt, the immediately preceding sentence
shall apply to Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated
to all rights of the Company Party or Investor Party (as the case may be) with respect to all third parties, firms or corporations relating
to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Investor Party or Company
Party (as the case may be) under this Section 6, except to the extent that the indemnifying party is materially and adversely prejudiced
in its ability to defend such action.
14
(d)
No Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale
of Registrable Securities who is not guilty of fraudulent misrepresentation.
(e)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred; provided that any Person receiving any payment
pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such payment to the extent a court
of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.
(f)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Company
Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.
7.
Contribution.
To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for
indemnification under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable
Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection
with such sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of
fraudulent misrepresentation; and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount
of net proceeds received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement.
Notwithstanding the provisions of this Section 7, the Investor shall not be required to contribute, in the aggregate, any amount in excess
of the amount by which the net proceeds actually received by the Investor from the applicable sale of the Registrable Securities subject
to the Claim exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise be required to
pay under Section 6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission.
8.
Reports Under the Exchange Act.
With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to:
(a)
use its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule
144;
15
(b)
use its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood
that nothing herein shall limit any of the Company’s obligations under the Purchase Agreement) and the filing of such reports and
other documents is required for the applicable provisions of Rule 144;
(c)
furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the Commission
if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor
to sell such securities pursuant to Rule 144 without registration; and
(d)
take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant
to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions
to the Company’s transfer agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate
with Investor and Investor’s broker to effect such sale of securities pursuant to Rule 144.
9.
Assignment of Registration Rights.
Neither
the Company nor the Investor shall assign this Agreement or any of their respective rights or obligations hereunder; provided,
however, that any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby
the Company remains the surviving entity immediately after such transaction shall not be deemed an assignment.
10.
Amendment or Waiver.
No
provision of this Agreement may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately preceding
the date on which the Initial Registration Statement is initially filed with the Commission. Subject to the immediately preceding sentence,
no provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other
than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise
any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a
waiver thereof.
11.
Miscellaneous.
(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed
to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.
16
(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.
(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity
of showing economic loss and without any bond or other security being required), this being in addition to any other remedy to which
either party may be entitled by law or equity.
(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any law or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits
to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR
IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.
(e)
The Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersede all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject
matter hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without
implication that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner
whatsoever (i) the conditions precedent to a Purchase contained in Article VII of the Purchase Agreement or (ii) any of the Company’s
obligations under the Purchase Agreement.
17
(f)
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is
not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in Sections 6 and 7 hereof.
(g)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.
(h)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.
(i)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(j)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.
[Signature
Pages Follow]
18
IN
WITNESS WHEREOF, Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be
duly executed as of the date first written above.
THE
COMPANY:
POLAR
POWER, INC.
By:
/s/
Arthur D. Sams
Name:
Arthur
D. Sams
Title:
Chief
Executive Officer
19
IN
WITNESS WHEREOF, Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be
duly executed as of the date first written above.
THE
INVESTOR:
ROTH
PRINCIPAL INVESTMENTS, LLC
By:
/s/
Joe Tonnos
Name:
Joe
Tonnos
Title:
Co-President
20
EXHIBIT
A
FORM
OF NOTICE OF EFFECTIVENESS
OF REGISTRATION STATEMENT
[●]
[●]
[●]
Re:
Polar Power, Inc.
Ladies
and Gentlemen:
We
have acted as counsel to Polar Power, Inc., a Delaware corporation (the “Company”), in connection with that
certain Common Stock Purchase Agreement, dated as of July 27, 2026 (the “Purchase Agreement”), entered
into by and between the Company and the Investor named therein (the “Holder”), pursuant to which the Company
has issued and may issue to the Holder from time to time shares of the Company’s common stock, par value $0.0001 per share (the
“Common Stock”). Pursuant to the Purchase Agreement, the Company also has entered into a Registration Rights
Agreement, dated as of July 27, 2026, with the Holder (the “Registration Rights Agreement”), pursuant
to which the Company agreed, among other things, to register the offer and sale by the Holder of the Registrable Securities (as defined
in the Registration Rights Agreement) under the Securities Act of 1933, as amended (the “Securities Act”).
In connection with the Company’s obligations under the Registration Rights Agreement, on [●], 2026, the Company filed a Registration
Statement on Form S-1 (File No. 333-[●]) (the “Registration Statement”) with the Securities and Exchange
Commission (the “Commission”) relating to the resale by the holder of Registrable Securities and which names
the Holder as an underwriter and a selling stockholder thereunder.
In
connection with the foregoing, we advise you that the Registration Statement has become effective under the Securities Act; and no stop
order suspending its effectiveness has been issued and no proceedings for that purpose are pending or threatened by the Commission. The
statement with respect to effectiveness of the Registration Statement under the Securities Act is based solely on the Notice of Effectiveness
relating to the Registration Statement issued by the Commission or published by the Commission on its website, as applicable. The statement
with respect to no stop order suspending the effectiveness of the Registration Statement having been issued and no proceedings for that
purpose being pending or threatened by the Commission is based solely on the review, by lawyers in our firm actively engaged in our representation
of the Company in this matter, of the Commission’s “Stop Orders” web page (http://www.sec.gov/litigation/stoporders.shtml)
at [●], Eastern Time, on the date hereof.
This
letter is limited in all respects to the federal securities laws of the United States of America. We express no opinion as to matters
relating to state securities laws or Blue Sky laws.
We
assume no obligation to update this letter with respect to matters occurring subsequent to the date hereof.
This
letter is addressed to you and is solely for your benefit and made only in connection with the transactions contemplated by the Registration
Rights Agreement. This letter may not be relied upon by you for any other purpose or furnished to, circulated, quoted or relied upon
by any other person or entity other than you for any purpose without our prior written consent solely for the benefit of the person to
whom it is addressed; accordingly, it may not be quoted, filed with any governmental authority or other regulatory agency or otherwise
circulated or utilized for any purposes without our prior written consent.
Very truly yours,
[ISSUER’S COUNSEL]
By:
cc:
Roth Principal Investments, LLC
EXHIBIT
B
SELLING
STOCKHOLDER
This
prospectus relates to the offer and sale by Roth Principal Investments of up to 18,341,893 shares of our common stock that may
be issued by us to Roth Principal Investments under the Purchase Agreement. For additional information regarding the shares of our common
stock included in this prospectus, see the section titled “The Committed Equity Facility” above. We are registering
the shares of our common stock included in this prospectus pursuant to the provisions of the Registration Rights Agreement we entered
into with Roth Principal Investments on July 27, 2026 in order to permit the Selling Stockholder to offer the shares of common
stock included in this prospectus for resale from time to time. Except for the transactions contemplated by the Purchase Agreement and
the Registration Rights Agreement and as set forth in the section titled “Plan of Distribution (Conflict of Interest)”
in this prospectus, Roth Principal Investments has not had any material relationship with us within the past three years. As used in
this prospectus, the term “Selling Stockholder” means Roth Principal Investments, LLC.
The
table below presents information regarding the Selling Stockholder and the shares of our common stock that may be resold by the Selling
Stockholder from time to time under this prospectus. This table is prepared based on information supplied to us by the Selling Stockholder,
and reflects holdings as of [●], 2026. The number of shares in the column “Maximum Number of Shares of common stock to be
Offered Pursuant to this Prospectus” represents all of the shares of our common stock being offered for resale by the Selling Stockholder
under this prospectus. The Selling Stockholder may sell some, all or none of the shares of common stock being offered for resale in this
offering. We do not know how long the Selling Stockholder will hold the shares before selling them and, except as set forth in the section
titled “Plan of Distribution (Conflict of Interest)” in this prospectus, we are not aware of any existing arrangements
between the Selling Stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution
of the shares of our common stock being offered for resale by this prospectus.
Beneficial
ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of our common
stock with respect to which the Selling Stockholder has sole or shared voting and investment power. Because the Purchase Price to be
paid by the Selling Stockholder for shares of our common stock, if any, that we may elect to sell to the Selling Stockholder in one or
more Purchases from time to time under the Purchase Agreement will be determined on the applicable Purchase Dates therefor, the actual
number of shares of our common stock that we may sell to the Selling Stockholder under the Purchase Agreement may be fewer than the number
of shares being offered for resale under this prospectus. The fourth column assumes the resale by the Selling Stockholder of all of the
shares of our common stock being offered for resale pursuant to this prospectus.
Name
of Selling Stockholder
Number
of Shares of
Common Stock Owned
Prior to Offering
Maximum Number
of
Shares of
Common
Stock to be
Offered Pursuant
to this Prospectus
Number of Shares of
Common Stock Owned
After Offering
Number(1)
Percent
Number(2)
Percent
Roth Principal
Investments, LLC(3)
0
—
[●]
0
—
(1)
In
accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares of common stock beneficially owned
prior to the offering all of the shares of common stock that Roth Principal Investments may be required to purchase under the Purchase
Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase
Agreement, the satisfaction of which are entirely outside of Roth Principal Investments’ control, including the registration
statement that includes this prospectus becoming and remaining effective. Furthermore, the Purchases of common stock under the Purchase
Agreement are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement
prohibits us from issuing and selling any shares of common stock to Roth Principal Investments to the extent such shares, when aggregated
with all other shares of common stock then beneficially owned by Roth Principal Investments, would cause Roth Principal Investments’
beneficial ownership of our common stock to exceed the 4.99% Beneficial Ownership Limitation. The Purchase Agreement also prohibits
us from issuing or selling shares of our common stock under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we
obtain stockholder approval to do so, or unless the average price for all shares of our common stock purchased by Roth Principal
Investments under the Purchase Agreement equals or exceeds $[2.0994] per share, such that the Exchange Cap limitation would
not apply under applicable Nasdaq rules. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable
under Nasdaq) may be amended or waived under the Purchase Agreement.
(2)
Assumes
the sale of all shares of common stock being offered pursuant to this prospectus.
(3)
The
business address of Roth Principal Investments, LLC (“Roth Principal Investments”) is 2340 Collins Avenue, Suite 402,
Miami Beach, Florida 33139. The principal business of Roth Principal Investments is that of a private investor. Roth Principal Investments
is a wholly owned subsidiary of CR Financial Holdings, Inc. (“CRFH”). CRFH expressly disclaims beneficial ownership of
securities held of record by Roth Principal Investments, except to the extent of its pecuniary interest therein. All voting and investment
decisions with respect to securities held of record by Roth Principal Investments are made by majority vote of an investment policy
committee of Roth Principal Investments composed of five individuals, each of whom is not involved in the management of CRFH and
at least three of whom are not affiliates or associated persons of Roth Capital Partners, LLC (“RCP”), a registered broker-dealer
and member of the Financial Industry Regulatory Authority, Inc. (“FINRA”), and a wholly owned subsidiary of CRFH. We
have been advised that neither CRFH nor Roth Principal Investments is a FINRA member or an independent broker-dealer. Because each
of Roth Principal Investments and RCP is a wholly owned subsidiary of CRFH, Roth Principal Investments is deemed to be an affiliate
of RCP. RCP will act as an executing broker that will effectuate resales of our common stock that may be acquired by Roth Principal
Investments from us pursuant to the Purchase Agreement to the public in this offering. See “Plan of Distribution (Conflict
of Interest)” for more information about the relationship between Roth Principal Investments and RCP.
PLAN
OF DISTRIBUTION (CONFLICT OF INTEREST)
EXHIBIT
C
The
business address of Roth Principal Investments, LLC (“Roth Principal Investments”) is 2340 Collins Avenue, Suite 402, Miami
Beach, Florida 33139. The principal business of Roth Principal Investments is that of a private investor. Roth Principal Investments
is a wholly owned subsidiary of CR Financial Holdings, Inc. (“CRFH”). CRFH expressly disclaims beneficial ownership of securities
held of record by Roth Principal Investments, except to the extent of its pecuniary interest therein. All voting and investment decisions
with respect to securities held of record by Roth Principal Investments are made by majority vote of an investment policy committee of
Roth Principal Investments composed of five individuals, each of whom is not involved in the management of CRFH and at least three of
whom are not affiliates or associated persons of Roth Capital Partners, LLC (“RCP”), a registered broker-dealer and member
of the Financial Industry Regulatory Authority, Inc. (“FINRA”), and a wholly owned subsidiary of CRFH. Neither CRFH nor Roth
Principal Investments is a FINRA member or an independent broker-dealer. Because each of Roth Principal Investments and RCP is a wholly
owned subsidiary of CRFH, Roth Principal Investments is deemed to be an affiliate of RCP. RCP will act as an executing broker that will
effectuate resales of common stock that may be acquired by Roth Principal Investments from the Company pursuant to the Purchase Agreement
to the public in this offering.
EX-99.1
EX-99.1
Filename: ex99-1.htm · Sequence: 4
Exhibit
99.1
Polar
Power Secures Up to $25 Million Committed Equity Facility to Support Growth
Facility
Expected to Provide Access to Additional Working Capital and to Support
Continued Growth of the Company’s DC Power Systems Business, Including Data-Center Power and Cooling and Drone-Charging Systems
GARDENA,
Calif., July 27, 2026 – Polar
Power, Inc. (NASDAQ: POLA) (“Polar Power” or the “Company”), a global provider of DC power systems for telecommunications,
military, EV charging, micro/nano grids, and other applications, today announced that it has entered into a Committed Equity Facility
(“CEF”) with Roth Principal Investments, LLC (“RPI”), an affiliate of CR Financial Holdings, Inc., the holding
company for Roth Capital Partners.
The
CEF allows, but does not obligate, Polar Power to issue and sell up to $25 million of its shares of common stock to RPI, at the
Company’s discretion and subject to certain conditions set forth in the CEF agreement, following the filing and effectiveness of
a registration statement registering the resale of such shares. Polar Power intends to use any net proceeds for working capital and general
corporate purposes, including continued development and growth of its DC power systems business. The Company may access capital opportunistically
over time and is under no obligation to utilize the full amount available under the facility. The Company may not be able to sell the
full $25 million of shares available under the facility due to limitations, including the number of shares registered for resale and
applicable Nasdaq rules. Sales of common stock under the facility, if any, are expected to be made at prices based on the prevailing
market price of the common stock at the time of sale, and such sales, together with the resale of shares by RPI, may be dilutive to the
Company’s existing stockholders.
“We
are pleased to have entered into this Committed Equity Facility, which is intended to provide additional financial and working
capital flexibility to support the continued growth of our DC power systems business. Building on our proven DC power technology, we
have expanded into new markets—including charging systems for drones, micro/nano grids, EV charging, robotics, and power and cooling
solutions for data centers—and this facility is intended to provide added flexibility to pursue these markets,” stated Arthur
D. Sams, President and Chief Executive Officer of Polar Power.
This
press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale
of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification
under the securities laws of such jurisdiction. The Company intends to file a registration statement with the SEC to register the resale
of the shares issuable under the CEF. These securities may not be sold until that registration statement is filed and becomes effective.
Forward
Looking Statements
This
press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the “safe harbor” created by
those sections. All statements in this release that are not based on historical fact are “forward-looking statements.” These
statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,”
“strategy,” “goal,” or “planned,” “seeks,” “may,” “might”, “will,”
“expects,” “intends,” “believes,” “would,” “should,” and similar expressions,
or the negative versions thereof, and which also may be identified by their context. All statements that address availability of capital,
Polar Power’s potential use of the CEF, including the use of proceeds, and anticipated demand for Polar Power’s DC power
systems that are not otherwise historical facts, are forward-looking statements.
Forward-looking
statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Actual results
and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety
of factors. These factors include, but are not limited to, anticipated use of the CEF, the ability to use the CEF, Polar Power’s ability
to sell its DC power systems and other risks, including the risks discussed in Polar Power’s Securities and Exchange Commission
filings. Polar Power undertakes no obligation to update publicly any forward-looking statement for any reason, except as required by
law, even as new information becomes available or other events occur in the future.
About
Polar Power, Inc.
Polar
Power, Inc. (NASDAQ: POLA) designs, manufactures and sells direct current, or DC, power systems for telecommunications, military, automotive,
industrial and other applications. Polar Power’s systems provide reliable, low-cost prime and backup power for applications requiring
high reliability and low maintenance. The Company has also expanded its product portfolio to include power and cooling systems for data
centers, as well as charging systems for drones. For additional information, please visit www.polarpower.com.
Polar
Power and the Polar Power logo are trademarks of Polar Power, Inc. in the U.S. and/or other countries.
Company
Contact:
Arthur
D. Sams, President and CEO
Polar Power, Inc.
P: (310) 830-9153
E: ir@polarpower.com
Investor
Relations Contact
Polar
Power, Inc.
Investor
Relations
P:
(310) 830-9153
E:
ir@polarpower.com
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 20
v3.26.1
Cover
Jul. 27, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Jul. 27, 2026
Entity File Number
001-37960
Entity Registrant Name
Polar
Power, Inc.
Entity Central Index Key
0001622345
Entity Tax Identification Number
33-0479020
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
249
East Gardena Boulevard
Entity Address, City or Town
Gardena
Entity Address, State or Province
CA
Entity Address, Postal Zip Code
90248
City Area Code
(310)
Local Phone Number
830-9153
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, par value
$0.0001 per share
Trading Symbol
POLA
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration